CCC Intelligent Solutions (CCCS) 10-K25 Feb 252024 FY Annual reportFinancial data

Company Profile

Cover Page

Cover Page - USD ($) $ in Millions	12 Months Ended
Cover Page - USD ($) $ in Millions	Dec. 31, 2024	Feb. 18, 2025	Jun. 30, 2024
Document Information [Line Items]
Document Type	10-K
Amendment Flag	false
Document Period End Date	Dec. 31, 2024
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	FY
Current Fiscal Year End Date	--12-31
Entity Registrant Name	CCC Intelligent Solutions Holdings Inc.
Entity Central Index Key	0001818201
Entity File Number	001-39447
Entity Current Reporting Status	Yes
Entity Filer Category	Large Accelerated Filer
Entity Interactive Data Current	Yes
Entity Shell Company	false
Entity Small Business	false
Entity Emerging Growth Company	false
Document Annual Report	true
Document Transition Report	false
Entity Tax Identification Number	98-1546280
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	167 N. Green Street
Entity Address, Address Line Two	9th Floor
Entity Address, City or Town	Chicago
Entity Address, State or Province	IL
Entity Address, Postal Zip Code	60607
City Area Code	800
Local Phone Number	621-8070
Entity Common Stock, Shares Outstanding		656,781,611
Title of 12(b) Security	Common stock, par value $0.0001 per share
Trading Symbol	CCCS
Security Exchange Name	NASDAQ
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Public Float			$ 4,483
ICFR Auditor Attestation Flag	true
Auditor Name	Deloitte & Touche LLP
Auditor Firm ID	34
Auditor Location	Chicago, IL
Document Financial Statement Error Correction [Flag]	false
Documents Incorporated by Reference [Text Block]	Our definitive proxy statement relating to our 2025 annual meeting of shareholders will be filed with the Securities and Exchange Commission within 120 days after the close of our fiscal year ended December 31, 2024 and is incorporated by reference in Part III to the extent described therein.
Auditor Opinion	Opinion on the Financial Statements We have audited the accompanying consolidated balance sheets of CCC Intelligent Solutions Holdings Inc. and subsidiaries (the "Company") as of December 31, 2024 and 2023, the related consolidated statements of operations and comprehensive income (loss), mezzanine equity and stockholders' equity, and cash flows, for each of the three years in the period ended December 31, 2024, and the related notes (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2024 and 2023, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2024, in conformity with accounting principles generally accepted in the United States of America. We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial reporting as of December 31, 2024, based on criteria established in Internal Control — Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission and our report dated February 25, 2025, expressed an unqualified opinion on the Company's internal control over financial reporting.

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
CURRENT ASSETS:
Cash and cash equivalents	$ 398,983	$ 195,572
Accounts receivable - Net of allowances of $4,692 and $5,574 as of December 31, 2024 and 2023, respectively	106,578	102,365
Income taxes receivable	7,743	1,798
Deferred contract costs	22,373	17,900
Other current assets	28,973	32,364
Total current assets	564,650	349,999
SOFTWARE, EQUIPMENT, AND PROPERTY—Net	172,079	160,416
OPERATING LEASE ASSETS	29,762	30,456
INTANGIBLE ASSETS—Net	934,278	1,015,046
GOODWILL	1,417,724	1,417,724
DEFERRED FINANCING FEES, REVOLVER—Net	1,743	1,672
DEFERRED CONTRACT COSTS	18,692	22,302
EQUITY METHOD INVESTMENT	10,228	10,228
OTHER ASSETS	34,062	43,197
TOTAL	3,183,218	3,051,040
CURRENT LIABILITIES:
Accounts payable	18,393	16,324
Accrued expenses	72,543	71,478
Income taxes payable	80	3,689
Current portion of long-term debt	8,000	8,000
Current portion of long-term licensing agreement—Net	3,257	3,061
Operating lease liabilities	7,658	6,788
Deferred revenues	44,915	43,567
Total current liabilities	154,846	152,907
LONG-TERM DEBT - Net	761,053	767,504
DEFERRED INCOME TAXES—Net	164,844	195,365
LONG-TERM LICENSING AGREEMENT—Net	24,435	27,692
OPERATING LEASE LIABILITIES	47,235	50,796
WARRANT LIABILITIES	0	51,501
OTHER LIABILITIES	11,303	6,414
Total liabilities	1,163,716	1,252,179
COMMITMENTS AND CONTINGENCIES (Notes 22 and 23)
MEZZANINE EQUITY:
Redeemable non-controlling interest	21,679	16,584
STOCKHOLDERS' EQUITY:
Preferred stock, $0.0001 par; 100,000,000 shares authorized; no shares issued or outstanding	0	0
Common stock - $0.0001 par; 5,000,000,000 shares authorized; 629,207,115 and 603,128,781 shares issued and outstanding at December 31, 2024 and 2023, respectively	63	60
Additional paid-in capital	3,094,182	2,909,757
Accumulated deficit	(1,095,227)	(1,126,467)
Accumulated other comprehensive loss	(1,195)	(1,073)
Total stockholders' equity	1,997,823	1,782,277
TOTAL	$ 3,183,218	$ 3,051,040

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Statement of Financial Position [Abstract]
Allowances for doubtful accounts receivable current	$ 4,692	$ 5,574
Preferred Stock, Par or Stated Value Per Share	$ 0.0001	$ 0.0001
Preferred Stock, Shares Authorized	100,000,000	100,000,000
Preferred Stock, Shares Issued	0	0
Preferred Stock, Shares Outstanding	0	0
Common Stock, Par or Stated Value Per Share	$ 0.0001	$ 0.0001
Common Stock, Shares Authorized	5,000,000,000	5,000,000,000
Common Stock, Shares, Issued	629,207,115	603,128,781
Common Stock, Shares, Outstanding	629,207,115	603,128,781

Consolidated Statements of Oper

Consolidated Statements of Operations and Comprehensive Income (Loss) - USD ($)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Statement of Comprehensive Income
REVENUES	$ 944,800,000	$ 866,378,000	$ 782,448,000
COST OF REVENUES
Cost of revenues, exclusive of amortization and impairment of acquired technologies	221,997,000	203,324,000	187,001,000
Amortization of acquired technologies	9,000,000	26,464,000	26,938,000
Impairment of acquired technologies	0	431,000	0
Total cost of revenues	230,997,000	230,219,000	213,939,000
GROSS PROFIT	713,803,000	636,159,000	568,509,000
OPERATING EXPENSES:
Research and development	201,493,000	173,106,000	156,957,000
Selling and marketing	142,217,000	140,851,000	119,594,000
General and administrative	218,220,000	191,844,000	167,758,000
Amortization of intangible assets	71,768,000	71,972,000	72,278,000
Impairment of goodwill	0	77,405,000	0
Impairment of intangible assets	0	4,906,000	0
Total operating expenses	633,698,000	660,084,000	516,587,000
OPERATING INCOME (LOSS)	80,105,000	(23,925,000)	51,922,000
INTEREST EXPENSE	(64,608,000)	(63,577,000)	(38,990,000)
INTEREST INCOME	12,203,000	16,252,000	908,000
CHANGE IN FAIR VALUE OF WARRANT LIABILITIES	14,378,000	(15,096,000)	26,073,000
GAIN ON SALE OF COST METHOD INVESTMENT	0	0	3,587,000
OTHER INCOME — Net	2,236,000	1,799,000	6,362,000
PRETAX INCOME (LOSS)	44,314,000	(84,547,000)	49,862,000
INCOME TAX PROVISION	(13,074,000)	(5,524,000)	(11,456,000)
NET INCOME (LOSS) INCLUDING NON-CONTROLLING INTEREST	31,240,000	(90,071,000)	38,406,000
LESS: ACCRETION OF REDEEMABLE NON-CONTROLLING INTEREST	(5,095,000)	(2,405,000)	0
NET INCOME (LOSS) ATTRIBUTABLE TO CCC INTELLIGENT SOLUTIONS HOLDINGS INC.'s COMMON STOCKHOLDERS	$ 26,145,000	$ (92,476,000)	$ 38,406,000
Net income (loss) per share attributable to common stockholders:
Basic	$ 0.04	$ (0.15)	$ 0.06
Diluted	$ 0.04	$ (0.15)	$ 0.06
Weighted-average shares used in computing net income (loss) per share attributable to common stockholders:
Basic	610,761,424	617,889,384	607,760,886
Diluted	641,875,525	617,889,384	642,841,596
COMPREHENSIVE INCOME (LOSS):
Net income (loss) including non-controlling interest	$ 31,240,000	$ (90,071,000)	$ 38,406,000
Other comprehensive loss - Foreign currency translation adjustment	(122,000)	(189,000)	(569,000)
COMPREHENSIVE INCOME (LOSS) INCLUDING NON-CONTROLLING INTEREST	31,118,000	(90,260,000)	37,837,000
Less: accretion of redeemable non-controlling interest	(5,095,000)	(2,405,000)	0
COMPREHENSIVE INCOME (LOSS) ATTRIBUTABLE TO CCC INTELLIGENT SOLUTIONS HOLDINGS INC. COMMON STOCKHOLDERS	$ 26,023,000	$ (92,665,000)	$ 37,837,000

Consolidated Statements of Mezz

Consolidated Statements of Mezzanine Equity and Stockholders' Equity - USD ($) $ in Thousands	Total	Redeemable Non-Controlling Interest [Member]	Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]	Accumulated Other Comprehensive Loss [Member]
Redeemable Non-Controlling Interest, Beginning balance at Dec. 31, 2021	$ 14,179	$ 14,179
Beginning balance at Dec. 31, 2021	1,872,318		$ 0	$ 61	$ 2,618,924	$ (746,352)	$ (315)
Beginning balance, Shares at Dec. 31, 2021			0	609,768,296
Stock-based compensation expense	109,387				109,387
Exercise of stock options—net of tax	27,563			$ 1	27,562
Exercise of stock options—net of tax , Shares				10,074,354
Exercise of warrants-Net, Shares				1,246
Issuance of common stock under employee stock purchase plan	3,197				3,197
Issuance of common stock under employee stock purchase plan, Shares				408,879
Issuance of common stock upon vesting of RSUs-net of tax	(5,015)				(5,015)
Issuance of common stock upon vesting of RSUs-net of tax, Shares				1,820,130
Accretion of redeemable non-controlling interest	0
Accretion of redeemable non-controlling interest	0
Foreign currency translation adjustment	(569)						(569)
Net income (loss)	38,406					38,406
Redeemable Non-Controlling Interest, Ending balance at Dec. 31, 2022	14,179	14,179
Ending balance at Dec. 31, 2022	2,045,287		$ 0	$ 62	2,754,055	(707,946)	(884)
Ending balance, Shares at Dec. 31, 2022			0	622,072,905
Stock-based compensation expense	144,628				144,628
Exercise of stock options—net of tax	25,434			$ 1	25,433
Exercise of stock options—net of tax , Shares				8,923,718
Issuance of common stock under employee stock purchase plan	4,761				4,761
Issuance of common stock under employee stock purchase plan, Shares				641,691
Issuance of common stock upon vesting of RSUs-net of tax	(16,715)				(16,715)
Issuance of common stock upon vesting of RSUs-net of tax, Shares				3,990,467
Repurchase and retirement of common stock	(328,453)			$ (3)		(328,450)
Repurchase and retirement of common stock, Shares				(32,500,000)
Accretion of redeemable non-controlling interest	2,405	2,405
Accretion of redeemable non-controlling interest	(2,405)				(2,405)
Foreign currency translation adjustment	(189)						(189)
Net income (loss)	(90,071)					(90,071)
Redeemable Non-Controlling Interest, Ending balance at Dec. 31, 2023	16,584	16,584
Ending balance at Dec. 31, 2023	$ 1,782,277		$ 0	$ 60	2,909,757	(1,126,467)	(1,073)
Ending balance, Shares at Dec. 31, 2023			0	603,128,781
Issuance of common stock, Shares	171,500,000
Stock-based compensation expense	$ 171,038				171,038
Stock-based compensation expense, Shares				0
Exercise of stock options—net of tax	33,444			$ 2	33,442
Exercise of stock options—net of tax , Shares				12,427,044
Issuance of common stock under employee stock purchase plan	5,745				5,745
Warrant Redemption Shares				3,809,200
Warrant Redemption Value	37,122				37,122
Issuance of common stock under employee stock purchase plan, Shares				608,891
Issuance of common stock upon vesting of RSUs-net of tax	(57,826)			$ 1	(57,827)
Issuance of common stock upon vesting of RSUs-net of tax, Shares				9,233,199
Accretion of redeemable non-controlling interest	5,095	5,095
Accretion of redeemable non-controlling interest	(5,095)				(5,095)
Foreign currency translation adjustment	(122)						(122)
Net income (loss)	31,240					31,240
Redeemable Non-Controlling Interest, Ending balance at Dec. 31, 2024	21,679	$ 21,679
Ending balance at Dec. 31, 2024	$ 1,997,823			$ 63	$ 3,094,182	$ (1,095,227)	$ (1,195)
Ending balance, Shares at Dec. 31, 2024				629,207,115

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss)	$ 31,240	$ (90,071)	$ 38,406
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization of software, equipment, and property	42,908	36,902	27,933
Amortization of intangible assets	80,768	98,436	99,216
Impairment of goodwill and intangible assets	0	82,742	0
Deferred income taxes	(30,521)	(46,333)	(34,401)
Stock-based compensation	171,038	144,518	109,497
Amortization of deferred financing fees	1,871	1,753	1,878
Amortization of discount on debt	261	233	257
Change in fair value of derivative instruments	5,233	5,743	(5,663)
Change in fair value of warrant liabilities	(14,378)	15,096	(26,073)
Change in fair value of estimated contingent consideration	(100)	0	(100)
Non-cash lease expense	0	1,232	3,697
Gain on sale of cost method investment	0	0	(3,587)
Loss on disposal of software, equipment and property	302	79	2,651
Other	221	620	104
Changes in:
Accounts receivable—Net	(4,196)	(4,001)	(19,844)
Deferred contract costs	(4,473)	(1,344)	(1,487)
Other current assets	4,319	4,046	9,792
Deferred contract costs—Non-current	3,610	(2,141)	1,956
Other assets	2,771	(3,649)	(14,501)
Operating lease assets	2,301	1,186	3,448
Income taxes	(7,147)	4,984	(10,018)
Accounts payable	2,070	(11,270)	15,516
Accrued expenses	797	1,041	4,592
Operating lease liabilities	(4,298)	(2,145)	(7,241)
Deferred revenues	1,355	8,321	4,196
Other liabilities	(2,066)	4,055	(317)
Net cash provided by operating activities	283,886	250,033	199,907
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of software, equipment, and property	(53,012)	(55,032)	(47,951)
Proceeds from sale of cost method investment	0	0	3,901
Acquisition of Safekeep, Inc., net of cash	0	0	(32,242)
Net cash used in investing activities	(53,012)	(55,032)	(76,292)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from exercise of stock options	33,506	25,381	27,693
Proceeds from employee stock purchase plan	5,745	4,761	3,197
Principal payments on long-term debt	(8,000)	(8,000)	(8,000)
Payments for employee taxes withheld upon vesting of equity awards	(57,826)	(16,715)	(5,015)
Payment of fees associated with the revolver debt modification	(719)	0	0
Repurchase of common stock	0	(328,453)	0
Net cash (used in) provided by financing activities	(27,294)	(323,026)	17,875
NET EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS	(169)	(191)	(246)
NET CHANGE IN CASH AND CASH EQUIVALENTS	203,411	(128,216)	141,244
Beginning of period	195,572	323,788	182,544
End of period	398,983	195,572	323,788
NONCASH INVESTING AND FINANCING ACTIVITIES:
Noncash purchases of software, equipment, and property	7,154	2,044	100
Fair value of redeemed private warrants	37,122	0	0
Contingent consideration related to business acquisition	0	0	200
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:
Cash paid for interest	62,898	61,367	36,636
Cash paid for income taxes-Net	$ 50,742	$ 42,948	$ 55,697

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	12 Months Ended
Pay vs Performance Disclosure - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Pay vs Performance Disclosure
Net Income (Loss)	$ 31,240	$ (90,071)	$ 38,406

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
Insider Trading Arrangements	Dec. 31, 2024 shares
Trading Arrangements, by Individual
Material Terms of Trading Arrangement	During the three months ended December 31, 2024, each of Eileen Schloss , a Director of the Company , and Brian Herb , Executive Vice President, Chief Financial and Administrative Officer of the Company adopted a Rule 10b5-1 trading arrangement intended to satisfy the affirmative defense of Rule 10b5-1(c). The 10b5-1 trading arrangement was adopted by Ms. Schloss on December 20, 2024 and provides for the sale of up to 61,533 shares of the Common Stock of the Company in the period commencing on March 21, 2025 and ending on the earlier of April 3, 2025 or the execution of all trades contemplated by the plan. The 10b5-1 trading arrangement was adopted by Mr. Herb on December 20, 2024 and provides for the sale of up to 259,008 shares of the Common Stock of the Company in the period commencing on March 20, 2025 and ending on the earlier of December 19, 2025 or the execution of all trades contemplated by the plan. The number of shares to be sold under Mr. Herb ’ s plan assumes the vesting of the maximum number of shares under performance-based RSUs; the actual number of shares to be sold under his plan will depend on the achievement of the applicable performance conditions under the performance-based RSUs and the number of shares withheld to satisfy tax obligations upon the vesting of the applicable awards.
Eileen Schloss [Member]
Trading Arrangements, by Individual
Name	Eileen Schloss
Title	Director of the Company
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	December 20, 2024
Arrangement Duration	42 days
Aggregate Available	61,533
Brian Herb [Member]
Trading Arrangements, by Individual
Name	Brian Herb
Title	Executive Vice President, Chief Financial and Administrative Officer of the Company
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	December 20, 2024
Arrangement Duration	303 days
Aggregate Available	259,008

Cybersecurity Risk Management S

Cybersecurity Risk Management Strategy and Governance	12 Months Ended
Cybersecurity Risk Management Strategy and Governance	Dec. 31, 2024
Cybersecurity Risk Management, Strategy, and Governance [Line Items]
Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]	Item 1C . Cybersecurity Disclosures Cybersecurity is the responsibility of our Chief Information Security Officer (“CISO”) who oversees an information security team responsible for maintaining the confidentiality, integrity, and accessibility of data within CCC while continuously monitoring for and responding to cybersecurity threats, with oversight by our EVP, Chief Product and Technology Officer who is responsible for all of our IT systems. Our CISO has 18 years of experience managing risks from security threats and developing and implementing security policies and procedures, as well as relevant degrees and certifications, including a bachelor of science in information systems and cybersecurity and being a Certified Information Security Manager and a Certified Information Systems Security Professional. Our EVP, Chief Product and Technology Officer has over three decades of experience in the technology industry and holds a bachelor of science in computer science. Our Board has tasked the Audit Committee with oversight of enterprise risk management, including cybersecurity risk management. Our CISO or EVP, Chief Product and Technology Officer briefs the Audit Committee on cybersecurity risks at each of the quarterly meetings of the Audit Committee. These briefings include assessments of cyber risks, the threat landscape, updates on incidents, and reports on our investments in cybersecurity risk mitigation and governance. The Audit Committee and/or the EVP, Chief Product and Technology Officer also regularly briefs the entire Board on cybersecurity matters. Our cybersecurity strategy prioritizes detection, analysis and response to known, anticipated or unexpected threats, effective management of security risks and resiliency against incidents. Our cybersecurity risk management processes include technical security controls, policy enforcement mechanisms, monitoring systems, contractual arrangements, tools and related services from third-party providers, and management oversight to assess, identify and manage risks from cybersecurity threats. We implement risk-based controls to protect our information, the information of our customers and other third parties, our information systems, our business operations, and our products and related services. We have adopted security-control principles based on the National Institute of Standards and Technology Cybersecurity Framework and contractual, industry and regulatory best practices and requirements. Our written Cybersecurity Incident Response Program coordinates the activities we take to prepare for, detect, respond to and recover from cybersecurity incidents, and includes processes to prepare for, assess severity of, escalate information about, contain, eradicate, and recover from the incident, as well as to conduct post-incident activities, including reporting and conducting root cause analysis and remediation activities. Our incident response policies and the cybersecurity posture are subject to annual testing to evaluate our adherence to policies and compliance requirements. Policies and practices are reviewed periodically to improve processes and practice. We carry cybersecurity insurance to provide a level of financial protection should a covered incident occur. Our cybersecurity and privacy program includes mandatory annual training for all employees and contractors reinforced by targeted phishing tests. The annual training includes training on how to identify potential cybersecurity and privacy risks and protect our resources and information. Additionally, we provide additional specialized security training for employees in roles relating to product development or information technology. While we believe our cybersecurity and privacy program to be appropriately designed in light of the risks we have identified, we have experienced, and may in the future experience, whether directly or through our supply chain or other channels, cybersecurity incidents. While prior incidents have not had a material impact on us, future incidents could have a material impact on our business strategy, results of operations or financial condition. See “Risk Factors—Our solutions or our third-party cloud providers have experienced in the past, and could experience in the future, data security breaches, which could adversely impact our reputation, business, and ongoing operations.”
Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]	true
Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]	false
Cybersecurity Risk Board of Directors Oversight [Text Block]	Our Board has tasked the Audit Committee with oversight of enterprise risk management, including cybersecurity risk management. Our CISO or EVP, Chief Product and Technology Officer briefs the Audit Committee on cybersecurity risks at each of the quarterly meetings of the Audit Committee. These briefings include assessments of cyber risks, the threat landscape, updates on incidents, and reports on our investments in cybersecurity risk mitigation and governance. The Audit Committee and/or the EVP, Chief Product and Technology Officer also regularly briefs the entire Board on cybersecurity matters. Our cybersecurity strategy prioritizes detection, analysis and response to known, anticipated or unexpected threats, effective management of security risks and resiliency against incidents. Our cybersecurity risk management processes include technical security controls, policy enforcement mechanisms, monitoring systems, contractual arrangements, tools and related services from third-party providers, and management oversight to assess, identify and manage risks from cybersecurity threats. We implement risk-based controls to protect our information, the information of our customers and other third parties, our information systems, our business operations, and our products and related services. We have adopted security-control principles based on the National Institute of Standards and Technology Cybersecurity Framework and contractual, industry and regulatory best practices and requirements. Our written Cybersecurity Incident Response Program coordinates the activities we take to prepare for, detect, respond to and recover from cybersecurity incidents, and includes processes to prepare for, assess severity of, escalate information about, contain, eradicate, and recover from the incident, as well as to conduct post-incident activities, including reporting and conducting root cause analysis and remediation activities. Our incident response policies and the cybersecurity posture are subject to annual testing to evaluate our adherence to policies and compliance requirements. Policies and practices are reviewed periodically to improve processes and practice. We carry cybersecurity insurance to provide a level of financial protection should a covered incident occur. Our cybersecurity and privacy program includes mandatory annual training for all employees and contractors reinforced by targeted phishing tests. The annual training includes training on how to identify potential cybersecurity and privacy risks and protect our resources and information. Additionally, we provide additional specialized security training for employees in roles relating to product development or information technology.
Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]	Our Board has tasked the Audit Committee with oversight of enterprise risk management, including cybersecurity risk management. Our CISO or EVP, Chief Product and Technology Officer briefs the Audit Committee on cybersecurity risks at each of the quarterly meetings of the Audit Committee. These briefings include assessments of cyber risks, the threat landscape, updates on incidents, and reports on our investments in cybersecurity risk mitigation and governance. The Audit Committee and/or the EVP, Chief Product and Technology Officer also regularly briefs the entire Board on cybersecurity matters.
Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]	Our CISO or EVP, Chief Product and Technology Officer briefs the Audit Committee on cybersecurity risks at each of the quarterly meetings of the Audit Committee. These briefings include assessments of cyber risks, the threat landscape, updates on incidents, and reports on our investments in cybersecurity risk mitigation and governance. The Audit Committee and/or the EVP, Chief Product and Technology Officer also regularly briefs the entire Board on cybersecurity matters.
Cybersecurity Risk Role of Management [Text Block]	Cybersecurity is the responsibility of our Chief Information Security Officer (“CISO”) who oversees an information security team responsible for maintaining the confidentiality, integrity, and accessibility of data within CCC while continuously monitoring for and responding to cybersecurity threats, with oversight by our EVP, Chief Product and Technology Officer who is responsible for all of our IT systems. Our CISO has 18 years of experience managing risks from security threats and developing and implementing security policies and procedures, as well as relevant degrees and certifications, including a bachelor of science in information systems and cybersecurity and being a Certified Information Security Manager and a Certified Information Systems Security Professional. Our EVP, Chief Product and Technology Officer has over three decades of experience in the technology industry and holds a bachelor of science in computer science. Our Board has tasked the Audit Committee with oversight of enterprise risk management, including cybersecurity risk management. Our CISO or EVP, Chief Product and Technology Officer briefs the Audit Committee on cybersecurity risks at each of the quarterly meetings of the Audit Committee. These briefings include assessments of cyber risks, the threat landscape, updates on incidents, and reports on our investments in cybersecurity risk mitigation and governance. The Audit Committee and/or the EVP, Chief Product and Technology Officer also regularly briefs the entire Board on cybersecurity matters. Our cybersecurity strategy prioritizes detection, analysis and response to known, anticipated or unexpected threats, effective management of security risks and resiliency against incidents. Our cybersecurity risk management processes include technical security controls, policy enforcement mechanisms, monitoring systems, contractual arrangements, tools and related services from third-party providers, and management oversight to assess, identify and manage risks from cybersecurity threats. We implement risk-based controls to protect our information, the information of our customers and other third parties, our information systems, our business operations, and our products and related services. We have adopted security-control principles based on the National Institute of Standards and Technology Cybersecurity Framework and contractual, industry and regulatory best practices and requirements. Our written Cybersecurity Incident Response Program coordinates the activities we take to prepare for, detect, respond to and recover from cybersecurity incidents, and includes processes to prepare for, assess severity of, escalate information about, contain, eradicate, and recover from the incident, as well as to conduct post-incident activities, including reporting and conducting root cause analysis and remediation activities. Our incident response policies and the cybersecurity posture are subject to annual testing to evaluate our adherence to policies and compliance requirements. Policies and practices are reviewed periodically to improve processes and practice. We carry cybersecurity insurance to provide a level of financial protection should a covered incident occur.
Cybersecurity Risk Management Positions or Committees Responsible [Flag]	true
Cybersecurity Risk Management Positions or Committees Responsible [Text Block]	Cybersecurity is the responsibility of our Chief Information Security Officer (“CISO”) who oversees an information security team responsible for maintaining the confidentiality, integrity, and accessibility of data within CCC while continuously monitoring for and responding to cybersecurity threats, with oversight by our EVP, Chief Product and Technology Officer who is responsible for all of our IT systems.
Cybersecurity Risk Management Expertise of Management Responsible [Text Block]	Our CISO has 18 years of experience managing risks from security threats and developing and implementing security policies and procedures, as well as relevant degrees and certifications, including a bachelor of science in information systems and cybersecurity and being a Certified Information Security Manager and a Certified Information Systems Security Professional. Our EVP, Chief Product and Technology Officer has over three decades of experience in the technology industry and holds a bachelor of science in computer science.
Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]	Our written Cybersecurity Incident Response Program coordinates the activities we take to prepare for, detect, respond to and recover from cybersecurity incidents, and includes processes to prepare for, assess severity of, escalate information about, contain, eradicate, and recover from the incident, as well as to conduct post-incident activities, including reporting and conducting root cause analysis and remediation activities.
Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]	true

Organization and Nature of Oper

Organization and Nature of Operations	12 Months Ended
Organization and Nature of Operations	Dec. 31, 2024
Text Block [Abstract]
Organization and Nature of Operations	1. ORGANIZATION AND NATURE OF OPERATIONS CCC Intelligent Solutions Holdings Inc., a Delaware corporation, is a leading software as a service (“SaaS”) platform for the multi-trillion-dollar property and casualty (“P&C”) insurance economy powering operations for insurers, repairers, automakers, parts suppliers, lenders and more. CCC’s cloud technology connects businesses digitizing mission-critical workflows, commerce and customer experiences. CCC’s cloud-based SaaS platform connects trading partners, facilitates commerce, and supports mission-critical, artificial intelligence (“AI”) enabled digital workflows. The Company is headquartered in Chicago, Illinois. The Company’s primary operations are in the United States (“US”) and it also has operations in China. The Company was originally incorporated as a Cayman Islands exempted company on July 3, 2020 as a special purpose acquisition company under the name Dragoneer Growth Opportunities Corp (“Dragoneer”). On February 2, 2021, Cypress Holdings Inc., (“CCCIS”) entered into the Business Combination Agreement with Dragoneer. In connection with the closing of the business combination (“Business Combination”), Dragoneer changed its jurisdiction of incorporation by deregistering as an exempted company in the Cayman Islands and continuing and domesticating as a Delaware corporation on July 30, 2021, upon which Dragoneer changed its name to CCC Intelligent Solutions Holdings Inc.

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
Summary of Significant Accounting Policies	Dec. 31, 2024
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation —The consolidated balance sheets as of December 31, 2024 and 2023, the consolidated statements of operations and comprehensive income (loss), the consolidated statements of mezzanine equity and stockholders’ equity and the consolidated statements of cash flows for the years ended December 31, 2024, 2023 and 2022, have been prepared in conformity with accounting principles generally accepted in the United States (“GAAP”). Basis of Accounting —The accompanying consolidated financial statements are prepared in accordance with GAAP and include the accounts of the Company and its wholly-owned subsidiaries and majority-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. The consolidated financial statements include 100% of the accounts of wholly-owned and majority-owned subsidiaries. The ownership interest of the minority investor is recorded as a non-controlling interest in a subsidiary. Use of Estimates —The preparation of the consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts, and the disclosures of contingent amounts in the Company’s consolidated financial statements and the accompanying notes. The Company bases its estimates on historical experience and various other assumptions that it believes to be reasonable under the circumstances. Although the Company regularly assesses its estimates, actual results could differ from management’s estimates if past experience or other assumptions are not substantially accurate. Changes in estimates are recorded in the period in which they become known. Significant estimates in these consolidated financial statements include the estimation of contract transaction prices, the determination of the amortization period for contract assets, the valuation of goodwill and intangible assets, the estimates and assumptions associated with the valuation of the warrant liabilities, and the estimates and assumptions associated with stock incentive plans. Cash and Cash Equivalents —The Company considers all highly liquid investments, including money market funds, purchased with an original maturity of three months or less at the date of purchase to be cash and cash equivalents. Cash and cash equivalents are carried at cost, which approximates fair value. The Company believes it is not exposed to any significant credit risk on cash and cash equivalents. While the Company has deposits that exceed federally insured limits at financial institutions, the Company places its cash and cash equivalents in highly rated institutions. The Company has never experienced losses related to these balances. Foreign Currency —The Company’s functional currency is the US dollar, however, for operations located in China, the functional currency is the local currency. Assets and liabilities of the foreign operations are translated to US dollars at exchange rates in effect at the consolidated balance sheet date, while statement of operations accounts are translated to US dollars at the average exchange rates for the period. Translation gains and losses are recorded and remain as a component of accumulated other comprehensive loss in stockholders’ equity until transactions are settled or the foreign entity is sold or liquidated. Gains and losses resulting from transactions that are denominated in a currency that is not the functional currency are recorded to other income–net, in the consolidated statements of operations and comprehensive income (loss) . Significant Customers and Concentration of Credit Risks —The Company is potentially subject to concentration of credit risk primarily through its accounts receivable. The Company performs ongoing credit evaluations of its customers and maintains allowances for potential credit losses which, when realized, have been within the range of management’s expectations. The Company generally does not require collateral. Credit risk on accounts receivables is minimized as a result of the large and diverse nature of the Company’s customer base. During the years ended December 31, 2024, 2023 , and 2022 no single customer represented more than 10 % of revenue. As of December 31, 2024 , one customer had an account receivable of 11 % of accounts receivable. As of December 31, 2023 , no customer had an account receivable greater than 10 % of accounts receivable. Revenue Recognition —The Company’s revenue recognition policy follows guidance from Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers. The Company generates revenue from contracts that are generally billed either on a monthly subscription or transactional basis. Other revenue primarily consists of professional services and other non-software services revenue that is generally transaction-based (where a fee per transaction is charged). Revenues are recognized as control of these services is transferred to customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those services. The Company determines revenue recognition based on the application of the following steps: • Identification of the contract, or contracts, with a customer • Identification of the performance obligation(s) in the contract • Determination of the transaction price • Allocation of the transaction price to the performance obligation(s) in the contract • Recognition of revenue when, or as a performance obligation is satisfied Software Subscription Revenues —Software services are hosted and provide customers with the right to use the hosted software over the contract period without taking possession of the software and are generally billed on either a monthly subscription or transactional basis. Revenues related to services billed on a subscription basis are recognized ratably over the contract period as this is the time period over which services are transferred to the customer, generally between three and five years. Revenues from subscription services represent a stand-ready obligation to provide access to the Company’s platform. As each day of providing services is substantially the same and the customer simultaneously receives and consumes the benefits as access is provided, subscription arrangements include a series of distinct services. The Company may provide certain of its customers with implementation activities such as basic setup, installation and initial training that the Company must undertake to fulfill the contract. These are considered fulfillment activities that do not transfer the service to the customer. For contracts with fixed and variable consideration, to the extent that customers’ usage exceeds the committed contracted amounts under their subscriptions, they are charged for their incremental usage. In addition to overage fees, consideration may vary due to discounts, incentives, and potential service level credits or contractual penalties. For such variable consideration, the Company includes an estimate of the most likely amount it expects to receive for the total transaction price if it is probable that a significant reversal of cumulative revenue recognized will not occur. When customers’ usage falls below the committed contracted amounts, the customer does not receive any credits or refunds for the shortfall. For contracts where fees are solely based on transaction volume, the amount invoiced corresponds directly with the value provided to the customer, and revenue is recognized when invoiced using the as-invoiced practical expedient. Other Revenue —Other revenues consist of professional services and other non-software services and are recognized over time as the services are performed. Other revenues are generally invoiced monthly in arrears. Revenues related to such services that are billed on a transactional basis are recognized when the transaction for the related service occurs. Transaction revenue is primarily comprised of fees for services applied to the volume of transactions. These are typically based on a per-unit rate and are invoiced for the same period in which the transactions were processed and as the performance obligation is satisfied. For contracts with transaction fees, the amount invoiced corresponds directly with the value provided to the customer, and revenue is recognized when invoiced using the as-invoiced practical expedient. Contracts with Multiple Performance Obligations —The Company’s contracts with customers can include access to different software applications such as CCC workflow, estimating, valuation and analytics, each of which is its own performance obligation. These additional services are either sold on a standalone basis or could be used on their own with readily available resources. For these contracts, the Company accounts for individual performance obligations separately, if they are distinct. The transaction price is allocated to the separate performance obligations on a relative standalone selling price basis. The standalone selling price for distinct performance obligations is generally based on directly observable pricing. In instances where standalone selling price is not directly observable, the Company determines standalone selling price based on overall pricing objectives, which take into consideration observable data, market conditions and entity-specific factors. The Company may occasionally recognize an adjustment in revenue in the current period for performance obligations partially or fully satisfied in the previous periods resulting from changes in estimates for the transaction price, including any changes to the Company’s assessment of whether an estimate of variable consideration is constrained. For the years ended December 31, 2024, 2023 and 2022, the impact on revenue recognized in the current period, from performance obligations partially or fully satisfied in the previous period, was not significant. Contract Liabilities —Contract liabilities consist of deferred revenue and include customer billings in advance of revenues being recognized from subscription contracts and professional services. Deferred revenue that is expected to be recognized during the succeeding twelve-month period is recorded as current, and the remaining portion is recorded as noncurrent and included within other liabilities on the consolidated balance sheets. Costs to Obtain and Fulfill the Contract —The Company defers costs that are considered to be incremental and recoverable costs of obtaining a contract with a customer, including sales commissions. Costs to fulfill contracts are capitalized when such costs are direct and related to implementation activities for hosted software solutions. Capitalized costs to obtain a contract and costs to fulfill a contract are generally amortized over a period between three and five years, which represents the expected period of benefit of these costs and corresponds to the contract period. In instances where the contract term is significantly different than our general contract terms of between three and five years, costs to obtain and fulfill are amortized over the contract term which the Company believes best reflects the period of benefit of these costs. Cost of Revenues —Cost of revenues is primarily composed of personnel costs, including stock-based compensation, and costs of external resources used in the delivery of services to customers, including software configuration, integration and implementation services, customer support activities, third party costs related to hosting the Company’s software for its customers, internal support of production infrastructure, information technology (“IT”) security costs, depreciation expense, cost of software production, and data licensing and royalty fees paid to third parties. Cost of revenues also includes amortization of internal use software, including capitalized development costs, and amortization and impairment of acquired technologies. Research and Development —Research and development expenses consist primarily of personnel-related costs, including stock-based compensation, and costs of external development resources involved in the engineering, design and development of new solutions, as well as expenses associated with significant ongoing improvements to existing solutions. Research and development expenses also include IT hosting costs for the development and test environments. Research and development costs, other than software development costs qualifying for capitalization, are expensed as incurred. Selling and Marketing —Selling and marketing expenses consist primarily of personnel-related costs for our sales and marketing functions, including sales commissions and stock-based compensation. Additional expenses include advertising costs, marketing costs and event costs, including the Company’s annual industry conference. The Company expenses advertising and other promotional expenditures as incurred. Advertising expenses were $ 2.0 million, $ 1.5 million and $ 1.1 million for the years ended December 31, 2024, 2023 and 2022 , respectively. General and Administrative —General and administrative expenses consist primarily of personnel-related costs, including stock-based compensation, for our executive management and administrative employees, including finance and accounting, human resources, internal systems IT, facilities and legal functions. Additional expenses include professional service fees, insurance premiums, and other corporate expenses that are not allocated to the above expense categories. Amortization of Intangible Assets —Amortization of intangible assets consists of the capitalized costs of intangible assets. These intangible assets are amortized on a straight-line basis over their estimated useful lives (see Note 11). Goodwill and Intangible Asset Impairments —Goodwill and intangible asset impairments includes the goodwill and intangible asset impairment charges specific to the Company's China reporting unit (see Note 11). Stock-Based Compensation —The Company’s stock-based compensation plans are described in Note 20. The Company accounts for stock-based payment awards based on the grant date fair value. The incremental fair value of modifications to stock-based payment awards is estimated at the date of modification. Stock-based payment awards that are settled in cash are accounted for as liabilities. The Company recognizes stock-based compensation expense for only the portion of awards expected to vest, based on an estimated forfeiture rate. The Company recognizes stock-based compensation expense for time-based awards on a straight-line basis over the requisite service period, which is generally the vesting period of the respective awards. Stock-based compensation expense for performance-based awards with a market condition is recognized over the estimated service period, regardless of whether the market condition is satisfied. The fair value of RSUs with only a time-based vesting component or a performance-based vesting component is determined using the quoted price of our common stock on the date of grant. As of each reporting period, we estimate the number of RSUs with a performance-based vesting component that are expected to vest based on our current estimate of performance compared to the target metrics and record a cumulative-effect adjustment to stock-based compensation expense when necessary. For stock-based awards that are accounted for as liabilities, we remeasure the fair value of the associated liability at each reporting date through settlement using the Black-Scholes option pricing model and recognize the adjustment as stock-based compensation expense. The fair value of the Company’s stock options with only a time-based component is estimated using the Black-Scholes option pricing model. The fair value of the Company’s performance-based awards with a market condition is estimated using a Monte Carlo simulation model. Stock-based compensation expense related to purchase rights issued under the CCC Intelligent Solutions Holdings Inc. 2021 Employee Stock Purchase Plan (“ESPP”) is based on the Black-Scholes option pricing model’s fair value of the estimated number of awards as of the beginning of the applicable offering period. Stock-based compensation expense is recognized using the straight-line method over the applicable offering period. The inputs and assumptions utilized under these methods require judgments and estimates. Changes in the inputs and assumptions could affect the measurement of the estimated fair value of the related compensation expense of these stock-based payment awards. Accounts Receivable—Net —An account receivable is recorded when an unconditional right to consideration exists, such that only the passage of time is required before of consideration is due. Accounts receivable—net includes contract assets resulting from subscription agreements with ramped billing schedules. Accounts receivable, as presented in the consolidated balance sheets, are net of customer sales allowances and credit losses. The Company determines allowances for its sales reserves and credit losses based on specific identification of customer accounts and historical experience to the remaining accounts receivable balance. The Company’s assessment of credit losses includes estimating its expected credit losses based on historical information and adjusted for current conditions and forecasts for the probability of collection from customers. Credit losses are charged to general and administrative expenses in the consolidated statements of operations and comprehensive income (loss) . Software, Equipment, and Property—Net —Software, equipment, and property are stated at cost, net of accumulated depreciation and amortization. Depreciation and amortization are computed on a straight-line basis over the assets’ estimated useful lives, which are as follows: Software, equipment, and property Estimated Useful Life Software and licenses 2 - 5 years Computer equipment 3 years Furniture and other equipment 5 years Database 25 years Building 39 years Leasehold improvements Lesser of the estimated useful life or life of lease Land Indefinite Maintenance and repairs are expensed as incurred. Significant improvements and enhancements are capitalized. Internal Use Software —The Company capitalizes the direct costs incurred in developing or obtaining internal use software, including platform development, infrastructure and tools, as well as certain payroll and payroll-related costs of employees who are directly associated with internal use computer software projects. The amount of capitalized payroll costs with respect to these employees is limited to the time directly spent on such projects. The costs associated with preliminary project stage activities, training, maintenance, and all other post-implementation activities are expensed as incurred. Additionally, the Company expenses internal costs related to minor upgrades and enhancements as it is impractical to separate these costs from normal maintenance activities. Capitalized internal use software costs are recorded within software, equipment, and property on the Company’s consolidated balance sheets. Goodwill and Intangible Assets —Goodwill and intangible assets deemed to have indefinite lives are not amortized, but are subject to an annual impairment test, or more frequently if events or changes in circumstances indicate that the carrying value may not be recoverable. The Company performs its annual impairment assessment of goodwill and indefinite life intangible assets as of November 30 of each year. Under GAAP, the Company has the option to first assess qualitative factors in order to determine if it is more likely than not that the fair value of one of its reporting units or indefinite life intangible assets is greater than its carrying value (“Step 0”). If the qualitative assessment leads to a determination that the fair value is less than its carrying value, or if the Company elects to bypass the qualitative assessment, it is required to perform a quantitative impairment test (“Step 1”) by calculating the fair value of the reporting unit or indefinite life intangible asset and comparing the fair value with its associated carrying value. If the carrying value exceeds the fair value, an impairment loss is recognized in an amount equal to the excess, up to the carrying value of the goodwill or indefinite life intangible asset. For the years ended December 31, 2024, 2023 and 2022, the Company performed its annual impairment tests as of November 30 for its goodwill and indefinite lived intangible assets and determined no impairment existed. During May 2023, the Company performed an interim quantitative impairment test for its China reporting unit due to events which indicated that the carrying amount was in excess of its estimated fair value. As a result of the interim quantitative impairment test, the Company recorded a goodwill impairment charge of $ 77.4 million (see Note 11). Subsequent to the impairment charge recognized in May 2023, the Company performed its annual impairment test for its Domestic reporting unit, its remaining reporting unit with goodwill and indefinite lived assets as of November 30, 2023 and determined no impairment existed. Long-Lived Assets —Long-lived assets, other than goodwill, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets might not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the asset or asset group to estimated undiscounted future cash flows expected to be generated by such assets. If the carrying amount of the assets exceeds their estimated future cash flows, an impairment charge is recognized equal to the amount by which the carrying amount of the assets exceeds their fair value. There were no events or changes in circumstances that indicated the carrying value may not be recoverable and no impairment charges were recognized during the years ended December 31, 2024. During the year ended December 31, 2023, the Company performed the recoverability test on its China reporting unit’ s intangible assets due to events which indicated the carrying amount may not be recoverable. As a result, the Company recorded impairment charges totaling $ 5.3 million (see Note 11). There were no events or changes in circumstances that indicated the carrying value may not be recoverable and no impairment charges were recognized during the years ended December 31, 2022. Equity Method Investment —The Company accounts for its 7 % investment in a limited partnership using the equity method of accounting. Under the equity method of accounting, the investee’s accounts are not reflected within the Company’s consolidated balance sheets and consolidated statements of operations and comprehensive income (loss) . The Company’s investment was initially recognized at cost and adjusted thereafter for the post acquisition changes in the Company’s share of the investee’s earnings which would be recorded in other income-net. Deferred Financing Costs —Deferred financing costs are capitalized and amortized over the life of the underlying financing agreement (see Note 15). Business Combinations —The Company allocates the purchase consideration of acquired companies to tangible and intangible assets acquired and liabilities assumed based on their estimated fair values at the acquisition date, with the excess recorded to goodwill. These estimates are inherently uncertain and subject to refinement. During the measurement period, which may be up to one year from the acquisition date, adjustments may be recorded to the fair value of these tangible and intangible assets acquired and liabilities assumed, including uncertain tax positions and tax-related valuation allowances, with the corresponding offset to goodwill. Upon the conclusion of the measurement period or final determination of the fair value of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to the consolidated statements of operations and comprehensive income (loss). The Company estimates the fair value of contingent consideration related to business combinations on the date of acquisition (see Note 3). The fair value of the contingent consideration was remeasured each reporting period, with any change in the fair value recorded within the consolidated statements of operations and comprehensive income (loss) . Fair Value of Financial Instruments and Fair Value Measurements —Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. To increase the comparability of fair value measures, the following hierarchy prioritizes the inputs to valuation methodologies used to measure fair value. Level 1 —Valuations based on quoted prices for identical assets and liabilities in active markets. Level 2 —Valuations based on observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data. Level 3 —Valuations based on unobservable inputs reflecting the Company’s own assumptions, consistent with reasonably available assumptions made by other market participants. These valuations require significant judgment. Warrant Liability —Upon consummation of the Business Combination, the Company assumed the outstanding warrants previously sold in a private placement (“Private Warrants”) by Dragoneer. The Company accounted for its Private Warrants under ASC 815-40, Derivatives and Hedging-Contracts in Entity’s Own Equity , in conjunction with the SEC Division of Corporation Finance’s April 12, 2021 Public Statement, Staff Statement on Accounting and Reporting Considerations for Warrants Issued by Special Purpose Acquisition Companies (“SPACs”) . The terms of the warrants provided for potential changes to the settlement amounts dependent upon the characteristics of the warrant holder, and precluded the warrants from being classified in equity and thus the warrants were classified as a liability. Accordingly, the Company recorded the warrants as long-term liabilities on its consolidated balance sheet at fair value upon the closing of the Business Combination, with subsequent changes in the fair value of the warrants recognized in the consolidated statements of operations and comprehensive income (loss) at each reporting date. The Private Warrants were redeemed during the year ended December 31, 2024 (see Note 21). Prior to their redemption, the Private Warrants were valued using the Black-Scholes option pricing model. The assumptions utilized under the Black-Scholes option pricing model require judgments and estimates. Changes in these inputs and assumptions could affect the measurement of the estimated fair value of the related fair value of the Private Warrants. Derivative Instruments —The Company records derivative instruments as an asset or liability measured at fair value each reporting period. The Company has not designated its derivatives as hedging instruments for accounting purposes and recognizes the changes in fair value within its consolidated statement of operations and comprehensive income (loss). Gain and losses from the change in fair value and cash payments and receipts related to the derivative instruments are recognized in other income (expense)—net, in the consolidated statements of operations and comprehensive income (loss) . The Company does not enter into derivative instrument transactions for trading or speculative purposes. Income Taxes —Deferred income tax assets and liabilities are recognized for the expected future tax effects of temporary differences between the financial and income tax reporting basis of assets and liabilities using tax rates in effect for the years in which the differences are expected to reverse. Deferred income taxes relate to the timing of recognition of certain revenue and expense items, and the timing of the deductibility of certain reserves and accruals for income tax purposes that differs from the timing for financial reporting purposes. The Company establishes a tax valuation allowance to the extent that it is more likely than not that a deferred tax asset will not be realizable against future taxable income. A tax benefit from an uncertain tax position may be recognized when it is more likely than not that the position will be sustained upon examination, including resolutions of any related appeals or litigation process, based on its technical merits. Income tax positions must meet a more-likely-than-not recognition threshold to be recognized. The Company recognizes interest and penalties related to unrecognized tax benefits in income tax expense. Employee Insurance Benefits —The Company maintains a self-insured group medical program. The program contains stop loss thresholds with amounts in excess of the self-insured levels fully insured by third-party insurers. Liabilities associated with this program are estimated in part by considering historical claims experience and medical cost trends. Leases —The Company’s lease policy follows guidance from ASC 842, Leases . In accordance with ASC 842, the Company, at the inception of the contract, determines whether a contract is or contains a lease. For leases with terms greater than 12 months, the Company records the related operating or finance right of use asset and lease liability at the present value of lease payments over the lease term. The Company is generally not able to readily determine the implicit rate in the lease and therefore uses the determined incremental borrowing rate at lease commencement to determine the present value of lease payments. The incremental borrowing rate represents an estimate of the market interest rate the Company would incur at lease commencement to borrow an amount equal to the lease payments on a collateralized basis over the term of a lease. Renewal options are not included in the measurement of the right of use assets and lease liabilities unless the Company is reasonably certain to exercise the optional renewal periods. Some leases also include early termination options, which can be exercised under specific conditions. Additionally, certain leases contain incentives, such as construction allowances from landlords. These incentives reduce the right-of-use asset related to the lease. Some of the Company’s leases contain rent escalations over the lease term. The Company recognizes expense for operating leases on a straight-line basis over the lease term. The Company has elected the practical expedient to combine lease and non-lease components for all asset categories. Therefore, the lease payments used to measure the lease liability for these leases include fixed minimum rentals along with fixed non-lease component charges. Lease related costs, which are variable rather than fixed, are expensed in the period incurred. The Company does not have significant residual value guarantees or restrictive covenants in the lease portfolio. Redeemable Non-Controlling Interest —The Company presents a redeemable non-controlling interest as mezzanine equity within its consolidated balance sheets when it is redeemable at a fixed or determinable price on a fixed or determinable date at the option of the holder or upon the occurrence of an event that is not solely within the control of the Company. The redeemable non-controlling interest was initially measured at fair value on the date of issuance. When the redemption of a mezzanine-classified non-controlling interest becomes probable, the carrying amount of the redeemable non-controlling interest is increased by periodic accretions using the interest method so that the carrying amount will equal the redemption amount on the date that the shares become redeemable. These adjustments are recorded as accretion of redeemable non-controlling interest, with an offset to additional paid-in capital, on the consolidated statements of mezzanine equity and stockholders’ equity (see Note 17). Any such charges to additional paid-in capital affect net income (loss) available to CCC common stockholders as part of the Company’s calculation of net income (loss) per share attributable to common stockholders. Recently Adopted Accounting Pronounce

Business Acquisition

Business Acquisition	12 Months Ended
Business Acquisition	Dec. 31, 2024
Business Combinations [Abstract]
Business Acquisition	3. BUSINESS ACQUISITION On February 8, 2022, the Company completed its acquisition of Safekeep, Inc. (“Safekeep”), a privately held company that leverages AI to streamline and improve subrogation management across auto, property, workers’ compensation and other insurance lines of business. Leveraging Safekeep’s AI-enabled subrogation solutions, the acquisition broadens the Company’s portfolio of cloud-based solutions available to its insurance customers. In exchange for all the outstanding shares of Safekeep, the Company paid total cash consideration of $ 32.3 million upon closing. In accordance with the acquisition agreement, the Company placed $ 6.0 million in escrow for a general indemnity holdback to be paid to the sellers within 15 months of closing, subject to reduction for certain indemnifications and other potential obligations of the selling shareholders. The remaining cash held in escrow was paid to the sellers in May 2023. As additional consideration for the shares, the acquisition agreement includes a contingent earnout for additional cash consideration. The potential amount of the earnout is calculated as a multiple of revenue, above a defined floor, during the 12-month measurement period ending December 31, 2024 and was not to exceed $ 90.0 million. The fair value of the contingent consideration as of the acquisition date of $ 0.2 million was estimated using a Monte Carlo simulation model that relies on unobservable inputs, including management estimates and assumptions. Upon the end of the 12-month measurement period, the contingent earnout was determined to be zero and no additional consideration was paid to the selling shareholders. The acquisition date fair value of the consideration transferred was $ 32.5 million, which consisted of the following (in thousands): Cash paid through closing $ 32,300 Fair value of contingent earnout consideration 200 Total acquisition date fair value of the consideration transferred $ 32,500 The acquisition was accounted for as a business combination and reflects the application of acquisition accounting in accordance with ASC 805, Business Combinations . The total purchase consideration was allocated to the assets acquired and liabilities assumed based on their fair values as of the acquisition date with the excess purchase price assigned to goodwill. The goodwill was primarily attributable to the expected synergies from the combined service offerings and the value of the acquired workforce. The goodwill is not deductible for tax purposes. The Company’s estimates of the fair values of the assets acquired, liabilities assumed and contingent consideration are based on information that was available at the date of the acquisition. During the measurement period, which may be up to one year from the acquisition date, adjustments may be recorded to the fair value of these tangible and intangible assets acquired and liabilities assumed, including uncertain tax positions and tax-related valuation allowances, with the corresponding offset to goodwill. The Company recorded a measurement period adjustment to reflect the facts and circumstances in existence at the acquisition date in December 2022. The adjustment relates to the valuation of the deferred tax liabilities for $ 0.9 million, with a corresponding increase in goodwill. There were no other significant changes to the preliminary purchase price allocation. The purchase price allocation of estimated fair values was finalized as of December 31, 2022. The following table summarizes the final allocation of the consideration to the fair values of the assets acquired and liabilities assumed at the acquisition date (in thousands): Assets acquired: Current assets $ 150 Intangible asset - acquired technology 4,800 Total assets acquired 4,950 Liabilities assumed: Current liabilities 147 Deferred tax liabilities 548 Total liabilities assumed 695 Net assets acquired 4,255 Goodwill 28,245 Total purchase price $ 32,500 The acquired technology intangible asset has an estimated useful life of seven years and is being amortized on a straight-line basis. The fair value of the acquired technology intangible asset was determined by a valuation model based on estimates of future operating projections as well as judgments on the discount rate and other variables. This fair value measurement is based on significant unobservable inputs, including management estimates and assumptions and thus represents a Level 3 measurement. The Company incurred transaction costs associated with the acquisition of $ 1.2 million, included in general and administrative expenses within the consolidated statements of operations and comprehensive income (loss) for the year ended December 31, 2022.

Revenue

Revenue	12 Months Ended
Revenue	Dec. 31, 2024
Revenue from Contract with Customer [Abstract]
Revenue	4. REVENUE Disaggregation of Revenue —The Company provides disaggregation of revenue based on type of service as it believes these categories best depict how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors. The following table summarizes revenue by type of service for the years ended December 31 (in thousands): Year Ended December 31, 2024 2023 2022 Software subscriptions $ 906,464 $ 830,117 $ 752,505 Other 38,336 36,261 29,943 Total revenues $ 944,800 $ 866,378 $ 782,448 Contract Assets and Liabilities — The balances of the Company’s receivables, contract assets and contract liabilities from contracts with customers are as follows (in thousands): December 31, December 31, December 31, 2024 2023 2022 Accounts receivables-Net of allowances $ 106,578 $ 102,365 $ 98,353 Deferred contract costs 22,373 17,900 16,556 Deferred contract costs-non-current 18,692 22,302 20,161 Other assets (accounts receivable, non-current) 16,946 15,198 16,437 Deferred revenues 44,915 43,567 35,239 Other liabilities (deferred revenues, non-current) 1,415 1,373 1,240 Deferred Contract Costs — A summary of the activity impacting the deferred contract costs during the years ended December 31, 2024, 2023 and 2022 is presented below (in thousands): Year Ended December 31, 2024 2023 2022 Balance at beginning of period $ 40,202 $ 36,717 $ 37,186 Costs amortized ( 22,085 ) ( 19,197 ) ( 17,986 ) Additional amounts deferred 22,948 22,682 17,517 Balance at end of period $ 41,065 $ 40,202 $ 36,717 Classified as: Current $ 22,373 $ 17,900 $ 16,556 Non-current 18,692 22,302 20,161 Total deferred contract costs $ 41,065 $ 40,202 $ 36,717 Deferred Revenue — A summary of the activity impacting deferred revenue balances during the years ended December 31, 2024, 2023 and 2022, is presented below (in thousands): Year Ended December 31, 2024 2023 2022 Balance at beginning of period $ 44,940 $ 36,479 $ 32,616 Revenue recognized 1 ( 494,598 ) ( 434,197 ) ( 380,977 ) Additional amounts deferred 1 495,988 442,658 384,840 Balance at end of period $ 46,330 $ 44,940 $ 36,479 Classified as: Current $ 44,915 $ 43,567 $ 35,239 Non-current 1,415 1,373 1,240 Total deferred revenue $ 46,330 $ 44,940 $ 36,479 1 Amounts include total revenue deferred and recognized during each respective period. During the years ended December 31, 2024, 2023 and 2022, $ 42.4 million, $ 35.1 million and $ 31.0 million, respectively, that was included in the deferred revenue balance at the beginning of each period was recognized as revenue. Transaction Price Allocated to the Remaining Performance Obligations —Remaining performance obligations represent contracted revenue that has not yet been recognized, which includes deferred revenue and amounts that will be invoiced and recognized as revenue in future periods. As of December 31, 2024 , approximately $ 1,492 million of revenue is expected to be recognized from remaining performance obligations with approximately $ 662 million impacting the next twelve months, and approximately $ 830 million thereafter. The estimated revenues do not include unexercised contract renewals. The remaining performance obligations exclude future transaction revenue where revenue is recognized as the services are rendered and in the amount to which the Company has the right to invoice.

Fair Value Measurements

Fair Value Measurements	12 Months Ended
Fair Value Measurements	Dec. 31, 2024
Fair Value Disclosures [Abstract]
Fair Value Measurements	5. FAIR VALUE MEASUREMENTS Assets and Liabilities Measured at Fair Value on a Recurring Basis Private Warrants —Upon consummation of the Business Combination, the Company assumed Private Warrants issued by Dragoneer. In May 2024, the Private Warrants were redeemed and as of December 31, 2024 , no Private Warrants were outstanding (see Note 21). As of December 31, 2023, the Company’s Private Warrants were recognized as liabilities and measured at fair value on a recurring basis. The Private Warrants were valued using Level 1 and Level 2 inputs within the Black-Scholes option pricing model. The assumption utilized under the Black-Scholes option pricing model require judgments and estimates. Changes in these inputs and assumptions could affect the measurement of the estimated fair value of the Private Warrants. Accordingly, the Private Warrants were classified within Level 2 of the fair value hierarchy. The valuation of the Private Warrants as of December 31, 2023 was determined using the Black-Scholes option pricing model using the following assumptions: December 31, 2023 Expected term (in years) 2.6 Expected volatility 34 % Expected dividend yield 0 % Risk-free interest rate 4.10 % The estimated fair value of each Private Warrant using the Company's stock price on the valuation date and the above assumptions was $ 2.89 as of December 31, 2023. Contingent Consideration Liability —During the year ended December 31, 2024, the Company determined that the threshold for contingent consideration relating to its acquisition of Safekeep (see Note 3) was not met and as of December 31, 2024, the Company does not have a liability for the estimated fair value of the contingent consideration. As of December 31, 2023, the contingent consideration liability had an estimated fair value of $ 0.1 million. The contingent consideration liability was adjusted each reporting period for changes in fair value, which can result from changes in anticipated payments and changes in the assumed discount rate. These inputs are unobservable in the market and therefore, the contingent consideration liability was classified within Level 3 of the fair value hierarchy as of December 31, 2023. The estimated fair value of the contingent consideration at the date of acquisition was determined using probability-weighted discounted cash flows and a Monte Carlo simulation model. The discount rate used to estimate fair value is based on the Company’ s estimated cost of debt and was 10 %. As of December 31, 2023, the contingent consideration liability was classified within other liabilities in the accompanying consolidated balance sheets. Interest Rate Cap —In August 2022, the Company entered into two interest rate cap agreements to reduce its exposure to increases in interest rates applicable to its floating rate long-term debt (See Note 15). The fair value of the interest rate cap agreements was estimated using inputs that were observable or that could be corroborated by observable market data and therefore, was classified within Level 2 of the fair value hierarchy as of December 31, 2024 and 2023. The Company did not designate its interest rate cap agreements as hedging instruments and records the changes in fair value within other income-net on the consolidated statement of operations and comprehensive income (loss). The interest rate cap agreements’ fair value was $ 1.0 million, classified within other current assets in the accompanying consolidated balance sheet as of December 31, 2024. The interest rate cap agreements' fair value was $ 6.2 million, classified within other assets in the accompanying consolidated balance sheet as of December 31, 2023. The following table presents the fair value of the assets measured at fair value on a recurring basis at December 31, 2024 (in thousands): Fair Value Level 1 Level 2 Level 3 Assets Interest rate cap $ 975 $ — $ 975 $ — Total Assets $ 975 $ — $ 975 $ —

Income Taxes

Income Taxes	12 Months Ended
Income Taxes	Dec. 31, 2024
Income Tax Disclosure [Abstract]
Income Taxes	6. INCOME TAXES The components of pretax income (loss) attributable to domestic and foreign operations are as follows (in thousands): Year Ended December 31, 2024 2023 2022 Domestic $ 46,557 $ ( 80,486 ) $ 54,799 Foreign ( 2,243 ) ( 4,061 ) ( 4,937 ) Pretax income (loss) $ 44,314 $ ( 84,547 ) $ 49,862 The goodwill and intangible asset impairment charges (see Note 11) recognized during the year ended December 31, 2023 are included in the domestic pretax loss in the table above. The Company ’s income tax provision consisted of the following (in thousands): Year Ended December 31, 2024 2023 2022 Current provision: Federal $ 38,378 $ 41,804 $ 37,470 State 5,217 10,053 8,387 Total current provision 43,595 51,857 45,857 Deferred provision (benefit): Federal ( 24,566 ) ( 36,253 ) ( 26,570 ) State ( 5,955 ) ( 10,080 ) ( 7,831 ) Foreign 115 ( 502 ) 1,054 Change in valuation allowance ( 115 ) 502 ( 1,054 ) Total deferred benefit ( 30,521 ) ( 46,333 ) ( 34,401 ) Total income tax provision $ 13,074 $ 5,524 $ 11,456 The Company’s effective income tax rate differs from the federal statutory rate as follows (in thousands, except percentages): Year Ended December 31, 2024 2023 2022 Federal income tax provision (benefit) at statutory rate $ 9,306 21.0 % $ ( 17,755 ) 21.0 % $ 10,471 21.0 % Executive compensation 20,788 46.9 12,555 ( 14.8 ) 12,508 25.0 Stock-based compensation ( 11,386 ) ( 25.7 ) ( 3,844 ) 4.5 ( 4,074 ) ( 8.1 ) Research and experimentation credit ( 6,950 ) ( 15.7 ) ( 6,920 ) 8.2 ( 3,510 ) ( 7.0 ) Fair value of warrants ( 3,019 ) ( 6.8 ) 3,170 ( 3.7 ) ( 5,475 ) ( 11.0 ) Goodwill impairment — — 16,255 ( 19.2 ) — — Impact of foreign operations 653 1.5 1,794 ( 2.1 ) 2,807 5.6 Valuation allowance ( 115 ) ( 0.3 ) 502 ( 0.6 ) ( 1,054 ) ( 2.1 ) State and local taxes-net of federal income tax effect ( 583 ) ( 1.3 ) ( 22 ) 0.0 439 0.9 Other nondeductible expenses 2,195 5.0 836 ( 1.0 ) 344 0.7 Uncertain tax positions 926 2.1 396 ( 0.5 ) ( 303 ) ( 0.6 ) Foreign rate difference ( 67 ) ( 0.2 ) ( 164 ) 0.2 ( 182 ) ( 0.4 ) Other—net 1,326 3.0 ( 1,279 ) 1.5 ( 515 ) ( 1.0 ) Income tax provision $ 13,074 29.5 % $ 5,524 ( 6.5 )% $ 11,456 23.0 % The Company made income tax payments of $ 51.1 million, $ 43.0 million and $ 55.7 million for the years ended December 31, 2024, 2023 and 2022, respectively. The Company received insignificant refunds from various states during the years ended December 31, 2024, 2023 and 2022, respectively. The approximate income tax effect of each type of temporary difference giving rise to deferred income tax assets and liabilities as of December 31, 2024 and 2023 was as follows (in thousands): Year Ended December 31, 2024 2023 Deferred income tax assets: Stock-based compensation $ 35,539 $ 36,329 Capitalized R&E—net of amortization 43,083 26,082 Operating lease liabilities 13,142 13,751 Net operating losses—foreign 10,468 10,875 Accrued compensation 8,203 10,373 Sales allowances and doubtful accounts 1,160 1,393 Research and experimental credit 785 373 Net operating losses—domestic (state) — 479 Other 1,563 775 Total deferred income tax assets 113,943 100,430 Valuation allowance for deferred tax asset ( 10,468 ) ( 10,875 ) Net deferred income tax assets 103,475 89,555 Deferred income tax liabilities: Intangible asset amortization 234,362 255,572 Software, equipment and property depreciation and amortization 16,813 11,541 Deferred contract costs 10,149 10,044 Operating lease assets 6,995 7,078 Interest rate caps — 685 Total deferred income tax liabilities 268,319 284,920 Net deferred income tax liabilities $ 164,844 $ 195,365 Valuation Allowance —The Company has accumulated net operating losses related to its foreign subsidiaries of $ 10.5 million and $ 10.9 million at December 31, 2024 and 2023 , respectively. A valuation allowance equal to 100 % of the related tax benefit has been established as of December 31, 2024 and 2023 . The valuation allowance changed $( 0.4 ) million, $ 0.5 million and $( 1.0 ) million during the years ended December 31, 2024, 2023 and 2022, respectively. The changes in the valuation allowance during each year were due to foreign subsidiaries ’ net operating losses in the current year and the expiration of prior year’s net operating losses. No amounts were released during the years ended December 31, 2024, 2023 and 2022 . The net operating losses are set to expire in 2025 through 2029 as China allows for a five-year carryforward. The change in unrecognized tax benefits excluding interest and penalties for the years ended December 31, 2024 and 2023 was as follows (in thousands): Year Ended December 31, 2024 2023 Balance at beginning of year $ 4,415 $ 3,723 Additions based on tax positions related to the current year 1,700 1,062 Additions based on adjustments to tax positions related to prior years 862 527 Reductions based on adjustments to tax positions related to prior years ( 221 ) — Reductions as a result of a lapse of statutes of limitations ( 564 ) ( 897 ) Balance at end of year $ 6,192 $ 4,415 The Company believes its liability for unrecognized tax benefits, excluding interest and penalties, will not significantly change over the following twelve months. However, due to the open statute of limitations within the various jurisdictions in which the Company files tax returns, the amount of any change cannot be reasonably estimated and it is possible there could be significant changes in the amount of unrecognized tax benefits over the following twelve months. The Company recognizes interest and penalties related to unrecognized tax benefits in income tax expense. As of December 31, 2024 and 2023, the amount accrued for interest and penalties was not material. The Company reflects its liability for unrecognized tax benefits within income taxes payable and other liabilities in its consolidated balance sheets. The amounts included in “reductions for tax positions of prior years” represent expirations of statutes of limitation and decreases in the unrecognized tax benefits relating to settlements reached with taxing authorities during each year shown. With few US State exceptions, the major jurisdictions subject to examination by the relevant taxing authorities and open tax years, stated as the Company’s fiscal years, are as follows: Jurisdiction Open Tax Years US Federal 2021 - 2023 US States 2021 - 2023 China 2021 - 2023 Canada 2021 - 2023

Accounts Receivable

Accounts Receivable	12 Months Ended
Accounts Receivable	Dec. 31, 2024
Receivables [Abstract]
Accounts Receivable	7. ACCOUNTS RECEIVABLE Accounts receivable–Net as of December 31, 2024 and 2023, consists of the following (in thousands): December 31, 2024 2023 Accounts receivable $ 111,270 $ 107,939 Allowance for credit losses and sales reserves ( 4,692 ) ( 5,574 ) Accounts receivable–Net $ 106,578 $ 102,365 Changes to the allowance for credit losses and sales reserves during the years ended December 31, 2024, 2023 and 2022, consists of the following (in thousands): Year Ended December 31, 2024 2023 2022 Balance at beginning of period $ 5,574 $ 5,339 $ 3,791 Charges to bad debt and sales reserves 4,272 7,079 4,262 Write-offs, net ( 5,154 ) ( 6,844 ) ( 2,714 ) Balance at end of period $ 4,692 $ 5,574 $ 5,339

Other Current Assets

Other Current Assets	12 Months Ended
Other Current Assets	Dec. 31, 2024
Prepaid Expense and Other Assets, Current [Abstract]
Other Current Assets	8. OTHER CURRENT ASSETS Other current assets as of December 31, 2024 and 2023, consists of the following (in thousands): December 31, 2024 2023 Prepaid SaaS costs $ 9,112 $ 7,833 Prepaid service fees 7,352 5,992 Prepaid insurance 2,561 2,289 Prepaid software and equipment maintenance 673 5,547 Other 9,275 10,703 Total other current assets $ 28,973 $ 32,364

Software, Equipment, and Proper

Software, Equipment, and Property	12 Months Ended
Software, Equipment, and Property	Dec. 31, 2024
Property, Plant and Equipment [Abstract]
Software, Equipment, and Property	9. SOFTWARE, EQUIPMENT, AND PROPERTY Software, equipment, and property as of December 31, 2024 and 2023, consists of the following (in thousands): December 31, 2024 2023 Software, licenses and database $ 275,127 $ 220,625 Computer equipment 18,993 27,467 Leasehold improvements 30,993 31,046 Building and land 4,910 4,910 Furniture and other equipment 1,332 1,370 Total software, equipment, and property 331,355 285,418 Less accumulated depreciation and amortization ( 159,276 ) ( 125,002 ) Net software, equipment, and property $ 172,079 $ 160,416 Depreciation and amortization expense related to software, equipment, and property was $ 42.9 million, $ 36.9 million and $ 27.9 million for the years ended December 31, 2024, 2023 and 2022 , respectively.

Leases

Leases	12 Months Ended
Leases	Dec. 31, 2024
Leases [Abstract]
Leases	10. LEASES The Company leases real estate in the form of office space and data center facilities. Generally, at the inception of the contract, the term for real estate leases ranges from 2 to 17 years and the term for equipment leases is 1 to 3 years. Some real estate leases include options to renew that can extend the original term by 3 to 5 years. Operating lease costs are included within cost of revenues, exclusive of amortization and impairment of acquired technologies, research and development and general and administrative expenses on the consolidated statements of operations and comprehensive income (loss). The Company does not have any finance leases. In December 2022, the Company terminated a corporate office lease which otherwise would have expired in March 2026. In connection with the lease termination, the Company agreed to a termination fee in the amount of $ 3.8 million, which released the Company from all future minimum lease payments and variable lease costs related to this facility. As of the termination date, the Company derecognized the operating lease asset and operating lease liability and recognized a loss on lease termination of $ 3.1 million, included within general and administrative expenses in the consolidated statement of operations and comprehensive income (loss). The components of lease expense for the years ended December 31, 2024, 2023 and 2022 were as follows (in thousands): December 31, 2024 2023 2022 Operating lease costs $ 6,396 $ 5,958 $ 12,390 Variable lease costs 4,112 3,497 2,319 Total lease costs $ 10,508 $ 9,455 $ 14,709 The $ 3.1 million loss on lease termination is included in operating lease costs for the year ended December 31, 2022. The lease term and discount rate consisted of the following as of December 31, 2024, 2023 and 2022: December 31, 2024 2023 2022 Weighted-average remaining lease term (years) 11.9 12.9 13.6 Weighted-average discount rate 6.5 % 6.5 % 6.4 % Supplemental cash flow and other information related to leases for the years ended December 31, 2024, 2023 and 2022 were as follows (in thousands): December 31, 2024 2023 2022 Cash payments for operating leases $ 8,146 $ 5,706 $ 11,933 Operating lease assets obtained in exchange for lease liabilities 1,792 — 2,825 The $ 3.8 million lease termination fee is included in the cash payments for operating leases for the year ended December 31, 2022. The table below reconciles the undiscounted future minimum lease payments (in thousands) under noncancelable operating leases with terms of more than one year to the total operating lease liabilities recognized on the consolidated balance sheet as of December 31, 2024. Years Ending December 31: 2025 7,869 2026 7,370 2027 5,576 2028 6,323 2029 6,108 Thereafter 44,894 Total lease payments 78,140 Less: Interest ( 23,247 ) Total $ 54,893

Goodwill and Intangible Assets

Goodwill and Intangible Assets	12 Months Ended
Goodwill and Intangible Assets	Dec. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets	11. GOODWILL AND INTANGIBLE ASSETS Goodwill and intangible assets are primarily the result of business acquisitions. The Company performs its annual impairment assessment of goodwill and indefinite life intangible assets as of November 30 of each year. During the year ended December 31, 2024 and 2023, the Company performed a qualitative assessment for its reporting unit with goodwill and its trademark indefinite life intangible assets. For the qualitative analysis performed as of November 30 each year, the Company assessed several events and circumstances that could affect the significant inputs used to determine the fair values of the reporting unit and trademarks, including the significance of the amount of excess fair value over carrying value, consistency of operating margins and cash flows, budgeted-to-actual performance from prior year, no significant changes to projected forecasts, overall change in economic climate, changes in the industry and competitive environment, key management turnover, and earnings quality and sustainability. There were no unanticipated changes or negative indicators in the above qualitative factors that would impact the fair values as of the annual impairment date. As such, the Company determined there were no indicators of impairment and that it is more likely than not that the fair value of the reporting unit and trademarks are greater than their carrying values and therefore performing the next step of the impairment test was unnecessary. During the year ended December 31, 2023, the Company’s China reporting unit experienced adverse impacts as a result of changes in market conditions and increases in interest rates which contributed to reduced forecasted revenues and reduced projected future cash flows. As a result of these adverse impacts, the Company performed an interim quantitative assessment of goodwill impairment by comparing the fair value of its China reporting unit to its carrying value, including goodwill. When performing the assessment, the Company determined the fair value of its China reporting unit based on forecasted future cash flows. Based on the Company’s forecast of the future cash flows of its China reporting unit, it was determined the carrying value of goodwill for its China reporting unit was impaired and the Company recorded a goodwill impairment charge of $ 77.4 million during the year ended December 31, 2023. The Company used a quantitative approach to measure the fair value of its China reporting unit using a discounted cash flow approach, which is a Level 3 measurement. The discounted cash flow analysis requires significant judgments, including estimates of future cash flows, which are dependent on internal forecasts and determination of the Company’s weighted average cost of capital, which is risk-adjusted to reflect the specific risk profile of the reporting unit being tested. The weighted average cost of capital used for the China reporting unit in the Company’s analysis was 12.5 %. For the year ended December 31, 2022 the Company performed a quantitative impairment test which indicated no impairment and there was no change to the carrying amount of goodwill or trademarks due to impairment. The following table presents the gross amount, accumulated impairment loss, and net carrying amount of goodwill as of December 31, 2024 and 2023 (in thousands): Accumulated Net Gross Amount Impairment Loss Carrying Amount Balance as of December 31, 2024 1,520,926 ( 103,202 ) 1,417,724 Balance as of December 31, 2023 $ 1,520,926 $ ( 103,202 ) $ 1,417,724 In addition to the aforementioned impairment loss recognized during the year ended December 31, 2023, the accumulated impairment loss includes an impairment loss recognized during the year ended December 31, 2019. Changes in the net carrying amount of goodwill were as follows during the year ended December 31, 2023 (in thousands): Net Carrying Amount Balance as of December 31, 2022 $ 1,495,129 Impairment ( 77,405 ) Balance as of December 31, 2023 $ 1,417,724 There were no changes in the carrying amount of goodwill during the year ended December 31, 2024. The intangible assets balance as of December 31, 2024, is reflected below (in thousands): Weighted- Average Estimated Remaining Gross Net Useful Life Useful Life Carrying Accumulated Carrying (Years) (Years) Amount Amortization Amount Intangible assets: Customer relationships 18 10.3 $ 1,291,830 $ ( 550,822 ) $ 741,008 Acquired technologies 7 4.1 4,800 ( 2,000 ) 2,800 Subtotal 1,296,630 ( 552,822 ) 743,808 Trademarks—indefinite life 190,470 — 190,470 Total intangible assets $ 1,487,100 $ ( 552,822 ) $ 934,278 The intangible assets balance as of December 31, 2023, is reflected below (in thousands): Weighted- Average Estimated Remaining Gross Net Useful Life Useful Life Carrying Accumulated Carrying (Years) (Years) Amount Amortization Amount Intangible assets: Customer relationships 16 – 18 11.3 $ 1,291,830 $ ( 479,054 ) $ 812,776 Acquired technologies 3 – 7 1.7 184,640 ( 172,840 ) 11,800 Subtotal 1,476,470 ( 651,894 ) 824,576 Trademarks—indefinite life 190,470 — 190,470 Total intangible assets $ 1,666,940 $ ( 651,894 ) $ 1,015,046 The decrease in the acquired technologies’ gross carrying amount and accumulated amortization as of December 31, 2024 was due to the write-off of fully amortized intangible assets. During the year ended December 31, 2023, the Company recorded an impairment charge to its China reporting unit’s customer relationships and acquired technologies intangible assets. The Company’s forecast of the China reporting unit’s expected cash flows indicated the carrying amounts of the intangible assets were no t recoverable and therefore the Company recorded an impairment charge of $ 5.3 million. No intangible asset impairments were recorded during the year ended December 31, 2022. Amortization expense for intangible assets w as $ 80.8 million, $ 98.4 million and $ 99.2 million for the years ended December 31, 2024, 2023 and 2022, respectively. Future amortization expense for each of the next five years and thereafter for intangible assets as of December 31, 2024, is as follows (in thousands): Years Ending December 31: 2025 72,454 2026 72,454 2027 72,454 2028 72,454 2029 71,825 Thereafter 382,167 Total $ 743,808

Equity Method Investment

Equity Method Investment	12 Months Ended
Equity Method Investment	Dec. 31, 2024
Schedule of Equity Method Investments [Line Items]
Equity Method Investment	12. EQUITY METHOD INVESTMENT The Company maintains an investment in a limited partnership (the “Investee”), which is affiliated with one of the Company’s principal equity owners. The Company invested $ 10.2 million, including related fees and expenses, for an approximate 7 % interest of the Investee. Since the Company’s investment in June 2021, the Investee has not recognized any income or loss, thus there have been no changes to the carrying value of the Company’s equity method investment and the investment is recorded at $ 10.2 million as of December 31, 2024 and 2023 on the consolidated balance sheets.

Accrued Expenses

Accrued Expenses	12 Months Ended
Accrued Expenses	Dec. 31, 2024
Payables and Accruals [Abstract]
Accrued Expenses	13. ACCRUED EXPENSES Accrued expenses as of December 31, 2024 and 2023, consist of the following (in thousands): December 31, 2024 2023 Compensation $ 47,505 $ 54,593 Professional services 6,260 2,183 Royalties and licenses 5,116 4,381 Software license agreements 4,613 2,233 Sales tax 3,620 2,968 Employee insurance benefits 2,235 2,572 Other 3,194 2,548 Total accrued expenses $ 72,543 $ 71,478

Other Liabilities

Other Liabilities	12 Months Ended
Other Liabilities	Dec. 31, 2024
Other Liabilities Disclosure [Abstract]
Other Liabilities	14. OTHER LIABILITIES Other liabilities as of December 31, 2024 and 2023, consist of the following (in thousands): December 31, 2024 2023 Income taxes payable - non current $ 6,344 $ 3,937 Software license agreements 3,544 1,004 Deferred revenue-non-current 1,415 1,373 Contingent consideration — 100 Total other liabilities $ 11,303 $ 6,414

Long-Term Debt

Long-Term Debt	12 Months Ended
Long-Term Debt	Dec. 31, 2024
Debt Disclosure [Abstract]
Long-Term Debt	15. LONG-TERM DEBT On September 21, 2021, CCC Intelligent Solutions Inc., an indirect wholly owned subsidiary of the Company, together with certain of the Company’s subsidiaries acting as guarantors entered into a credit agreement (as subsequently amended, the “2021 Credit Agreement”). The proceeds of the 2021 Credit Agreement and cash on hand were used to repay all outstanding borrowings under the Company’s previous credit agreement. 2021 Credit Agreement —The 2021 Credit Agreement consists of an $ 800.0 million term loan (the “Term B Loan”) and a revolving credit facility for an aggregate principal amount of $ 250.0 million (the “2021 Revolving Credit Facility” and together with the Term B Loan, the “2021 Credit Facilities”). The 2021 Revolving Credit Facility has a sublimit of $ 75.0 million for letters of credit. The Company received proceeds of $ 798.0 million, net of debt discount of $ 2.0 million, related to the Term B Loan. The Company incurred $ 9.8 million in financing costs related to the Term B Loan, recorded to a contra debt account. The financing costs are being amortized to interest expense over the terms of the Term B Loan and 2021 Revolving Credit Facility using the effective interest method. The Term B Loan requires quarterly principal payments of $ 2.0 million until June 30, 2028 , with the remaining outstanding principal amount required to be paid on the maturity date, September 21, 2028 . If the Company’s leverage ratio, as defined in the 2021 Credit Agreement is greater than 3.5, the Term B Loan requires a prepayment of principal, subject to certain exceptions, in connection with the receipt of proceeds from certain asset sales, casualty events, and debt issuances by the Company, and up to 50 % of annual excess cash flow, as defined in and as further set forth in the 2021 Credit Agreement. When a principal prepayment is required, the prepayment offsets the future quarterly principal payments of the same amount. As of December 31, 2024 and 2023, the Company’ s leverage ratio did not exceed the 3.5 threshold and the Company was not subject to the annual excess cash flow calculation, and as such, no t required to make a prepayment of principal. As of December 31, 2024 and 2023 , the amount outstanding on the Term B Loan is $ 776.0 million and $ 784.0 million, respectively, of which $ 8.0 million is classified as current in the accompanying consolidated balance sheets. Borrowings under the 2021 Credit Facilities bear interest at rates based on the ratio of CCC Intelligent Solutions Inc. and certain of its subsidiaries’ consolidated first lien net indebtedness to consolidated EBITDA for applicable periods specified in the 2021 Credit Agreement. In May 2023, the Company entered into Amendment No. 1 to the 2021 Credit Agreement (the “Amendment”) to establish SOFR as the benchmark rate for determining the applicable interest rate, replacing LIBOR. No other terms, including the amount of borrowings, required payments or maturity date, were changed as a result of the Amendment. The Company did not incur any significant costs associated with the Amendment. Subsequent to the execution of the Amendment, the interest rate per annum applicable to the loans is based on a fluctuating rate of interest equal to the sum of an applicable rate and term SOFR (other than with respect to Euros, Euribor and with respect to British Pounds Sterling, SONIA) with a term as selected by the Company, of one, three or six months (subject to (x) in the case of term loans, a 0.50 % per annum floor and (y) in the case of revolving loans, a 0.00 % per annum floor. Prior to the execution of the Amendment, the interest rate per annum applicable to the loans was based on a fluctuating rate of interest equal to the sum of an applicable rate and, at the Company’s election from time to time, either: (1) a base rate determined by reference to the highest of (a) the rate last quoted by the Wall Street Journal as the “prime rate,” (b) the federal funds effective rate plus 0.50 %, (c) one-month LIBOR plus 1.00 % and (d) with respect to the Term B Loan, 1.50 % and with respect to the 2021 Revolving Credit Facility, 1.00 %, or (2) a Eurocurrency rate determined by reference to LIBOR (other than with respect to Euros, Euribor and with respect to British Pounds Sterling, SONIA) with a term as selected by the Company, of one, three or six months (subject to (x) in the case of term loans, a 0.50 % per annum floor and (y) in the case of revolving loans, a 0.00 % per annum floor). In September 2024, the Company entered into Amendment No. 2 to the 2021 Credit Agreement (the “Second Amendment”) to (i) remove the SOFR credit adjustment applicable to the 2021 Revolving Credit Facility and (ii) reduce the applicable interest rate for the 2021 Revolving Credit Facility by 0.25 %. Additionally, the maturity date for the 2021 Revolving Credit Facility was extended to September 23, 2029, subject to a springing maturity date of June 22, 2028 if greater than $ 234.0 million of the initial Term B Loan remains outstanding as of such date. At the time of entering into the 2021 Credit Agreement, the Company incurred $ 3.1 million in financing costs related to the 2021 Revolving Credit Facility. The Company incurred $ 0.7 million in financing costs related to the Second Amendment. These costs were recorded to a deferred financing fees asset account and are being amortized to interest expense over the term of the 2021 Revolving Credit Facility. A quarterly com mitment fee of up to 0.50 % is payable on the unused portion of the 2021 Revolving Credit Facility. During the years ended December 31, 2024, 2023, and 2022 , the weighted-average interest rate on the outstanding borrowings under the Term B Loan was 7.6 %, 7.5 % and 4.2 %, respectively. The Company has an outstanding standby letter of credit for $ 0.7 million which reduces the amount available to be borrowed under the 2021 Revolving Credit Facility and as of December 31, 2024 and 2023 , $ 249.3 million was available to be borrowed. Borrowings under the 2021 Credit Agreement are guaranteed by Cypress Holdings Intermediate Holdings II, Inc., and certain of its US subsidiaries by a perfected first priority lien on the stock of CCC Intelligent Solutions Inc., and substantially all of its assets, subject to various limitations and exceptions. The 2021 Credit Agreement contains representations and warranties, and affirmative and negative covenants, that among other things, restrict, subject to certain exceptions, our ability to: incur additional indebtedness, incur liens, engage in mergers, consolidations, liquidations or dissolutions; pay dividends and distributions on, or redeem, repurchase or retire our capital stock; and make certain investments, acquisitions, loans, or advances. The terms of the 2021 Credit Agreement include a financial covenant which requires that, at the end of each fiscal quarter, if the aggregate amount of borrowings under the 2021 Revolving Credit Facility exceeds 35 % of the aggregate commitments, the Company’s leverage ratio cannot exceed 6.25 to 1.00 . Borrowings under the 2021 Revolving Credit Facility did not exceed 35% of the aggregate commitments and the Company was not subject to the leverage test during the years ended December 31, 2024 and 2023. Long-term debt as December 31, 2024 and 2023, consists of the following (in thousands): December 31, 2024 2023 Term B Loan $ 776,000 $ 784,000 Term B Loan—discount ( 1,175 ) ( 1,436 ) Term B Loan—deferred financing fees ( 5,772 ) ( 7,060 ) Term B Loan—net of discount and fees 769,053 775,504 Less: Current portion ( 8,000 ) ( 8,000 ) Total long-term debt—net of current portion $ 761,053 $ 767,504 The table below is a roll forward of the Company ’s contra debt deferred financing fees and discount and deferred financing fees asset balances (in thousands): Deferred Discount— Financing Contra Fees Debt Balance—December 31, 2022 $ 10,485 $ 1,669 Amortization of fees and discount ( 1,753 ) ( 233 ) Balance—December 31, 2023 8,732 1,436 Payment of fees associated with revolver modification 719 — Amortization of fees and discount ( 1,871 ) ( 261 ) Balance—December 31, 2024 $ 7,580 $ 1,175 As of December 31, 2024 and 2023, the deferred financing fees asset balance includes $ 1.7 million in relation to the 2021 Revolving Credit Facility. Scheduled Payments for Debt —Principal amounts due in each of the next five years, as of December 31, 2024, are as follows (in thousands): Years Ending December 31: 2025 $ 8,000 2026 8,000 2027 8,000 2028 8,000 2029 744,000 Total $ 776,000 Interest Rate Caps —In August 2022, the Company entered into two interest rate cap agreements to reduce its exposure to increases in interest rates applicable to its floating rate long-term debt. The interest rate cap agreements have an aggregate notional amount of $ 600.0 million and a one-month SOFR cap rate of 4.00 % through their expiration in July 2025 . The fair value of the interest rate cap agreements was estimated using inputs that were observable or that could be corroborated by observable market data and therefore, was classified within Level 2 of the fair value hierarchy as of December 31, 2024 and 2023. The Company did not designate its interest rate cap agreements as hedging instruments and records the changes in fair value within earnings. During the year ended December 31, 2023, the Company transitioned the referenced interest rate within the two interest rate cap agreements from LIBOR to SOFR by terminating the original agreements and simultaneously entering into new agreements. The terms of the new agreements were unchanged except for the referenced interest rate. The Company elected the optional expedients available within ASC 848 to allow for this transition without any modification to the derivative classification of the interest rate cap agreements. As of December 31, 2024 , the interest rate cap agreements had a fair value of $ 1.0 million, classified within other current assets in the accompanying consolidated balance sheet. As of December 31, 2023 , the interest rate cap agreements had a fair value of $ 6.2 million classified within other assets in the accompanying consolidated balance sheet. Cash received related to the interest rate cap agreements was $ 7.2 million and $ 6.5 million for the years ended December 31, 2024 and December 31, 2023, respectively, recorded within other income-net on the consolidated statement of operations and comprehensive income (loss) . Cash received related to the interest rate cap agreements was insignificant for the year ended December 31, 2022.

Long-Term Licensing Agreement

Long-Term Licensing Agreement	12 Months Ended
Long-Term Licensing Agreement	Dec. 31, 2024
Contractors [Abstract]
Long-Term Licensing Agreement	16. LONG-TERM LICENSING AGREEMENT During 2018, the Company entered into a licensing agreement with a third party to obtain a perpetual software license (“Licensing Agreement”) for a database structure, tools, and historical data used within the Company’s software. The Company has included the present value of the future payments required as a long-term licensing agreement within the accompanying consolidated balance sheets. The present value of the future payments was computed using an effective annual interest rate of 6.25 %, and the Licensing Agreement requires the Company to make quarterly principal and interest installment payments of approximately $ 1.2 million through December 2031. The present value of the future cash flows upon execution of the agreement was $ 45.6 million, which included an original discount of $ 23.2 million. At December 31, 2024, the remaining liability, net of the dis count was $ 27.7 million, with $ 3.3 million classified as current. At December 31, 2023 , the remaining liability, net of the discount was $ 30.8 million, with $ 3.1 million classified as current. The discount was recorded to a contra liability account and is being amortized to interest expense over the term of the agreement using the effective interest method. During the years ended December 31, 2024, 2023 and 2022, the Company recognized $ 1.9 million , $ 2.0 million and $ 2.2 million, respectively, in interest expense related to the Licensing Agreement. The unamortized discount as of December 31, 2024 and 2023 was $ 6.7 million and $ 8.6 million, respectively. Principal amounts due in each of the next five years and thereafter for the Licensing Agreement as of December 31, 2024, are as follows (in thousands): Years Ending December 31: 2025 $ 3,257 2026 3,466 2027 3,689 2028 3,926 2029 4,177 Thereafter 9,177 Total $ 27,692

Redeemable Non-Controlling Inte

Redeemable Non-Controlling Interest	12 Months Ended
Redeemable Non-Controlling Interest	Dec. 31, 2024
Noncontrolling Interest [Abstract]
Redeemable Non-Controlling Interest	17. REDEEMABLE NON-CONTROLLING INTEREST On March 12, 2020 (the “Close Date”), the Company closed a stock purchase agreement (the “Stock Purchase Agreement”) with a third-party investor (the “Investor”) for purchase by the Investor of Series A Preferred Stock in CCCIS Cayman Holdings Limited (“CCC Cayman”), the parent of the Company’s China operations. On the Close Date, CCC Cayman, a subsidiary of the Company, issued 1,818 shares of Series A Preferred Stock (the “Preferred Shares”) at $ 7,854 per share to the Investor for net proceeds of $ 14.2 million. As of December 31, 2024 and 2023, on an as-converted basis, the Preferred Shares represent an aggregate 10.0 % ownership interest of the issued and outstanding capital stock of CCC Cayman, or 8.6 % on a fully-diluted basis. The Preferred Shares are entitled to non-cumulative dividends at an annual rate of 8.0 %, when and if declared. At the option of the Investor, the Preferred Shares are convertible into ordinary shares of CCC Cayman, initially on a one-for-one basis but subject to potential adjustment, as defined by the Stock Purchase Agreement, at any time, or automatically upon the closing of an initial public offering. The Preferred Shares are redeemable upon an actual or deemed redemption event as defined in the Stock Purchase Agreement or at the option of the Investor beginning on the five-year anniversary of the Close Date, if an actual or deemed redemption event has not yet occurred. The redemption price, as defined by the Stock Purchase Agreement, is equal to the original issue price of the Preferred Shares, plus 10.0 % compound interest per annum on the Preferred Share issue price, plus any declared but unpaid dividends on the Preferred Shares. The Preferred Shares are entitled to distributions upon the occurrence of a sale or liquidation of CCC Cayman representing an amount that is equal to the original issue price of the Preferred Shares, plus 10.0% compound interest per annum on the Preferred Share issue price, plus any declared but unpaid dividends. The Preferred Shares do not participate in net income or losses. As of December 31, 2024 and 2023, the Investor’s ownership in CCC Cayman is classified in mezzanine equity as a redeemable non-controlling interest, because it is redeemable on an event that is not solely in the control of the Company. As of May 31, 2023, the Company determined it was probable the non-controlling interest would become redeemable and began to accrete the non-controlling interest to its redemption value. Changes in the carrying value of the non-controlling interest are recorded as adjustments to additional paid-in capital. The activity impacting the redeemable non-controlling interest during the years ending December 31 is presented below (in thousands): Year Ended December 31, 2024 2023 2022 Balance at beginning of period $ 16,584 $ 14,179 $ 14,179 Accretion of redeemable non-controlling interest 5,095 2,405 — Balance at end of period $ 21,679 $ 16,584 $ 14,179

Capital Stock

Capital Stock	12 Months Ended
Capital Stock	Dec. 31, 2024
Stockholders' Equity Note [Abstract]
Capital Stock	18. CAPITAL STOCK Preferred Stock —The Company is authorized to issue up to 100,000,000 shares of undesignated preferred stock with a par value of $ 0.0001 per share with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s Board of Directors (the “Board”). As of December 31, 2024 , there were no shares of preferred stock issued or outstanding. Common Stock —The Company is authorized to issue up to 5,000,000,000 shares of common stock with a par value of $ 0.0001 per share. Each holder of common stock is entitled to one (1) vote for each share of common stock held of record by such holder on all matters voted upon by the stockholders, subject to the restrictions set out in the Certificate of Incorporation. Holders of common stock are entitled to receive any dividends as may be declared from time to time by the board of directors. Upon a liquidation event, subject to the rights of the holders of any Preferred Stock issued and outstanding at such time, any distribution shall be made on a pro rata basis to the common stockholders. There we re 629,207,115 and 603,128,781 shares of common stock issued and outstanding as of December 31, 2024 and 2023, respectively. Effective upon closing of the Business Combination, 8,625,000 shares issued and held by Dragoneer Growth Opportunities Holdings (the “Sponsor Vesting Shares”) became non-transferable and subject to forfeiture on the tenth anniversary of Closing if neither of the following triggering events has occurred: (a) the share price of the Company’s common stock has been greater than or equal to $ 13.00 per share for any twenty trading days within any thirty consecutive trading day period beginning after Closing, or (b) a change in control as defined in the Business Combination Agreement. As part of the Business Combination, 15.0 million shares of the Company’s common stock (the “Company Earnout Shares”) shall be issued to CCCIS shareholders existing as of immediately prior to Closing and holders of vested and unvested equity awards of CCCIS as of the date of the Business Combination Agreement (subject to continued employment), following a triggering event (“CCC Triggering Event”). A CCC Triggering Event is defined as the earlier of (a) the first date on which the shares of the Company’s common stock have traded for greater than or equal to $ 15.00 per share for any twenty trading days within any thirty consecutive trading day period commencing after the Closing or (b) a change in control as defined in the Business Combination Agreement. If a CCC Triggering Event does not occur within ten years after Closing, the CCC Earnout Shares will be forfeited. The Company Earnout Shares are no t issued shares and are excluded from the shares of common stock issued and outstanding. Secondary Offerings and Stock Repurchase —During the year ended December 31, 2024 , certain existing stockholders completed secondary offerings where the selling stockholders sold an aggregate of 171.5 million shares of the Company's common stock. The Company did no t receive proceeds from the sale of the shares by the selling stockholders. In connection with the offerings, the Company incurred costs of $ 1.9 million during the year ended December 31, 2024, included within general and administrative expenses on the consolidated statement of operations and comprehensive income (loss). In November 2023, certain existing stockholders completed a secondary offering where the selling stockholders sold 65.0 million shares of common stock. In addition, the underwriters exercised an option granted by the selling stockholders to purchase an additional 4.875 million shares of the Company’s common stock at the same per share price. The Company did no t receive any of the proceeds from the sale of the shares by the selling stockholders. Concurrent with the closing of the secondary offering in November 2023, 32.5 million shares of common stock were repurchased by the Company for an aggregate price of $ 328.5 million. The shares repurchased by the Company were formally retired. The excess purchase price over par value was charged directly to accumulated deficit. In connection with the offering and repurchase, the Company incurred costs of $ 2.0 million during the year ended December 31, 2023, included within general and administrative expenses on the consolidated statement of operations and comprehensive income (loss). During the year ended December 31, 2022, certain existing stockholders completed a secondary offering where the selling stockholders sold an aggregate of 20.0 million shares of the Company ’ s common stock. The Company did no t receive proceeds from the sale of the shares by the selling stockholders. In connection with the offerings, the Company incurred costs of $ 1.2 million during the year ended December 31, 2022, included within general and administrative expenses on the consolidated statement of operations and comprehensive income (loss). Share Repurchase Program —In December 2024, the Company’ s Board authorized the repurchase of up to $ 300.0 million of the Company's outstanding shares of common stock (the “2024 Share Repurchase Program”). Under the 2024 Share Repurchase Program, the Company is authorized to repurchase shares through open market purchases, privately negotiated transactions, accelerated share repurchases, or by other means, including through the use of trading plans intended to qualify under Rule 10b5-1 under the Securities Exchange Act of 1934, in accordance with applicable securities laws and other restrictions. The 2024 Repurchase Program does not obligate the Company to repurchase any amount of common stock. The specific timing and amount of repurchases may vary based on available capital resources, market conditions, management’s discretion, securities law limitations, and other factors. As of December 31, 2024, the Company has no t repurchased any shares and $ 300.0 million remains available to purchase outstanding shares under the Share Repurchase Program.

Employee Benefit Plans

Employee Benefit Plans	12 Months Ended
Employee Benefit Plans	Dec. 31, 2024
Employee Benefit Plans	19. EMPLOYEE BENEFIT PLANS The Company sponsors a tax-qualified defined contribution savings and investment plan, CCC 401(k) Retirement Savings and Investment Plan (the “Savings Plan”). Participation in the Savings Plan is voluntary with substantially all domestic employees eligible to participate. Expenses related to the Savings Plan consist primarily of the Company’s contributions that are based on percentages of employees’ contributions. The defined contribution expense for the years ended December 31, 2024, 2023 and 2022 was $ 7.0 million, $ 6.5 million and $ 6.1 million, respectively.

Stock Incentive Plans

Stock Incentive Plans	12 Months Ended
Stock Incentive Plans	Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]
Stock Incentive Plans	20. STOCK INCENTIVE PLANS In July 2021, the Company’s board of directors and stockholders adopted and approved the CCC Intelligent Solutions Holdings Inc. 2021 Incentive Equity Plan (the “2021 Plan”). Prior to the adoption of the 2021 Plan, the Company maintained its 2017 Stock Option Plan (the “2017 Plan”). The purpose of the 2021 Plan is to enable the Company to attract, retain, and motivate employees, consultants, and independent members of the board of directors of the Company and its subsidiaries by allowing them to become owners of common stock enabling them to benefit directly from the growth, development, and financial successes of the Company. Awards granted under the 2017 Plan had either time-based vesting or performance-based vesting with a market condition. Options expire on the tenth anniversary of the grant date. The total number of shares of common stock that will be reserved and that may be issued under the 2021 Plan will automatically increase on the first day of each fiscal year by a number of shares equal to 5.0 % of the total number of shares of common stock outstanding on the last day of the prior fiscal year or such lesser amount as determined by the board o f directors. For the year ended December 31, 2024 , the board of directors allowed the number of shares of common stock reserved under the 2021 Plan to increase, in accordance with the terms of the 2021 Plan, by 36,187,726 shares. For the year ended December 31, 2023, the board of directors elected not to increase the number of shares of common stock reserved under the 2021 Plan. The following table summarizes the shares of common stock reserved for future issuance under the 2021 Plan as of December 31, 2024 and 2023: December 31, 2024 2023 Stock options outstanding 23,349,505 35,788,469 Restricted stock units outstanding 31,042,552 36,329,881 Restricted stock units available for future grant 75,673,991 49,451,502 Reserved for ESPP 10,403,530 4,981,134 Common stock reserved for future issuance 140,469,578 126,550,986 Restricted Stock Units —RSUs are convertible into shares of the Company’s common stock upon vesting. The grant date fair value of each RSU with time-based vesting and performance-based vesting is determined using the fair value of the underlying common stock on the date of grant. The grant date fair value of each performance-based RSU with a market condition is estimated on the date of grant using the Monte Carlo simulation model. Stock-based compensation for RSUs with time-based vesting is recognized on a straight-line basis over the requisite service period for the number of RSUs that are probable of vesting. Stock-based compensation for performance-based RSUs or performance-based RSUs with a market condition is recognized on a straight-line basis over the performance period based on the number of RSUs that are probable of vesting. During 2023, the Company’ s Board approved modifications to the performance-based RSUs subject to a market condition. The modifications included: (i) the extension of the performance period by one year, (ii) a change to the performance criteria, (iii) a change to the number of units to be issued depending on performance and (iv) for certain grants, imposing a maximum number of units to be issued depending on performance equal to 100 % of the target. The modification to the performance-based RSUs subject to a market condition resulted in incremental stock-based compensation expense of $ 67.0 million, which will be recognized ratably over the modified performance periods. The table below summarizes the RSU activity for the years ended December 31, 2024, 2023, and 2022: Weighted- Average Shares Fair Value Non-vested RSUs—December 31, 2021 18,558,211 $ 10.74 Granted 16,426,878 10.07 Vested ( 2,324,324 ) 11.22 Canceled ( 1,372,077 ) 10.93 Non-vested RSUs—December 31, 2022 31,288,688 10.34 Granted 12,574,115 9.01 Vested ( 5,707,373 ) 10.57 Canceled ( 1,825,549 ) 9.90 Non-vested RSUs—December 31, 2023 36,329,881 10.56 Granted 10,538,732 11.80 Vested ( 14,232,526 ) 10.76 Canceled ( 1,593,535 ) 10.68 Non-vested RSUs—December 31, 2024 31,042,552 $ 10.92 During the year ended December 31, 2024 , the Company granted 10,538,732 RSUs, of which 8,266,649 have time-based vesting requirements and 2,272,083 have performance-based vesting requirements. During the year ended December 31, 2023, the Company granted 12,574,115 RSUs, of which 10,946,224 have time-based vesting requirements and 1,627,891 have performance-based vesting requirements. During the year ended December 31, 2022 , the Company granted 16,426,878 RSUs, of which 14,859,033 have time-based vesting requirements, 783,949 have performance-based vesting requirements and 783,896 have performance-based with a market condition vesting requirements. The Company did not grant any performance-based RSUs with a market condition during the year ending December 31, 2024. The valuation of the performance-based RSUs with a market condition granted during the year ended December 31, 2022 and modified during the year ended December 31, 2023, was determined using a Monte Carlo Simulation model using the following assumptions: 2023 2022 Expected term (in years) 1.1 - 2.1 2.8 Expected volatility 28 %- 32 % 35 % Expected dividend yield 0 % 0 % Risk-free interest rate 4.36 %- 4.87 % 2.28 % The Company uses a pre-vesting forfeiture rate to estimate the number of options that are expected to vest that was based on the Company’s historical turnover rate. Stock Options — The table below summarizes the option activity for the years ended December 31, 2024, 2023 and 2022 : Weighted- Weighted-Average Average Remaining Aggregate Exercise Contractual Life Intrinsic Value Shares Price (in years) (in thousands) Options outstanding—December 31, 2021 55,644,495 $ 2.95 6.0 $ 469,591 Exercised ( 10,081,164 ) 2.74 Forfeited and canceled ( 314,071 ) 4.46 Options outstanding—December 31, 2022 45,249,260 $ 2.99 4.9 258,470 Exercised ( 8,923,718 ) 2.85 Forfeited and canceled ( 537,073 ) 6.88 Options outstanding—December 31, 2023 35,788,469 $ 2.96 4.0 301,563 Exercised ( 12,427,044 ) 2.69 Forfeited and canceled ( 11,920 ) $ 3.40 Options outstanding—December 31, 2024 23,349,505 $ 3.11 3.2 $ 201,305 Options exercisable—December 31, 2024 22,539,617 $ 2.97 3.1 $ 197,353 Options vested and expected to vest—December 31, 2024 23,333,942 $ 3.11 3.1 $ 201,237 The fair value of the options that vested during the year ended December 31, 2024 was $ 2.2 million. During the year ended December 31, 2024 , the Company issued 12,427,044 shares of common stock upon exercise of stock options. During the year ended December 31, 2023 , the Company issued 8,923,718 shares of common stock upon exercise of stock options. During the year ended December 31, 2022, the Company issued 10,074,354 shares of common stock upon exercise of 10,081,164 stock options. As part of cashless exercises, 6,810 shares were applied to the exercise price and tax obligations of the option holders. Cayman Equity Incentive Plan —During the year ended December 31, 2022, the Company adopted the CCCIS Cayman Holdings Employees Equity Incentive Plans (“Cayman Incentive Plans”), which provide for the issuance of stock option awards in CCC Cayman (“Cayman Awards”) to eligible employees of the Company’s China subsidiaries. Pursuant to the Cayman Incentive Plans, the number of Cayman Shares that may be subject to stock incentives is not to exceed 3,000,000 in the aggregate. Awards under the Cayman Incentive Plans are settled in cash and thus accounted for as liability awards. Awards granted under the Cayman Incentive Plans have time-based vesting and expire on the tenth anniversary of the grant date. The Company records stock-based compensation expense on a straight-line basis over the vesting period. Time-based awards generally vest ratably over a four-year period based on continued service. Vesting of the time-based awards can be accelerated in certain circumstances, such as an initial public offering, as defined in the Cayman Incentive Plans. During the years ended December 31, 2024, 2023 and 2022, the Company granted 761,743 , 539,400 and 1,303,000 stock options under the Cayman Incentive Plans, respectively. The exercise price of the optio ns granted is at least equal to the fair value of the underlying shares at the grant date. As of December 31, 2024 and 2023, 2,363,514 and 1,735,900 , respectively, are outstanding, no ne of which are exercisable. Awards under the Cayman Incentive Plans are remeasured at fair value each reporting period with the change in fair value recognized as stock-based compensation expense in that period. The fair values of the outstanding awards at December 31, 2024, 2023 and 2022 were based on the Black-Scholes option pricing model using the following assumptions: 2024 2023 2022 Expected term (in years) 4.25 - 5.42 5.25 - 5.42 6.25 Expected volatility 40 % 40 % 40 % Expected dividend yield 0 % 0 % 0 % Risk-free interest rate 4.4 % 3.8 % 3.5 % Employee Stock Purchase Plan —In October 2021, the Company’s Board adopted the ESPP. The ESPP is intended to qualify as an employee stock purchase plan under Section 423 of the Internal Revenue Code of 1986, as amended. Under the ESPP, employee purchases occur at the end of discrete offering periods. The six-month offering periods begin on January 1 and July 1 of each year (or such other date determined by the board of directors). Under the ESPP, eligible employees can acquire shares of the Company’s common stock by accumulating funds through payroll deductions. Employees generally are eligible to participate in the ESPP if they are a U.S. employee and are employed for at least 20 hours per week. The Company may impose additional restrictions on eligibility. Eligible employees can select a rate of payroll deduction between 1 % and 15 % of their compensation. The purchase price for shares of common stock purchased under the ESPP is 85 % of the lesser of the fair market value of the Company’s common stock on (i) the first day of the applicable offering period or (ii) the last day of the purchase period in the applicable offering period. An employee’s participation automatically ends upon termination of employment for any reason. As of December 31, 2024 and 2023, 12,062,991 and 6,031,287 shares of common stock, respectively, are reserved for sale under the ESPP . The aggregate number of shares reserved for sale under the ESPP increases on January 1 by the lesser of 1 % of the total numbers of shares outstanding or a lesser amount as determined by the Board. For the year ended December 31, 2024, the board of directors allowed the number of shares of common stock reserved under the ESPP to increase, in accordance with the terms of the ESPP, by 6,031,287 shares. For the year ended December 31, 2023, the board of directors elected not to increase the number of shares of common stock reserved under the ESPP. During the years ending December 31, 2024 , 2023 and 2022, 608,891 , 641,691 and 408,879 shares were sold under the ESPP, respectively. The fair value of ESPP purchase rights sold during the years ended December 31, 2024, 2023 and 2022 was estimated using the Black-Scholes option pricing model with the following assumptions: 2024 2023 2022 Expected term (in years) 0.5 0.5 0.5 Expected volatility 25 %- 29 % 30 %- 51 % 47 % Expected dividend yield 0 % 0 % 0 % Risk-free interest rate 5.2 %- 5.5 % 2.5 %- 4.7 % 0.2 % Company Earnout Shares —Pursuant to the Business Combination Agreement, CCCIS shareholders and option holders, subject to continued employment, have the right to receive up to an additional 13.5 million shares and 1.5 million shares of common stock, respectively, if, before the tenth anniversary of the Closing, (a) the share price has been greater than or equal to $ 15.00 per share for any twenty trading days within any thirty consecutive trading day period beginning after Closing, or (b) there is a change in control, as defined in the Business Combination Agreement. The fair value of the Company Earnout Shares was estimated on the date of the grant, using the Monte Carlo simulation method. Compensation expense on the shares granted to option holders was recorded ratably over the implied service period of five months beginning on July 30, 2021. Stock-Based Compensation —Stock-based compensation expense has been recorded in the accompanying consolidated statements of operations and comprehensive income (loss) as follows for the years ended December 31, 2024, 2023 and 2022 (in thousands): Year Ended December 31, 2024 2023 2022 Cost of revenues $ 9,342 $ 8,802 $ 5,812 Research and development 47,191 25,467 19,536 Sales and marketing 28,083 33,204 25,309 General and administrative 86,422 77,045 58,840 Total stock-based compensation expense $ 171,038 $ 144,518 $ 109,497 As of December 31, 2024 , there was $ 159.0 million of unrecognized stock compensation expense related to non-vested time-based awards which is expected to be recognized over a weighted-average period of 2.4 years. As of December 31, 2024 , there was $ 34.2 million of unrecognized stock-based compensation expense related to non-vested performance-based awards, which is expected to be recognized over a weighted-average period of 1.1 years.

Warrants

Warrants	12 Months Ended
Warrants	Dec. 31, 2024
Warrants and Rights Note Disclosure [Abstract]
Warrants	21. WARRANTS Upon consummation of the Business Combination, the Company assumed the outstanding Private Warrants issued by Dragoneer. Private Warrants could only be exercised for a whole number of shares of the Company’s common stock. Each whole Private Warrant entitled the registered holder to purchase one share of the Company’s common stock. All warrants had an exercise price of $ 11.50 per share, subject to adjustment, beginning on August 29, 2021, and were to expire on July 30, 2026 or earlier upon redemption or liquidation. Additionally, the Private Warrants were exercisable on a cashless basis and were non-redeemable, so long as they were held by the initial purchasers or their permitted transferees. If the Private Warrants were held by someone other than the initial purchasers or their permitted transferees, the Private Warrants were redeemable by the Company and exercisable by such holders. During May 2024, the Company redeemed all of the outstanding Private Warrants for aggregate of 3,809,200 shares of the Company’s common stock. The holder of the Private Warrants received 0.214 shares of common stock for each Private Warrant exchanged. No cash was paid by the Company in exchange for the redeemed Private Warrants. The Private Warrants were valued at the time of redemption using the Black-Scholes option pricing model with the following assumptions: Expected term (in years) 2.2 Expected volatility 31 % Expected dividend yield 0 % Risk-free interest rate 4.8 % The estimated fair value of each Private Warrant using the Company's stock price on the date of redemption and above assumptions was $ 2.09 . Following the redemption, the Company had no Private Warrants outstanding. As of December 31, 2023, the Company had 17.8 million Private Warrants outstanding. The Company recognized income (expense) of $ 14.4 million, ($ 15.1 ) million and $ 26.1 million as a change in fair value of warrant liabilities in the consolidated statements of operations and comprehensive income (loss) for years ended December 31, 2024, 2023, and 2022, respectively. As of December 31, 2023 the Company’s warrant liability was $ 51.5 million.

Commitments

Commitments	12 Months Ended
Commitments	Dec. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments	22. COMMITMENTS Purchase Obligations —The Company has long-term agreements with suppliers and other parties related to licensing data used in its solutions and services, outsourced data center, disaster recovery, and software as a service that expire at various dates through 2031 . Under the terms of these agreements with suppliers, the Company has future minimum obligations as of December 31, 2024 as follows (in thousands): Years Ending December 31: 2025 $ 48,904 2026 48,362 2027 65,714 2028 9,945 2029 9,900 Thereafter 19,800 Total $ 202,625 Guarantees —The Company’s services and solutions are typically warranted to perform in a manner consistent with general industry standards that are reasonably applicable and substantially in accordance with the Company’s services and solutions documentation under normal use and circumstances. The Company’s services and solutions are generally warranted to be performed in a professional manner and to materially conform to the specifications set forth in the related customer contract. The Company’s arrangements also include certain provisions for indemnifying customers against liabilities if its services and solutions infringe a third party’s intellectual property rights. To date, the Company has not incurred any material costs as a result of such indemnifications or commitments and has not accrued any liabilities related to such obligations in the accompanying consolidated financial statements. Employment Agreements —The Company is a party to employment agreements with key employees that provide for compensation and certain other benefits. These agreements also provide for severance payments and bonus under certain circumstances.

Legal Proceedings and Contingen

Legal Proceedings and Contingencies	12 Months Ended
Legal Proceedings and Contingencies	Dec. 31, 2024
Legal Proceedings And Contingencies [Abstract]
Legal Proceedings and Contingencies	23. LEGAL PROCEEDINGS AND CONTINGENCIES In the ordinary course of business, the Company is from time to time, involved in various pending or threatened legal actions. The litigation process is inherently uncertain, and it is possible that the resolution of such matters might have a material adverse effect upon the Company’s consolidated financial condition and/or results of operations. The Company’s management believes, based on current information, matters currently pending or threatened are not expected to have a material adverse effect on the Company’s consolidated financial position or results of operations.

Related Parties

Related Parties	12 Months Ended
Related Parties	Dec. 31, 2024
Related Party Transactions [Abstract]
Related Parties	24. RELATED PARTIES The Company has engaged in transactions within the ordinary course of business with entities affiliated with its principal equity owners. The following table summarizes revenues and expenses with entities affiliated with one of its principal equity owners for the years ended December 31, 2024, 2023 and 2022 (in thousands): December 31, 2024 2023 2022 Revenues Credit card processing $ 1,382 $ 1,051 $ 811 Expenses Employee health insurance benefits 4,202 3,641 3,166 IT security software 510 ^ ^ Board of director fees for services, including related travel and out-of-pocket reimbursements 275 306 131 Human resources support services * 313 237 IT development software * 130 * Sales tax processing and license fees for tax information ^ ^ 561 * Not significant. ^ Not a related party during the year ended December 31. The Company had a related party payable due to its employee health insurance benefits vendor for $ 0.3 million and $ 0.5 million as of December 31, 2024 and December 31, 2023, respectively. During the year ended December 31, 2023, as part of the secondary offering (see Note 18), the Company entered into a share repurchase agreement with its principal equity owner, pursuant to which the Company agreed to repurchase 32.5 million shares of the Company ’ s common stock at a price equal to the price per share paid by the underwriters, net of commissions and discounts. The aggregate price paid by the Company for the repurchased shares was $ 328.5 million.

Other Income-Net

Other Income-Net	12 Months Ended
Other Income-Net	Dec. 31, 2024
Other Income, Nonoperating [Abstract]
Other Income-Net	25. OTHER INCOME—NET Other income—net consists of the following for the years ended December 31 (in thousands): Year Ended December 31, 2024 2023 2022 (Loss) gain from change in fair value of derivative instruments $ ( 5,233 ) $ ( 5,743 ) $ 5,663 Income from derivative instruments 7,167 6,460 — Other income–net 302 1,082 699 Total other income–net $ 2,236 $ 1,799 $ 6,362

Net Income (Loss) Per Share

Net Income (Loss) Per Share	12 Months Ended
Net Income (Loss) Per Share	Dec. 31, 2024
Earnings Per Share [Abstract]
Net Income (Loss) Per Share	26. NET INCOME (LOSS) PER SHARE The Company calculates basic earnings per share by dividing the net income (loss) by the weighted average number of shares of common stock outstanding for the period. The diluted earnings per share is computed by assuming the exercise, settlement and vesting of all potential dilutive common stock equivalents outstanding for the period using the treasury stock method. We exclude common stock equivalent shares from the calculation if their effect is anti-dilutive. In a period where the Company is in a net loss position, the diluted loss per share is calculated using the basic share count. The 8,625,000 Sponsor Vesting Shares that are issued and outstanding at December 31, 2024, 2023 and 2022 are excluded from the weighted average number of shares of common stock outstanding until the vesting requirement is met and the restriction is removed. The following table sets forth a reconciliation of the numerator and denominator used to compute basic earnings per share of common stock (in thousands, except for share and per share data). Year Ended December 31, 2024 2023 2022 Numerator Net income (loss) $ 31,240 $ ( 90,071 ) $ 38,406 Accretion of redeemable non-controlling interest ( 5,095 ) ( 2,405 ) — Net income (loss) attributable to common stockholders $ 26,145 $ ( 92,476 ) $ 38,406 Denominator Weighted average shares of common stock—basic 610,761,424 617,889,384 607,760,886 Dilutive effect of stock-based awards 31,114,101 — 35,080,710 Weighted average shares of common stock—diluted 641,875,525 617,889,384 642,841,596 Net income (loss) per share attributable to common stockholders: Basic $ 0.04 $ ( 0.15 ) $ 0.06 Diluted $ 0.04 $ ( 0.15 ) $ 0.06 Common stock equivalent shares of 0.2 million, 33.7 million and 8.1 million were excluded from the computation of diluted per share amounts for the years ended December 31, 2024, 2023 and 2022, respectively, because their effect was anti-dilutive.

Segment Information And Informa

Segment Information And Information About Geographic Areas	12 Months Ended
Segment Information And Information About Geographic Areas	Dec. 31, 2024
Segment Reporting [Abstract]
Segment Information And Information About Geographic Areas	27. SEGMENT INFORMATION AND INFORMATION ABOUT GEOGRAPHIC AREAS The Company organizes its segments around its operations by geographic region and operates in one reportable segment (the “Domestic Segment”). The Domestic Segment provides a SAAS platform for the P&C insurance economy and derives revenues from providing customers with software subscriptions to the platform in addition to providing professional services and non-software services. The accounting policies of the Domestic Segment are the same as those described in Note 2. The Company does not have intra-entity sales or transfers. The chief operating decision maker (“CODM”) of the Domestic Segment is the Company’s chief executive officer . The CODM assesses performance for the Domestic Segment at the segment level and uses the segment’s performance when making strategic decisions on how to allocate resources and capital. In addition, the segment’s performance is used when reviewing actual financial performance against budget and for establishing incentive compensation targets. The CODM uses net income to evaluate income generated from operations in deciding whether to reinvest profits into the Domestic Segment or use for acquisitions, to pay dividends or repurchase outstanding shares of common stock . The CODM reviews financial information, including significant expenses, of the Domestic Segment on an adjusted basis, excluding certain items that may not be indicative of the Company’s recurring core business operations. This financial information reviewed by the CODM is accompanied by information about revenue by type of service and geographic region, for purposes of allocating resources and evaluating financial performance. The Company’s financial information and performance measures used by the CODM do not include a metric or measure including segment assets and thus, no asset information is provided to the CODM for the purpose of making strategic decisions or allocating resources. The following table presents the Company’s financial information about reported segment revenue, significant segment expenses, and the Company’s reconciliation of segment profit (loss) to consolidated net income (loss) (in thousands): Year Ended December 31, 2024 2023 2022 Revenues: Revenue—Domestic Segment $ 938,031 $ 859,548 $ 774,697 Revenue—Other (1) 6,769 6,830 7,751 Total Revenue 944,800 866,378 782,448 Segment Expenses: Data licenses and royalties—adjusted (2) 43,698 40,957 39,837 Customer services—adjusted (3) 98,589 90,801 83,241 Products and technology—adjusted (4) 255,814 241,324 215,140 Revenue enablement—adjusted (5) 120,088 113,508 99,638 General corporate and administrative—adjusted (6) 69,641 62,985 58,349 Other segment items (7) 145,819 198,358 104,144 Amortization expense 80,768 98,035 97,993 Depreciation expense 42,809 36,793 27,898 Interest expense 64,608 63,577 38,990 Interest income ( 12,203 ) ( 16,252 ) ( 908 ) Significant non-cash items (8) ( 9,145 ) 20,839 ( 31,736 ) Income tax provision 13,074 5,524 11,456 Total segment expenses 913,560 956,449 744,042 Net income (loss) including non-controlling interest $ 31,240 $ ( 90,071 ) $ 38,406 1 Represents revenue from an insignificant segment that does not meet the quantitative thresholds for determining reportable segments. 2 Data licenses and royalties – adjusted expenses include third party costs for data licensing and royalty fees. Data licenses and royalties – adjusted excludes stock-based compensation expense and related employer payroll tax and contract termination costs. 3 Customer services – adjusted expenses include the costs to deliver services to customers, including software configuration, integration and implementation services and customer support activities. Customer services – adjusted excludes stock-based compensation expense and related employer payroll tax. 4 Products and technology – adjusted expenses include costs related to the engineering, product management design and development of the Company’s solutions, and costs related to the Company’s hosting environments, support of production infrastructure, support of internal systems and infrastructure and IT security. Products and technology – adjusted excludes stock-based compensation expense and related employer payroll tax and contract termination costs. 5 Revenue enablement – adjusted expenses include costs for sales and marketing functions, including sales incentives, advertising costs, and event costs. Revenue enablement – adjusted excludes stock-based compensation expense and related employer payroll tax. 6 General corporate and administrative – adjusted expenses include costs for our executive management and administrative employees, including finance and accounting, human resources, facilities and legal functions. Additional expenses include professional service fees, insurance premiums and other corporate expenses that are not allocated to the other adjusted expense categories. General corporate and administrative – adjusted excludes stock-based compensation expense and related employer payroll tax, litigation costs in which the Company is the plaintiff and related antitrust matters, costs associated with the acquisition and integration of completed and potential mergers and acquisitions, costs related to equity transactions, including secondary offerings, lease abandonment charges, lease overlap costs for the incremental expenses associated with the Company’s new corporate headquarters prior to termination of its then existing headquarters and changes in the fair value of contingent consideration. 7 Other segment items include those items excluded from the significant segment expense categories and identified in the above descriptions, adjustments for capitalized labor costs incurred on internal development projects, and expenses of an insignificant segment, including impairment charges, that does not meet the quantitative thresholds for determining reporting segments. 8 Significant non-cash items include changes in fair value of derivative instruments and changes in fair value of warrant liabilities. Revenues by geographic area presented based upon the location of the customer are as follows (in thousands): Year Ended December 31, 2024 2023 2022 United States $ 938,031 $ 859,548 $ 774,697 China 6,769 6,830 7,751 Total revenues $ 944,800 $ 866,378 $ 782,448 Software, equipment and property, net by geographic area are as follows (in thousands): December 31, 2024 2023 United States $ 171,864 $ 160,064 China 215 352 Total software, equipment and property-net $ 172,079 $ 160,416

Gain on Sale of Cost Method Inv

Gain on Sale of Cost Method Investment	12 Months Ended
Gain on Sale of Cost Method Investment	Dec. 31, 2024
Investments, Debt and Equity Securities [Abstract]
Gain on Sale of Cost Method Investment	28. GAIN ON SALE OF COST METHOD INVESTMENT During February 2022, the Company received cash proceeds of $ 3.9 million in exchange for its equity interest in an investee as a result of the acquisition of the investee. The Company had been accounting for its investment using the cost method and recognized a gain of $ 3.6 million during the year ended December 31, 2022. The investment’s carrying value was $ 0.3 million at time of the acquisition. The Company no longer has any ownership interest in the investee.

Subsequent Event

Subsequent Event	12 Months Ended
Subsequent Event	Dec. 31, 2024
Subsequent Events [Abstract]
Subsequent Events	29. SUBSEQUENT EVENTS Acquisition of Evolution IQ —On January 6, 2025, the Company completed its acquisition of EvolutionIQ, Inc. (“EvolutionIQ”), a privately held company that provides AI-powered guidance for disability and injury claims management. Leveraging EvolutionIQ’s platform, the acquisition will broaden the Company’s portfolio of AI-based solutions available to its insurance customers. In exchange for all the outstanding shares of EvolutionIQ, the Company paid total consideration of $ 730 million, net of cash acquired, subject to certain post-closing adjustments. The total consideration paid to the selling shareholders consisted of 58.9 % in cash and 41.1 % in shares of CCC’s common stock. The cash consideration paid to the selling shareholders was funded through cash on hand and an incremental term loan in an aggregate principal amount of $ 225.0 million (the “Incremental Term Loan”). During the year ended December 31, 2024, the Company incurred acquisition related expenses of $ 8.7 million, recognized within general and administrative expenses in the consolidated statement of operations and comprehensive income (loss). The initial accounting for the acquisition of EvolutionIQ, including the estimated fair value of the assets acquired and liabilities assumed, is incomplete as a result of the proximity of the acquisition date to the date these consolidated financial statements were issued. Long-Term Debt and Refinancing —In conjunction with the acquisition of EvolutionIQ, the Company entered into the third amendment to the 2021 Credit Agreement that provided the Company with an Incremental Term Loan for $ 225 million. Prior to the Fourth Amendment (as defined below) the Incremental Term Loan was repayable in quarterly installments in an amount equal to 0.25 % of the original principal amount, with the balance payable at maturity, September 21, 2028 . Prior to the Fourth Amendment, the interest rate per annum applicable to the Incremental Term Loan was based on a fluctuating rate of interest, determined by the Company's leverage ratio, as defined in the 2021 Credit Agreement, as amended. In connection with the Fourth Amendment, the Incremental Term Loan was refinanced together with other term loans outlined in the following paragraphs. On January 23, 2025, the Company entered into the fourth amendment (the “Fourth Amendment”) to the 2021 Credit Agreement. Pursuant to the terms of the Fourth Amendment, the Company incurred incremental term loans in an aggregate principal amount of $ 225 million, which were used to (i) refinance certain outstanding incremental term loans (including the Incremental Term Loan), (ii) extend the maturity of all term loans to January 23, 2032, (iii) remove the credit spread adjustment applicable to SOFR loans, and (iv) reduce the interest rate margin applicable to all term loans to the following rate: (1) 1.00 % in the case of base rate loans, and 2.00 % in the case of SOFR (or Euribor or SONIA) loans, and 2.00 %, in the case of SOFR (or Euribor or SONIA) loans, if S&P and Moody’s Debt First Lien Leverage Ratio Ratings (as defined in the Credit Agreement) are below BB- (with a stable outlook) or below Ba3 (with a stable outlook) (or if for any reason this category does not apply, including if the Borrower has only one Debt Rating or the Borrower does not have any Debt Rating), and (2) 0.75 %, in the case of base rate loans, and 1.75 %, in the case of SOFR (or Euribor or SONIA) loans, if S&P and Moody’s Debt First Lien Leverage Ratio Ratings are both BB- (with a stable outlook) or better and Ba3 (with a stable outlook) or better. Beginning March 31, 2025, the term loans are repayable in quarterly installments in an amount equal to 0.25 % of the original principal amount of the term loans with the balance payable at maturity, January 23, 2032 . As a result of the extended maturity date of the term loans to January 23, 2032, the Company’s 2021 Revolving Credit Facility matures on September 23, 2029. Interest Rate Swaps —In February 2025, the Company entered into two floating to fixed interest rate swap agreements (the "Swap Agreements") to reduce its exposure to the variability from future cash flows resulting from interest rate risk related to its floating rate long-term debt. Pursuant to the terms of the Swap Agreements, beginning on the effective date, July 31, 2025, the Company will pay an average fixed interest rate of 4.00 % on an aggregate notional amount corresponding to borrowings of $ 500.0 million in exchange for receipts on the same notional amount at a floating interest rate based on the applicable SOFR at the time of payment. The Swap Agreements expire on July 31, 2027 . The Company did not designate the Swap Agreements as a hedging instrument and will record the change in fair value within earnings.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	12 Months Ended
Summary of Significant Accounting Policies (Policies)	Dec. 31, 2024
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation —The consolidated balance sheets as of December 31, 2024 and 2023, the consolidated statements of operations and comprehensive income (loss), the consolidated statements of mezzanine equity and stockholders’ equity and the consolidated statements of cash flows for the years ended December 31, 2024, 2023 and 2022, have been prepared in conformity with accounting principles generally accepted in the United States (“GAAP”).
Basis of Accounting	Basis of Accounting —The accompanying consolidated financial statements are prepared in accordance with GAAP and include the accounts of the Company and its wholly-owned subsidiaries and majority-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. The consolidated financial statements include 100% of the accounts of wholly-owned and majority-owned subsidiaries. The ownership interest of the minority investor is recorded as a non-controlling interest in a subsidiary.
Use of Estimates	Use of Estimates —The preparation of the consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts, and the disclosures of contingent amounts in the Company’s consolidated financial statements and the accompanying notes. The Company bases its estimates on historical experience and various other assumptions that it believes to be reasonable under the circumstances. Although the Company regularly assesses its estimates, actual results could differ from management’s estimates if past experience or other assumptions are not substantially accurate. Changes in estimates are recorded in the period in which they become known. Significant estimates in these consolidated financial statements include the estimation of contract transaction prices, the determination of the amortization period for contract assets, the valuation of goodwill and intangible assets, the estimates and assumptions associated with the valuation of the warrant liabilities, and the estimates and assumptions associated with stock incentive plans.
Cash and Cash Equivalents	Cash and Cash Equivalents —The Company considers all highly liquid investments, including money market funds, purchased with an original maturity of three months or less at the date of purchase to be cash and cash equivalents. Cash and cash equivalents are carried at cost, which approximates fair value. The Company believes it is not exposed to any significant credit risk on cash and cash equivalents. While the Company has deposits that exceed federally insured limits at financial institutions, the Company places its cash and cash equivalents in highly rated institutions. The Company has never experienced losses related to these balances.
Foreign Currency	Foreign Currency —The Company’s functional currency is the US dollar, however, for operations located in China, the functional currency is the local currency. Assets and liabilities of the foreign operations are translated to US dollars at exchange rates in effect at the consolidated balance sheet date, while statement of operations accounts are translated to US dollars at the average exchange rates for the period. Translation gains and losses are recorded and remain as a component of accumulated other comprehensive loss in stockholders’ equity until transactions are settled or the foreign entity is sold or liquidated. Gains and losses resulting from transactions that are denominated in a currency that is not the functional currency are recorded to other income–net, in the consolidated statements of operations and comprehensive income (loss) .
Significant Customers and Concentration of Credit Risks	Significant Customers and Concentration of Credit Risks —The Company is potentially subject to concentration of credit risk primarily through its accounts receivable. The Company performs ongoing credit evaluations of its customers and maintains allowances for potential credit losses which, when realized, have been within the range of management’s expectations. The Company generally does not require collateral. Credit risk on accounts receivables is minimized as a result of the large and diverse nature of the Company’s customer base. During the years ended December 31, 2024, 2023 , and 2022 no single customer represented more than 10 % of revenue. As of December 31, 2024 , one customer had an account receivable of 11 % of accounts receivable. As of December 31, 2023 , no customer had an account receivable greater than 10 % of accounts receivable.
Revenue Recognition	Revenue Recognition —The Company’s revenue recognition policy follows guidance from Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers. The Company generates revenue from contracts that are generally billed either on a monthly subscription or transactional basis. Other revenue primarily consists of professional services and other non-software services revenue that is generally transaction-based (where a fee per transaction is charged). Revenues are recognized as control of these services is transferred to customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those services. The Company determines revenue recognition based on the application of the following steps: • Identification of the contract, or contracts, with a customer • Identification of the performance obligation(s) in the contract • Determination of the transaction price • Allocation of the transaction price to the performance obligation(s) in the contract • Recognition of revenue when, or as a performance obligation is satisfied Software Subscription Revenues —Software services are hosted and provide customers with the right to use the hosted software over the contract period without taking possession of the software and are generally billed on either a monthly subscription or transactional basis. Revenues related to services billed on a subscription basis are recognized ratably over the contract period as this is the time period over which services are transferred to the customer, generally between three and five years. Revenues from subscription services represent a stand-ready obligation to provide access to the Company’s platform. As each day of providing services is substantially the same and the customer simultaneously receives and consumes the benefits as access is provided, subscription arrangements include a series of distinct services. The Company may provide certain of its customers with implementation activities such as basic setup, installation and initial training that the Company must undertake to fulfill the contract. These are considered fulfillment activities that do not transfer the service to the customer. For contracts with fixed and variable consideration, to the extent that customers’ usage exceeds the committed contracted amounts under their subscriptions, they are charged for their incremental usage. In addition to overage fees, consideration may vary due to discounts, incentives, and potential service level credits or contractual penalties. For such variable consideration, the Company includes an estimate of the most likely amount it expects to receive for the total transaction price if it is probable that a significant reversal of cumulative revenue recognized will not occur. When customers’ usage falls below the committed contracted amounts, the customer does not receive any credits or refunds for the shortfall. For contracts where fees are solely based on transaction volume, the amount invoiced corresponds directly with the value provided to the customer, and revenue is recognized when invoiced using the as-invoiced practical expedient. Other Revenue —Other revenues consist of professional services and other non-software services and are recognized over time as the services are performed. Other revenues are generally invoiced monthly in arrears. Revenues related to such services that are billed on a transactional basis are recognized when the transaction for the related service occurs. Transaction revenue is primarily comprised of fees for services applied to the volume of transactions. These are typically based on a per-unit rate and are invoiced for the same period in which the transactions were processed and as the performance obligation is satisfied. For contracts with transaction fees, the amount invoiced corresponds directly with the value provided to the customer, and revenue is recognized when invoiced using the as-invoiced practical expedient. Contracts with Multiple Performance Obligations —The Company’s contracts with customers can include access to different software applications such as CCC workflow, estimating, valuation and analytics, each of which is its own performance obligation. These additional services are either sold on a standalone basis or could be used on their own with readily available resources. For these contracts, the Company accounts for individual performance obligations separately, if they are distinct. The transaction price is allocated to the separate performance obligations on a relative standalone selling price basis. The standalone selling price for distinct performance obligations is generally based on directly observable pricing. In instances where standalone selling price is not directly observable, the Company determines standalone selling price based on overall pricing objectives, which take into consideration observable data, market conditions and entity-specific factors. The Company may occasionally recognize an adjustment in revenue in the current period for performance obligations partially or fully satisfied in the previous periods resulting from changes in estimates for the transaction price, including any changes to the Company’s assessment of whether an estimate of variable consideration is constrained. For the years ended December 31, 2024, 2023 and 2022, the impact on revenue recognized in the current period, from performance obligations partially or fully satisfied in the previous period, was not significant. Contract Liabilities —Contract liabilities consist of deferred revenue and include customer billings in advance of revenues being recognized from subscription contracts and professional services. Deferred revenue that is expected to be recognized during the succeeding twelve-month period is recorded as current, and the remaining portion is recorded as noncurrent and included within other liabilities on the consolidated balance sheets. Costs to Obtain and Fulfill the Contract —The Company defers costs that are considered to be incremental and recoverable costs of obtaining a contract with a customer, including sales commissions. Costs to fulfill contracts are capitalized when such costs are direct and related to implementation activities for hosted software solutions. Capitalized costs to obtain a contract and costs to fulfill a contract are generally amortized over a period between three and five years, which represents the expected period of benefit of these costs and corresponds to the contract period. In instances where the contract term is significantly different than our general contract terms of between three and five years, costs to obtain and fulfill are amortized over the contract term which the Company believes best reflects the period of benefit of these costs.
Cost of Revenues	Cost of Revenues —Cost of revenues is primarily composed of personnel costs, including stock-based compensation, and costs of external resources used in the delivery of services to customers, including software configuration, integration and implementation services, customer support activities, third party costs related to hosting the Company’s software for its customers, internal support of production infrastructure, information technology (“IT”) security costs, depreciation expense, cost of software production, and data licensing and royalty fees paid to third parties. Cost of revenues also includes amortization of internal use software, including capitalized development costs, and amortization and impairment of acquired technologies.
Research and Development	Research and Development —Research and development expenses consist primarily of personnel-related costs, including stock-based compensation, and costs of external development resources involved in the engineering, design and development of new solutions, as well as expenses associated with significant ongoing improvements to existing solutions. Research and development expenses also include IT hosting costs for the development and test environments. Research and development costs, other than software development costs qualifying for capitalization, are expensed as incurred.
Selling and Marketing	Selling and Marketing —Selling and marketing expenses consist primarily of personnel-related costs for our sales and marketing functions, including sales commissions and stock-based compensation. Additional expenses include advertising costs, marketing costs and event costs, including the Company’s annual industry conference. The Company expenses advertising and other promotional expenditures as incurred. Advertising expenses were $ 2.0 million, $ 1.5 million and $ 1.1 million for the years ended December 31, 2024, 2023 and 2022 , respectively.
General and Administrative	General and Administrative —General and administrative expenses consist primarily of personnel-related costs, including stock-based compensation, for our executive management and administrative employees, including finance and accounting, human resources, internal systems IT, facilities and legal functions. Additional expenses include professional service fees, insurance premiums, and other corporate expenses that are not allocated to the above expense categories.
Amortization of Intangible Assets	Amortization of Intangible Assets —Amortization of intangible assets consists of the capitalized costs of intangible assets. These intangible assets are amortized on a straight-line basis over their estimated useful lives (see Note 11).
Goodwill and Intangible Asset Impairments	Goodwill and Intangible Asset Impairments —Goodwill and intangible asset impairments includes the goodwill and intangible asset impairment charges specific to the Company's China reporting unit (see Note 11).
Stock-Based Compensation	Stock-Based Compensation —The Company’s stock-based compensation plans are described in Note 20. The Company accounts for stock-based payment awards based on the grant date fair value. The incremental fair value of modifications to stock-based payment awards is estimated at the date of modification. Stock-based payment awards that are settled in cash are accounted for as liabilities. The Company recognizes stock-based compensation expense for only the portion of awards expected to vest, based on an estimated forfeiture rate. The Company recognizes stock-based compensation expense for time-based awards on a straight-line basis over the requisite service period, which is generally the vesting period of the respective awards. Stock-based compensation expense for performance-based awards with a market condition is recognized over the estimated service period, regardless of whether the market condition is satisfied. The fair value of RSUs with only a time-based vesting component or a performance-based vesting component is determined using the quoted price of our common stock on the date of grant. As of each reporting period, we estimate the number of RSUs with a performance-based vesting component that are expected to vest based on our current estimate of performance compared to the target metrics and record a cumulative-effect adjustment to stock-based compensation expense when necessary. For stock-based awards that are accounted for as liabilities, we remeasure the fair value of the associated liability at each reporting date through settlement using the Black-Scholes option pricing model and recognize the adjustment as stock-based compensation expense. The fair value of the Company’s stock options with only a time-based component is estimated using the Black-Scholes option pricing model. The fair value of the Company’s performance-based awards with a market condition is estimated using a Monte Carlo simulation model. Stock-based compensation expense related to purchase rights issued under the CCC Intelligent Solutions Holdings Inc. 2021 Employee Stock Purchase Plan (“ESPP”) is based on the Black-Scholes option pricing model’s fair value of the estimated number of awards as of the beginning of the applicable offering period. Stock-based compensation expense is recognized using the straight-line method over the applicable offering period. The inputs and assumptions utilized under these methods require judgments and estimates. Changes in the inputs and assumptions could affect the measurement of the estimated fair value of the related compensation expense of these stock-based payment awards.
Accounts Receivable—Net	Accounts Receivable—Net —An account receivable is recorded when an unconditional right to consideration exists, such that only the passage of time is required before of consideration is due. Accounts receivable—net includes contract assets resulting from subscription agreements with ramped billing schedules. Accounts receivable, as presented in the consolidated balance sheets, are net of customer sales allowances and credit losses. The Company determines allowances for its sales reserves and credit losses based on specific identification of customer accounts and historical experience to the remaining accounts receivable balance. The Company’s assessment of credit losses includes estimating its expected credit losses based on historical information and adjusted for current conditions and forecasts for the probability of collection from customers. Credit losses are charged to general and administrative expenses in the consolidated statements of operations and comprehensive income (loss) .
Software, Equipment, and Property—Net	Software, Equipment, and Property—Net —Software, equipment, and property are stated at cost, net of accumulated depreciation and amortization. Depreciation and amortization are computed on a straight-line basis over the assets’ estimated useful lives, which are as follows: Software, equipment, and property Estimated Useful Life Software and licenses 2 - 5 years Computer equipment 3 years Furniture and other equipment 5 years Database 25 years Building 39 years Leasehold improvements Lesser of the estimated useful life or life of lease Land Indefinite Maintenance and repairs are expensed as incurred. Significant improvements and enhancements are capitalized.
Internal Use Software	Internal Use Software —The Company capitalizes the direct costs incurred in developing or obtaining internal use software, including platform development, infrastructure and tools, as well as certain payroll and payroll-related costs of employees who are directly associated with internal use computer software projects. The amount of capitalized payroll costs with respect to these employees is limited to the time directly spent on such projects. The costs associated with preliminary project stage activities, training, maintenance, and all other post-implementation activities are expensed as incurred. Additionally, the Company expenses internal costs related to minor upgrades and enhancements as it is impractical to separate these costs from normal maintenance activities. Capitalized internal use software costs are recorded within software, equipment, and property on the Company’s consolidated balance sheets.
Goodwill and Intangible Assets	Goodwill and Intangible Assets —Goodwill and intangible assets deemed to have indefinite lives are not amortized, but are subject to an annual impairment test, or more frequently if events or changes in circumstances indicate that the carrying value may not be recoverable. The Company performs its annual impairment assessment of goodwill and indefinite life intangible assets as of November 30 of each year. Under GAAP, the Company has the option to first assess qualitative factors in order to determine if it is more likely than not that the fair value of one of its reporting units or indefinite life intangible assets is greater than its carrying value (“Step 0”). If the qualitative assessment leads to a determination that the fair value is less than its carrying value, or if the Company elects to bypass the qualitative assessment, it is required to perform a quantitative impairment test (“Step 1”) by calculating the fair value of the reporting unit or indefinite life intangible asset and comparing the fair value with its associated carrying value. If the carrying value exceeds the fair value, an impairment loss is recognized in an amount equal to the excess, up to the carrying value of the goodwill or indefinite life intangible asset. For the years ended December 31, 2024, 2023 and 2022, the Company performed its annual impairment tests as of November 30 for its goodwill and indefinite lived intangible assets and determined no impairment existed. During May 2023, the Company performed an interim quantitative impairment test for its China reporting unit due to events which indicated that the carrying amount was in excess of its estimated fair value. As a result of the interim quantitative impairment test, the Company recorded a goodwill impairment charge of $ 77.4 million (see Note 11). Subsequent to the impairment charge recognized in May 2023, the Company performed its annual impairment test for its Domestic reporting unit, its remaining reporting unit with goodwill and indefinite lived assets as of November 30, 2023 and determined no impairment existed.
Long-Lived Assets	Long-Lived Assets —Long-lived assets, other than goodwill, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of the assets might not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the asset or asset group to estimated undiscounted future cash flows expected to be generated by such assets. If the carrying amount of the assets exceeds their estimated future cash flows, an impairment charge is recognized equal to the amount by which the carrying amount of the assets exceeds their fair value. There were no events or changes in circumstances that indicated the carrying value may not be recoverable and no impairment charges were recognized during the years ended December 31, 2024. During the year ended December 31, 2023, the Company performed the recoverability test on its China reporting unit’ s intangible assets due to events which indicated the carrying amount may not be recoverable. As a result, the Company recorded impairment charges totaling $ 5.3 million (see Note 11). There were no events or changes in circumstances that indicated the carrying value may not be recoverable and no impairment charges were recognized during the years ended December 31, 2022.
Equity Method Investment	Equity Method Investment —The Company accounts for its 7 % investment in a limited partnership using the equity method of accounting. Under the equity method of accounting, the investee’s accounts are not reflected within the Company’s consolidated balance sheets and consolidated statements of operations and comprehensive income (loss) . The Company’s investment was initially recognized at cost and adjusted thereafter for the post acquisition changes in the Company’s share of the investee’s earnings which would be recorded in other income-net.
Deferred Financing Costs	Deferred Financing Costs —Deferred financing costs are capitalized and amortized over the life of the underlying financing agreement (see Note 15).
Business Combinations	Business Combinations —The Company allocates the purchase consideration of acquired companies to tangible and intangible assets acquired and liabilities assumed based on their estimated fair values at the acquisition date, with the excess recorded to goodwill. These estimates are inherently uncertain and subject to refinement. During the measurement period, which may be up to one year from the acquisition date, adjustments may be recorded to the fair value of these tangible and intangible assets acquired and liabilities assumed, including uncertain tax positions and tax-related valuation allowances, with the corresponding offset to goodwill. Upon the conclusion of the measurement period or final determination of the fair value of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to the consolidated statements of operations and comprehensive income (loss). The Company estimates the fair value of contingent consideration related to business combinations on the date of acquisition (see Note 3). The fair value of the contingent consideration was remeasured each reporting period, with any change in the fair value recorded within the consolidated statements of operations and comprehensive income (loss) .
Fair Value of Financial Instruments and Fair Value Measurements	Fair Value of Financial Instruments and Fair Value Measurements —Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. To increase the comparability of fair value measures, the following hierarchy prioritizes the inputs to valuation methodologies used to measure fair value. Level 1 —Valuations based on quoted prices for identical assets and liabilities in active markets. Level 2 —Valuations based on observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data. Level 3 —Valuations based on unobservable inputs reflecting the Company’s own assumptions, consistent with reasonably available assumptions made by other market participants. These valuations require significant judgment.
Warrant Liability	Warrant Liability —Upon consummation of the Business Combination, the Company assumed the outstanding warrants previously sold in a private placement (“Private Warrants”) by Dragoneer. The Company accounted for its Private Warrants under ASC 815-40, Derivatives and Hedging-Contracts in Entity’s Own Equity , in conjunction with the SEC Division of Corporation Finance’s April 12, 2021 Public Statement, Staff Statement on Accounting and Reporting Considerations for Warrants Issued by Special Purpose Acquisition Companies (“SPACs”) . The terms of the warrants provided for potential changes to the settlement amounts dependent upon the characteristics of the warrant holder, and precluded the warrants from being classified in equity and thus the warrants were classified as a liability. Accordingly, the Company recorded the warrants as long-term liabilities on its consolidated balance sheet at fair value upon the closing of the Business Combination, with subsequent changes in the fair value of the warrants recognized in the consolidated statements of operations and comprehensive income (loss) at each reporting date. The Private Warrants were redeemed during the year ended December 31, 2024 (see Note 21). Prior to their redemption, the Private Warrants were valued using the Black-Scholes option pricing model. The assumptions utilized under the Black-Scholes option pricing model require judgments and estimates. Changes in these inputs and assumptions could affect the measurement of the estimated fair value of the related fair value of the Private Warrants.
Derivative Instruments	Derivative Instruments —The Company records derivative instruments as an asset or liability measured at fair value each reporting period. The Company has not designated its derivatives as hedging instruments for accounting purposes and recognizes the changes in fair value within its consolidated statement of operations and comprehensive income (loss). Gain and losses from the change in fair value and cash payments and receipts related to the derivative instruments are recognized in other income (expense)—net, in the consolidated statements of operations and comprehensive income (loss) . The Company does not enter into derivative instrument transactions for trading or speculative purposes.
Income Taxes	Income Taxes —Deferred income tax assets and liabilities are recognized for the expected future tax effects of temporary differences between the financial and income tax reporting basis of assets and liabilities using tax rates in effect for the years in which the differences are expected to reverse. Deferred income taxes relate to the timing of recognition of certain revenue and expense items, and the timing of the deductibility of certain reserves and accruals for income tax purposes that differs from the timing for financial reporting purposes. The Company establishes a tax valuation allowance to the extent that it is more likely than not that a deferred tax asset will not be realizable against future taxable income. A tax benefit from an uncertain tax position may be recognized when it is more likely than not that the position will be sustained upon examination, including resolutions of any related appeals or litigation process, based on its technical merits. Income tax positions must meet a more-likely-than-not recognition threshold to be recognized. The Company recognizes interest and penalties related to unrecognized tax benefits in income tax expense.
Employee Insurance Benefits	Employee Insurance Benefits —The Company maintains a self-insured group medical program. The program contains stop loss thresholds with amounts in excess of the self-insured levels fully insured by third-party insurers. Liabilities associated with this program are estimated in part by considering historical claims experience and medical cost trends.
Leases	Leases —The Company’s lease policy follows guidance from ASC 842, Leases . In accordance with ASC 842, the Company, at the inception of the contract, determines whether a contract is or contains a lease. For leases with terms greater than 12 months, the Company records the related operating or finance right of use asset and lease liability at the present value of lease payments over the lease term. The Company is generally not able to readily determine the implicit rate in the lease and therefore uses the determined incremental borrowing rate at lease commencement to determine the present value of lease payments. The incremental borrowing rate represents an estimate of the market interest rate the Company would incur at lease commencement to borrow an amount equal to the lease payments on a collateralized basis over the term of a lease. Renewal options are not included in the measurement of the right of use assets and lease liabilities unless the Company is reasonably certain to exercise the optional renewal periods. Some leases also include early termination options, which can be exercised under specific conditions. Additionally, certain leases contain incentives, such as construction allowances from landlords. These incentives reduce the right-of-use asset related to the lease. Some of the Company’s leases contain rent escalations over the lease term. The Company recognizes expense for operating leases on a straight-line basis over the lease term. The Company has elected the practical expedient to combine lease and non-lease components for all asset categories. Therefore, the lease payments used to measure the lease liability for these leases include fixed minimum rentals along with fixed non-lease component charges. Lease related costs, which are variable rather than fixed, are expensed in the period incurred. The Company does not have significant residual value guarantees or restrictive covenants in the lease portfolio.
Redeemable Non-Controlling Interest	Redeemable Non-Controlling Interest —The Company presents a redeemable non-controlling interest as mezzanine equity within its consolidated balance sheets when it is redeemable at a fixed or determinable price on a fixed or determinable date at the option of the holder or upon the occurrence of an event that is not solely within the control of the Company. The redeemable non-controlling interest was initially measured at fair value on the date of issuance. When the redemption of a mezzanine-classified non-controlling interest becomes probable, the carrying amount of the redeemable non-controlling interest is increased by periodic accretions using the interest method so that the carrying amount will equal the redemption amount on the date that the shares become redeemable. These adjustments are recorded as accretion of redeemable non-controlling interest, with an offset to additional paid-in capital, on the consolidated statements of mezzanine equity and stockholders’ equity (see Note 17). Any such charges to additional paid-in capital affect net income (loss) available to CCC common stockholders as part of the Company’s calculation of net income (loss) per share attributable to common stockholders.
Recently Adopted Accounting Pronouncements	Recently Adopted Accounting Pronouncements —Effective for the year ended December 31, 2024, the Company adopted Accounting Standards Update (“ASU”) 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. This update improves reportable segment disclosure requirements, primarily through additional disclosures about significant segment expenses. Public entities with a single reportable segment are required to apply the disclosure requirements in ASU 2023-07, as well as all existing segment disclosures and reconciliation requirements in ASC 280 on an interim and annual basis. The Company adopted ASU 2023-07, which was applied retrospectively to all prior periods presented. The adoption of ASU 2023-07 did not have a material impact on the consolidated financial statements however it resulted in incremental disclosures (see Note 27).
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements —In November 2024, the Financial Accounting Standards Board (“FASB”) issued ASU 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses . This update requires new disclosures aimed at enhancing transparency in financial reporting by requiring disaggregation of specific expense captions within the statement of operations. Under the update, entities are required to disclose a breakdown of certain expense categories, such as: employee compensation; depreciation; amortization, and other material components. This ASU is effective for fiscal years beginning after December 15, 2026, with early adoption permitted. The Company is evaluating the disclosure requirements related to this update. In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. This update requires entities to disclose disaggregated information about their effective tax rate reconciliation as well as expanded information on income taxes paid by jurisdiction. The disclosure requirements will be applied on a prospective basis, with the option to apply them retrospectively. The amendments in this update are effective for fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is evaluating the disclosure requirements related to this update.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	12 Months Ended
Summary of Significant Accounting Policies (Tables)	Dec. 31, 2024
Accounting Policies [Abstract]
Schedule of Software,Equipment and Property	Software, equipment, and property Estimated Useful Life Software and licenses 2 - 5 years Computer equipment 3 years Furniture and other equipment 5 years Database 25 years Building 39 years Leasehold improvements Lesser of the estimated useful life or life of lease Land Indefinite

Business Acquisition (Tables)

Business Acquisition (Tables)	12 Months Ended
Business Acquisition (Tables)	Dec. 31, 2024
Business Combinations [Abstract]
Schedule of Business Acquisitions by Acquisition	The acquisition date fair value of the consideration transferred was $ 32.5 million, which consisted of the following (in thousands): Cash paid through closing $ 32,300 Fair value of contingent earnout consideration 200 Total acquisition date fair value of the consideration transferred $ 32,500
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed	The following table summarizes the final allocation of the consideration to the fair values of the assets acquired and liabilities assumed at the acquisition date (in thousands): Assets acquired: Current assets $ 150 Intangible asset - acquired technology 4,800 Total assets acquired 4,950 Liabilities assumed: Current liabilities 147 Deferred tax liabilities 548 Total liabilities assumed 695 Net assets acquired 4,255 Goodwill 28,245 Total purchase price $ 32,500

Revenue (Tables)

Revenue (Tables)	12 Months Ended
Revenue (Tables)	Dec. 31, 2024
Contract with Customer, Contract Asset, Contract Liability, and Receivable [Abstract]
Summarizes Revenue by Type of Service	The following table summarizes revenue by type of service for the years ended December 31 (in thousands): Year Ended December 31, 2024 2023 2022 Software subscriptions $ 906,464 $ 830,117 $ 752,505 Other 38,336 36,261 29,943 Total revenues $ 944,800 $ 866,378 $ 782,448
Summary of Receivables Contract Assets and Contract Liabilities from Contracts with Customers	The balances of the Company’s receivables, contract assets and contract liabilities from contracts with customers are as follows (in thousands): December 31, December 31, December 31, 2024 2023 2022 Accounts receivables-Net of allowances $ 106,578 $ 102,365 $ 98,353 Deferred contract costs 22,373 17,900 16,556 Deferred contract costs-non-current 18,692 22,302 20,161 Other assets (accounts receivable, non-current) 16,946 15,198 16,437 Deferred revenues 44,915 43,567 35,239 Other liabilities (deferred revenues, non-current) 1,415 1,373 1,240
Summary of Deferred Contract Costs	A summary of the activity impacting the deferred contract costs during the years ended December 31, 2024, 2023 and 2022 is presented below (in thousands): Year Ended December 31, 2024 2023 2022 Balance at beginning of period $ 40,202 $ 36,717 $ 37,186 Costs amortized ( 22,085 ) ( 19,197 ) ( 17,986 ) Additional amounts deferred 22,948 22,682 17,517 Balance at end of period $ 41,065 $ 40,202 $ 36,717 Classified as: Current $ 22,373 $ 17,900 $ 16,556 Non-current 18,692 22,302 20,161 Total deferred contract costs $ 41,065 $ 40,202 $ 36,717
Summary of Deferred Revenue	A summary of the activity impacting deferred revenue balances during the years ended December 31, 2024, 2023 and 2022, is presented below (in thousands): Year Ended December 31, 2024 2023 2022 Balance at beginning of period $ 44,940 $ 36,479 $ 32,616 Revenue recognized 1 ( 494,598 ) ( 434,197 ) ( 380,977 ) Additional amounts deferred 1 495,988 442,658 384,840 Balance at end of period $ 46,330 $ 44,940 $ 36,479 Classified as: Current $ 44,915 $ 43,567 $ 35,239 Non-current 1,415 1,373 1,240 Total deferred revenue $ 46,330 $ 44,940 $ 36,479 1 Amounts include total revenue deferred and recognized during each respective period.

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	12 Months Ended
Fair Value Measurements (Tables)	Dec. 31, 2024
Fair Value Disclosures [Abstract]
Fair Value Measurement Inputs and Valuation Techniques	The valuation of the Private Warrants as of December 31, 2023 was determined using the Black-Scholes option pricing model using the following assumptions: December 31, 2023 Expected term (in years) 2.6 Expected volatility 34 % Expected dividend yield 0 % Risk-free interest rate 4.10 %
Summary of Assets and Liabilities Measured at Fair Value on a Recurring Basis	The following table presents the fair value of the assets measured at fair value on a recurring basis at December 31, 2024 (in thousands): Fair Value Level 1 Level 2 Level 3 Assets Interest rate cap $ 975 $ — $ 975 $ — Total Assets $ 975 $ — $ 975 $ — The following table presents the fair value of the assets and liabilities measured at fair value on a recurring basis at December 31, 2023 (in thousands): Fair Value Level 1 Level 2 Level 3 Assets Interest rate cap $ 6,208 $ — $ 6,208 $ — Total Assets $ 6,208 $ — $ 6,208 $ — Liabilities Contingent consideration related to business acquisition $ 100 $ — $ — $ 100 Private Warrants 51,501 — 51,501 — Total Liabilities $ 51,601 $ — $ 51,501 $ 100
Summary of Carrying Amounts and Estimated Fair Value of the Financial Instruments	The following table presents the carrying amounts, net of debt discount, and estimated fair values of the Company’s financial instruments that are not recorded at fair value on the consolidated balance sheets (in thousands): December 31, 2024 December 31, 2023 Carrying Estimated Carrying Estimated Description Amount Fair Value Amount Fair Value Term B Loan, including current maturities $ 774,825 $ 776,970 $ 782,564 $ 784,000

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
Income Taxes (Tables)	Dec. 31, 2024
Income Tax Disclosure [Abstract]
Schedule of Components of Pretax Income (Loss) Attributable to Domestic and Foreign Operations	The components of pretax income (loss) attributable to domestic and foreign operations are as follows (in thousands): Year Ended December 31, 2024 2023 2022 Domestic $ 46,557 $ ( 80,486 ) $ 54,799 Foreign ( 2,243 ) ( 4,061 ) ( 4,937 ) Pretax income (loss) $ 44,314 $ ( 84,547 ) $ 49,862 The goodwill and intangible asset impairment charges (see Note 11) recognized during the year ended December 31, 2023 are included in the domestic pretax loss in the table above.
Schedule of Components of Income Tax Provision	The Company ’s income tax provision consisted of the following (in thousands): Year Ended December 31, 2024 2023 2022 Current provision: Federal $ 38,378 $ 41,804 $ 37,470 State 5,217 10,053 8,387 Total current provision 43,595 51,857 45,857 Deferred provision (benefit): Federal ( 24,566 ) ( 36,253 ) ( 26,570 ) State ( 5,955 ) ( 10,080 ) ( 7,831 ) Foreign 115 ( 502 ) 1,054 Change in valuation allowance ( 115 ) 502 ( 1,054 ) Total deferred benefit ( 30,521 ) ( 46,333 ) ( 34,401 ) Total income tax provision $ 13,074 $ 5,524 $ 11,456
Summary of Effective Income Tax Rate Differs from the Federal Statutory Rate	The Company’s effective income tax rate differs from the federal statutory rate as follows (in thousands, except percentages): Year Ended December 31, 2024 2023 2022 Federal income tax provision (benefit) at statutory rate $ 9,306 21.0 % $ ( 17,755 ) 21.0 % $ 10,471 21.0 % Executive compensation 20,788 46.9 12,555 ( 14.8 ) 12,508 25.0 Stock-based compensation ( 11,386 ) ( 25.7 ) ( 3,844 ) 4.5 ( 4,074 ) ( 8.1 ) Research and experimentation credit ( 6,950 ) ( 15.7 ) ( 6,920 ) 8.2 ( 3,510 ) ( 7.0 ) Fair value of warrants ( 3,019 ) ( 6.8 ) 3,170 ( 3.7 ) ( 5,475 ) ( 11.0 ) Goodwill impairment — — 16,255 ( 19.2 ) — — Impact of foreign operations 653 1.5 1,794 ( 2.1 ) 2,807 5.6 Valuation allowance ( 115 ) ( 0.3 ) 502 ( 0.6 ) ( 1,054 ) ( 2.1 ) State and local taxes-net of federal income tax effect ( 583 ) ( 1.3 ) ( 22 ) 0.0 439 0.9 Other nondeductible expenses 2,195 5.0 836 ( 1.0 ) 344 0.7 Uncertain tax positions 926 2.1 396 ( 0.5 ) ( 303 ) ( 0.6 ) Foreign rate difference ( 67 ) ( 0.2 ) ( 164 ) 0.2 ( 182 ) ( 0.4 ) Other—net 1,326 3.0 ( 1,279 ) 1.5 ( 515 ) ( 1.0 ) Income tax provision $ 13,074 29.5 % $ 5,524 ( 6.5 )% $ 11,456 23.0 %
Schedule of Deferred Income Tax Assets and Liabilities	The approximate income tax effect of each type of temporary difference giving rise to deferred income tax assets and liabilities as of December 31, 2024 and 2023 was as follows (in thousands): Year Ended December 31, 2024 2023 Deferred income tax assets: Stock-based compensation $ 35,539 $ 36,329 Capitalized R&E—net of amortization 43,083 26,082 Operating lease liabilities 13,142 13,751 Net operating losses—foreign 10,468 10,875 Accrued compensation 8,203 10,373 Sales allowances and doubtful accounts 1,160 1,393 Research and experimental credit 785 373 Net operating losses—domestic (state) — 479 Other 1,563 775 Total deferred income tax assets 113,943 100,430 Valuation allowance for deferred tax asset ( 10,468 ) ( 10,875 ) Net deferred income tax assets 103,475 89,555 Deferred income tax liabilities: Intangible asset amortization 234,362 255,572 Software, equipment and property depreciation and amortization 16,813 11,541 Deferred contract costs 10,149 10,044 Operating lease assets 6,995 7,078 Interest rate caps — 685 Total deferred income tax liabilities 268,319 284,920 Net deferred income tax liabilities $ 164,844 $ 195,365
Schedule of Change in Unrecognised Tax Benefits Excluding Interest and Penalties	The change in unrecognized tax benefits excluding interest and penalties for the years ended December 31, 2024 and 2023 was as follows (in thousands): Year Ended December 31, 2024 2023 Balance at beginning of year $ 4,415 $ 3,723 Additions based on tax positions related to the current year 1,700 1,062 Additions based on adjustments to tax positions related to prior years 862 527 Reductions based on adjustments to tax positions related to prior years ( 221 ) — Reductions as a result of a lapse of statutes of limitations ( 564 ) ( 897 ) Balance at end of year $ 6,192 $ 4,415
Summary of Major Jurisdictions Subject to Examination by the Relevant Tax Authorities and Open Tax Years	With few US State exceptions, the major jurisdictions subject to examination by the relevant taxing authorities and open tax years, stated as the Company’s fiscal years, are as follows: Jurisdiction Open Tax Years US Federal 2021 - 2023 US States 2021 - 2023 China 2021 - 2023 Canada 2021 - 2023

Accounts Receivable (Tables)

Accounts Receivable (Tables)	12 Months Ended
Accounts Receivable (Tables)	Dec. 31, 2024
Receivables [Abstract]
Schedule of Accounts Receivable, Net	Accounts receivable–Net as of December 31, 2024 and 2023, consists of the following (in thousands): December 31, 2024 2023 Accounts receivable $ 111,270 $ 107,939 Allowance for credit losses and sales reserves ( 4,692 ) ( 5,574 ) Accounts receivable–Net $ 106,578 $ 102,365
Schedule of Changes to the Allowance for Credit Losses and Sales Reserves	Changes to the allowance for credit losses and sales reserves during the years ended December 31, 2024, 2023 and 2022, consists of the following (in thousands): Year Ended December 31, 2024 2023 2022 Balance at beginning of period $ 5,574 $ 5,339 $ 3,791 Charges to bad debt and sales reserves 4,272 7,079 4,262 Write-offs, net ( 5,154 ) ( 6,844 ) ( 2,714 ) Balance at end of period $ 4,692 $ 5,574 $ 5,339

Other Current Assets (Tables)

Other Current Assets (Tables)	12 Months Ended
Other Current Assets (Tables)	Dec. 31, 2024
Prepaid Expense and Other Assets, Current [Abstract]
Schedule of Other Current Assets	Other current assets as of December 31, 2024 and 2023, consists of the following (in thousands): December 31, 2024 2023 Prepaid SaaS costs $ 9,112 $ 7,833 Prepaid service fees 7,352 5,992 Prepaid insurance 2,561 2,289 Prepaid software and equipment maintenance 673 5,547 Other 9,275 10,703 Total other current assets $ 28,973 $ 32,364

Software, Equipment, and Prop_2

Software, Equipment, and Property (Tables)	12 Months Ended
Software, Equipment, and Property (Tables)	Dec. 31, 2024
Property, Plant and Equipment [Abstract]
Schedule of Software,Equipment and Property	Software, equipment, and property as of December 31, 2024 and 2023, consists of the following (in thousands): December 31, 2024 2023 Software, licenses and database $ 275,127 $ 220,625 Computer equipment 18,993 27,467 Leasehold improvements 30,993 31,046 Building and land 4,910 4,910 Furniture and other equipment 1,332 1,370 Total software, equipment, and property 331,355 285,418 Less accumulated depreciation and amortization ( 159,276 ) ( 125,002 ) Net software, equipment, and property $ 172,079 $ 160,416

Leases (Tables)

Leases (Tables)	12 Months Ended
Leases (Tables)	Dec. 31, 2024
Leases [Abstract]
Summary of Lease Cost	The components of lease expense for the years ended December 31, 2024, 2023 and 2022 were as follows (in thousands): December 31, 2024 2023 2022 Operating lease costs $ 6,396 $ 5,958 $ 12,390 Variable lease costs 4,112 3,497 2,319 Total lease costs $ 10,508 $ 9,455 $ 14,709
Summary of Supplemental Cash Flow and Other Information Related to Leases	The lease term and discount rate consisted of the following as of December 31, 2024, 2023 and 2022: December 31, 2024 2023 2022 Weighted-average remaining lease term (years) 11.9 12.9 13.6 Weighted-average discount rate 6.5 % 6.5 % 6.4 % Supplemental cash flow and other information related to leases for the years ended December 31, 2024, 2023 and 2022 were as follows (in thousands): December 31, 2024 2023 2022 Cash payments for operating leases $ 8,146 $ 5,706 $ 11,933 Operating lease assets obtained in exchange for lease liabilities 1,792 — 2,825
Summary of Operating Lease Liabilities	The table below reconciles the undiscounted future minimum lease payments (in thousands) under noncancelable operating leases with terms of more than one year to the total operating lease liabilities recognized on the consolidated balance sheet as of December 31, 2024. Years Ending December 31: 2025 7,869 2026 7,370 2027 5,576 2028 6,323 2029 6,108 Thereafter 44,894 Total lease payments 78,140 Less: Interest ( 23,247 ) Total $ 54,893

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	12 Months Ended
Goodwill and Intangible Assets (Tables)	Dec. 31, 2024
Goodwill [Line Items]
Schedule of Gross Amount, Accumulated Impairment Loss, and Carrying Amount of Goodwill	The following table presents the gross amount, accumulated impairment loss, and net carrying amount of goodwill as of December 31, 2024 and 2023 (in thousands): Accumulated Net Gross Amount Impairment Loss Carrying Amount Balance as of December 31, 2024 1,520,926 ( 103,202 ) 1,417,724 Balance as of December 31, 2023 $ 1,520,926 $ ( 103,202 ) $ 1,417,724
Schedule of Changes in the Carrying Amount of Goodwill	Changes in the net carrying amount of goodwill were as follows during the year ended December 31, 2023 (in thousands): Net Carrying Amount Balance as of December 31, 2022 $ 1,495,129 Impairment ( 77,405 ) Balance as of December 31, 2023 $ 1,417,724
Summary of Intangible Assets Balance	The intangible assets balance as of December 31, 2024, is reflected below (in thousands): Weighted- Average Estimated Remaining Gross Net Useful Life Useful Life Carrying Accumulated Carrying (Years) (Years) Amount Amortization Amount Intangible assets: Customer relationships 18 10.3 $ 1,291,830 $ ( 550,822 ) $ 741,008 Acquired technologies 7 4.1 4,800 ( 2,000 ) 2,800 Subtotal 1,296,630 ( 552,822 ) 743,808 Trademarks—indefinite life 190,470 — 190,470 Total intangible assets $ 1,487,100 $ ( 552,822 ) $ 934,278 The intangible assets balance as of December 31, 2023, is reflected below (in thousands): Weighted- Average Estimated Remaining Gross Net Useful Life Useful Life Carrying Accumulated Carrying (Years) (Years) Amount Amortization Amount Intangible assets: Customer relationships 16 – 18 11.3 $ 1,291,830 $ ( 479,054 ) $ 812,776 Acquired technologies 3 – 7 1.7 184,640 ( 172,840 ) 11,800 Subtotal 1,476,470 ( 651,894 ) 824,576 Trademarks—indefinite life 190,470 — 190,470 Total intangible assets $ 1,666,940 $ ( 651,894 ) $ 1,015,046
Schedule of Future Amortization Expense for Intangible Assets	Future amortization expense for each of the next five years and thereafter for intangible assets as of December 31, 2024, is as follows (in thousands): Years Ending December 31: 2025 72,454 2026 72,454 2027 72,454 2028 72,454 2029 71,825 Thereafter 382,167 Total $ 743,808

Accrued Expenses (Tables)

Accrued Expenses (Tables)	12 Months Ended
Accrued Expenses (Tables)	Dec. 31, 2024
Payables and Accruals [Abstract]
Schedule of Accrued Expenses	Accrued expenses as of December 31, 2024 and 2023, consist of the following (in thousands): December 31, 2024 2023 Compensation $ 47,505 $ 54,593 Professional services 6,260 2,183 Royalties and licenses 5,116 4,381 Software license agreements 4,613 2,233 Sales tax 3,620 2,968 Employee insurance benefits 2,235 2,572 Other 3,194 2,548 Total accrued expenses $ 72,543 $ 71,478

Other Liabilities (Tables)

Other Liabilities (Tables)	12 Months Ended
Other Liabilities (Tables)	Dec. 31, 2024
Other Liabilities Disclosure [Abstract]
Summary of Other Liabilities	Other liabilities as of December 31, 2024 and 2023, consist of the following (in thousands): December 31, 2024 2023 Income taxes payable - non current $ 6,344 $ 3,937 Software license agreements 3,544 1,004 Deferred revenue-non-current 1,415 1,373 Contingent consideration — 100 Total other liabilities $ 11,303 $ 6,414

Long-Term Debt (Tables)

Long-Term Debt (Tables)	12 Months Ended
Long-Term Debt (Tables)	Dec. 31, 2024
Debt Disclosure [Abstract]
Summary of Long Term Debt	Long-term debt as December 31, 2024 and 2023, consists of the following (in thousands): December 31, 2024 2023 Term B Loan $ 776,000 $ 784,000 Term B Loan—discount ( 1,175 ) ( 1,436 ) Term B Loan—deferred financing fees ( 5,772 ) ( 7,060 ) Term B Loan—net of discount and fees 769,053 775,504 Less: Current portion ( 8,000 ) ( 8,000 ) Total long-term debt—net of current portion $ 761,053 $ 767,504
Summary of Debt Deferred Financing Fees and Discount	The table below is a roll forward of the Company ’s contra debt deferred financing fees and discount and deferred financing fees asset balances (in thousands): Deferred Discount— Financing Contra Fees Debt Balance—December 31, 2022 $ 10,485 $ 1,669 Amortization of fees and discount ( 1,753 ) ( 233 ) Balance—December 31, 2023 8,732 1,436 Payment of fees associated with revolver modification 719 — Amortization of fees and discount ( 1,871 ) ( 261 ) Balance—December 31, 2024 $ 7,580 $ 1,175
Summary of Aggregate Maturities of Our Long-Term Debt	Scheduled Payments for Debt —Principal amounts due in each of the next five years, as of December 31, 2024, are as follows (in thousands): Years Ending December 31: 2025 $ 8,000 2026 8,000 2027 8,000 2028 8,000 2029 744,000 Total $ 776,000

Long-Term Licensing Agreement (

Long-Term Licensing Agreement (Tables)	12 Months Ended
Long-Term Licensing Agreement (Tables)	Dec. 31, 2024
LongTerm Licensing Agreement [Line Items]
Summary of Principal Amounts Due in Each of the Next Five Years	Under the terms of these agreements with suppliers, the Company has future minimum obligations as of December 31, 2024 as follows (in thousands): Years Ending December 31: 2025 $ 48,904 2026 48,362 2027 65,714 2028 9,945 2029 9,900 Thereafter 19,800 Total $ 202,625
Licensing Agreement [Member]
LongTerm Licensing Agreement [Line Items]
Summary of Principal Amounts Due in Each of the Next Five Years	Principal amounts due in each of the next five years and thereafter for the Licensing Agreement as of December 31, 2024, are as follows (in thousands): Years Ending December 31: 2025 $ 3,257 2026 3,466 2027 3,689 2028 3,926 2029 4,177 Thereafter 9,177 Total $ 27,692

Redeemable Non-controlling In_2

Redeemable Non-controlling Interest (Tables)	12 Months Ended
Redeemable Non-controlling Interest (Tables)	Dec. 31, 2024
Noncontrolling Interest [Abstract]
Schedule of activities impacting the redeemable non-controllable interest	The activity impacting the redeemable non-controlling interest during the years ending December 31 is presented below (in thousands): Year Ended December 31, 2024 2023 2022 Balance at beginning of period $ 16,584 $ 14,179 $ 14,179 Accretion of redeemable non-controlling interest 5,095 2,405 — Balance at end of period $ 21,679 $ 16,584 $ 14,179

Stock Incentive Plans (Tables)

Stock Incentive Plans (Tables)	12 Months Ended
Stock Incentive Plans (Tables)	Dec. 31, 2024
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Schedule of Shares of Common Stock Reserved for Future Issuances	The following table summarizes the shares of common stock reserved for future issuance under the 2021 Plan as of December 31, 2024 and 2023: December 31, 2024 2023 Stock options outstanding 23,349,505 35,788,469 Restricted stock units outstanding 31,042,552 36,329,881 Restricted stock units available for future grant 75,673,991 49,451,502 Reserved for ESPP 10,403,530 4,981,134 Common stock reserved for future issuance 140,469,578 126,550,986
Schedule of Non-vested Restricted Stock Units Activity	The table below summarizes the RSU activity for the years ended December 31, 2024, 2023, and 2022: Weighted- Average Shares Fair Value Non-vested RSUs—December 31, 2021 18,558,211 $ 10.74 Granted 16,426,878 10.07 Vested ( 2,324,324 ) 11.22 Canceled ( 1,372,077 ) 10.93 Non-vested RSUs—December 31, 2022 31,288,688 10.34 Granted 12,574,115 9.01 Vested ( 5,707,373 ) 10.57 Canceled ( 1,825,549 ) 9.90 Non-vested RSUs—December 31, 2023 36,329,881 10.56 Granted 10,538,732 11.80 Vested ( 14,232,526 ) 10.76 Canceled ( 1,593,535 ) 10.68 Non-vested RSUs—December 31, 2024 31,042,552 $ 10.92
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions	The valuation of the performance-based RSUs with a market condition granted during the year ended December 31, 2022 and modified during the year ended December 31, 2023, was determined using a Monte Carlo Simulation model using the following assumptions: 2023 2022 Expected term (in years) 1.1 - 2.1 2.8 Expected volatility 28 %- 32 % 35 % Expected dividend yield 0 % 0 % Risk-free interest rate 4.36 %- 4.87 % 2.28 %
Summary of Share-based Compensation Arrangements by Share-based Payment Award	The table below summarizes the option activity for the years ended December 31, 2024, 2023 and 2022 : Weighted- Weighted-Average Average Remaining Aggregate Exercise Contractual Life Intrinsic Value Shares Price (in years) (in thousands) Options outstanding—December 31, 2021 55,644,495 $ 2.95 6.0 $ 469,591 Exercised ( 10,081,164 ) 2.74 Forfeited and canceled ( 314,071 ) 4.46 Options outstanding—December 31, 2022 45,249,260 $ 2.99 4.9 258,470 Exercised ( 8,923,718 ) 2.85 Forfeited and canceled ( 537,073 ) 6.88 Options outstanding—December 31, 2023 35,788,469 $ 2.96 4.0 301,563 Exercised ( 12,427,044 ) 2.69 Forfeited and canceled ( 11,920 ) $ 3.40 Options outstanding—December 31, 2024 23,349,505 $ 3.11 3.2 $ 201,305 Options exercisable—December 31, 2024 22,539,617 $ 2.97 3.1 $ 197,353 Options vested and expected to vest—December 31, 2024 23,333,942 $ 3.11 3.1 $ 201,237
Summary of Share-based Payment Arrangement, Expensed and Capitalized, Amount	Stock-Based Compensation —Stock-based compensation expense has been recorded in the accompanying consolidated statements of operations and comprehensive income (loss) as follows for the years ended December 31, 2024, 2023 and 2022 (in thousands): Year Ended December 31, 2024 2023 2022 Cost of revenues $ 9,342 $ 8,802 $ 5,812 Research and development 47,191 25,467 19,536 Sales and marketing 28,083 33,204 25,309 General and administrative 86,422 77,045 58,840 Total stock-based compensation expense $ 171,038 $ 144,518 $ 109,497
2021 Employee Stock Purchase Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions	The fair value of ESPP purchase rights sold during the years ended December 31, 2024, 2023 and 2022 was estimated using the Black-Scholes option pricing model with the following assumptions: 2024 2023 2022 Expected term (in years) 0.5 0.5 0.5 Expected volatility 25 %- 29 % 30 %- 51 % 47 % Expected dividend yield 0 % 0 % 0 % Risk-free interest rate 5.2 %- 5.5 % 2.5 %- 4.7 % 0.2 %
Cayman Equity Incentive Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions	The fair values of the outstanding awards at December 31, 2024, 2023 and 2022 were based on the Black-Scholes option pricing model using the following assumptions: 2024 2023 2022 Expected term (in years) 4.25 - 5.42 5.25 - 5.42 6.25 Expected volatility 40 % 40 % 40 % Expected dividend yield 0 % 0 % 0 % Risk-free interest rate 4.4 % 3.8 % 3.5 %

Warrants (Tables)

Warrants (Tables)	12 Months Ended
Warrants (Tables)	Dec. 31, 2024
Fair Value Measurement Inputs and Valuation Techniques [Table]
Summary of the Private Warrants Valued On the Redemption Date Using the Black-Scholes Option Pricing Model	The Private Warrants were valued at the time of redemption using the Black-Scholes option pricing model with the following assumptions: Expected term (in years) 2.2 Expected volatility 31 % Expected dividend yield 0 % Risk-free interest rate 4.8 %

Commitments (Tables)

Commitments (Tables)	12 Months Ended
Commitments (Tables)	Dec. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Schedule of Contractual Obligation Fiscal Year Maturity	Under the terms of these agreements with suppliers, the Company has future minimum obligations as of December 31, 2024 as follows (in thousands): Years Ending December 31: 2025 $ 48,904 2026 48,362 2027 65,714 2028 9,945 2029 9,900 Thereafter 19,800 Total $ 202,625

Related Parties (Tables)

Related Parties (Tables)	12 Months Ended
Related Parties (Tables)	Dec. 31, 2024
Related Party Transactions [Abstract]
Schedule of Revenues, Expenses and Amount Receivable with Entities Affiliated with Principal Owners	The following table summarizes revenues and expenses with entities affiliated with one of its principal equity owners for the years ended December 31, 2024, 2023 and 2022 (in thousands): December 31, 2024 2023 2022 Revenues Credit card processing $ 1,382 $ 1,051 $ 811 Expenses Employee health insurance benefits 4,202 3,641 3,166 IT security software 510 ^ ^ Board of director fees for services, including related travel and out-of-pocket reimbursements 275 306 131 Human resources support services * 313 237 IT development software * 130 * Sales tax processing and license fees for tax information ^ ^ 561 * Not significant. ^ Not a related party during the year ended December 31.

Other Income-Net (Tables)

Other Income-Net (Tables)	12 Months Ended
Other Income-Net (Tables)	Dec. 31, 2024
Other Income, Nonoperating [Abstract]
Schedule of Other Income-Net	Other income—net consists of the following for the years ended December 31 (in thousands): Year Ended December 31, 2024 2023 2022 (Loss) gain from change in fair value of derivative instruments $ ( 5,233 ) $ ( 5,743 ) $ 5,663 Income from derivative instruments 7,167 6,460 — Other income–net 302 1,082 699 Total other income–net $ 2,236 $ 1,799 $ 6,362

Net Income (Loss) Per Share (Ta

Net Income (Loss) Per Share (Tables)	12 Months Ended
Net Income (Loss) Per Share (Tables)	Dec. 31, 2024
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted	The following table sets forth a reconciliation of the numerator and denominator used to compute basic earnings per share of common stock (in thousands, except for share and per share data). Year Ended December 31, 2024 2023 2022 Numerator Net income (loss) $ 31,240 $ ( 90,071 ) $ 38,406 Accretion of redeemable non-controlling interest ( 5,095 ) ( 2,405 ) — Net income (loss) attributable to common stockholders $ 26,145 $ ( 92,476 ) $ 38,406 Denominator Weighted average shares of common stock—basic 610,761,424 617,889,384 607,760,886 Dilutive effect of stock-based awards 31,114,101 — 35,080,710 Weighted average shares of common stock—diluted 641,875,525 617,889,384 642,841,596 Net income (loss) per share attributable to common stockholders: Basic $ 0.04 $ ( 0.15 ) $ 0.06 Diluted $ 0.04 $ ( 0.15 ) $ 0.06

Segment Information And Infor_2

Segment Information And Information About Geographic Areas (Tables)	12 Months Ended
	Dec. 31, 2024
Revenues from External Customers and Long-Lived Assets [Line Items]
Schedule of segment revenue, significant segment expenses, and reconciliation of the company	The following table presents the Company’s financial information about reported segment revenue, significant segment expenses, and the Company’s reconciliation of segment profit (loss) to consolidated net income (loss) (in thousands): Year Ended December 31, 2024 2023 2022 Revenues: Revenue—Domestic Segment $ 938,031 $ 859,548 $ 774,697 Revenue—Other (1) 6,769 6,830 7,751 Total Revenue 944,800 866,378 782,448 Segment Expenses: Data licenses and royalties—adjusted (2) 43,698 40,957 39,837 Customer services—adjusted (3) 98,589 90,801 83,241 Products and technology—adjusted (4) 255,814 241,324 215,140 Revenue enablement—adjusted (5) 120,088 113,508 99,638 General corporate and administrative—adjusted (6) 69,641 62,985 58,349 Other segment items (7) 145,819 198,358 104,144 Amortization expense 80,768 98,035 97,993 Depreciation expense 42,809 36,793 27,898 Interest expense 64,608 63,577 38,990 Interest income ( 12,203 ) ( 16,252 ) ( 908 ) Significant non-cash items (8) ( 9,145 ) 20,839 ( 31,736 ) Income tax provision 13,074 5,524 11,456 Total segment expenses 913,560 956,449 744,042 Net income (loss) including non-controlling interest $ 31,240 $ ( 90,071 ) $ 38,406 1 Represents revenue from an insignificant segment that does not meet the quantitative thresholds for determining reportable segments. 2 Data licenses and royalties – adjusted expenses include third party costs for data licensing and royalty fees. Data licenses and royalties – adjusted excludes stock-based compensation expense and related employer payroll tax and contract termination costs. 3 Customer services – adjusted expenses include the costs to deliver services to customers, including software configuration, integration and implementation services and customer support activities. Customer services – adjusted excludes stock-based compensation expense and related employer payroll tax. 4 Products and technology – adjusted expenses include costs related to the engineering, product management design and development of the Company’s solutions, and costs related to the Company’s hosting environments, support of production infrastructure, support of internal systems and infrastructure and IT security. Products and technology – adjusted excludes stock-based compensation expense and related employer payroll tax and contract termination costs. 5 Revenue enablement – adjusted expenses include costs for sales and marketing functions, including sales incentives, advertising costs, and event costs. Revenue enablement – adjusted excludes stock-based compensation expense and related employer payroll tax. 6 General corporate and administrative – adjusted expenses include costs for our executive management and administrative employees, including finance and accounting, human resources, facilities and legal functions. Additional expenses include professional service fees, insurance premiums and other corporate expenses that are not allocated to the other adjusted expense categories. General corporate and administrative – adjusted excludes stock-based compensation expense and related employer payroll tax, litigation costs in which the Company is the plaintiff and related antitrust matters, costs associated with the acquisition and integration of completed and potential mergers and acquisitions, costs related to equity transactions, including secondary offerings, lease abandonment charges, lease overlap costs for the incremental expenses associated with the Company’s new corporate headquarters prior to termination of its then existing headquarters and changes in the fair value of contingent consideration. 7 Other segment items include those items excluded from the significant segment expense categories and identified in the above descriptions, adjustments for capitalized labor costs incurred on internal development projects, and expenses of an insignificant segment, including impairment charges, that does not meet the quantitative thresholds for determining reporting segments. 8 Significant non-cash items include changes in fair value of derivative instruments and changes in fair value of warrant liabilities.
Schedule of revenues by geographic area	Revenues by geographic area presented based upon the location of the customer are as follows (in thousands): Year Ended December 31, 2024 2023 2022 United States $ 938,031 $ 859,548 $ 774,697 China 6,769 6,830 7,751 Total revenues $ 944,800 $ 866,378 $ 782,448
Schedule of software, equipment and property, net by geographic area	Software, equipment and property, net by geographic area are as follows (in thousands): December 31, 2024 2023 United States $ 171,864 $ 160,064 China 215 352 Total software, equipment and property-net $ 172,079 $ 160,416

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Additional Information (Detail) - USD ($)	1 Months Ended	12 Months Ended
	May 31, 2023	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Accounting Policies [Line Items]
Advertising Expense		$ 2,000,000	$ 1,500,000	$ 1,100,000
Goodwill, Impairment Loss		0	77,405,000	0
Impairment of intangible assets		$ 0	4,906,000	0
Impairment of intangible assets, finite lived				$ 0
China [Member]
Accounting Policies [Line Items]
Goodwill, Impairment Loss	$ 77,400,000		77,400,000
Impairment of intangible assets			$ 5,300,000
Technology Company [Member]
Accounting Policies [Line Items]
Equity Method Investment, Ownership Percentage		7%
Customer Concentration Risk [Member] \| Revenue Benchmark [Member] \| No Single Customer [member]
Accounting Policies [Line Items]
Concentration Risk, Percentage		10%	10%	10%
Customer Concentration Risk [Member] \| Accounts Receivable [Member] \| Customer One [Member]
Accounting Policies [Line Items]
Concentration Risk, Percentage		11%
Customer Concentration Risk [Member] \| Accounts Receivable [Member] \| No Single Customer [member]
Accounting Policies [Line Items]
Concentration Risk, Percentage			10%

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Summary of Property Plant Equipment Estimated Useful Life (Detail)	Dec. 31, 2024
Computer Equipment [Member]
Accounting Policies [Line Items]
Property, Plant and Equipment, Useful Life	3 years
Furniture and Fixtures [Member]
Accounting Policies [Line Items]
Property, Plant and Equipment, Useful Life	5 years
Database [Member]
Accounting Policies [Line Items]
Property, Plant and Equipment, Useful Life	25 years
Building [Member]
Accounting Policies [Line Items]
Property, Plant and Equipment, Useful Life	39 years
Leasehold Improvements [Member]
Accounting Policies [Line Items]
Property, Plant, and Equipment, Useful Life, Term, Description [Extensible Enumeration]	us-gaap:UsefulLifeShorterOfTermOfLeaseOrAssetUtilityMember
Land [Member]
Accounting Policies [Line Items]
Property, Plant, and Equipment, Useful Life, Term, Description [Extensible Enumeration]	us-gaap:UsefulLifeShorterOfTermOfLeaseOrAssetUtilityMember
Maximum [Member] \| Software and Licenses [Member]
Accounting Policies [Line Items]
Property, Plant and Equipment, Useful Life	5 years
Minimum [Member] \| Software and Licenses [Member]
Accounting Policies [Line Items]
Property, Plant and Equipment, Useful Life	2 years

Business Acquisition - Addition

Business Acquisition - Additional Information (Detail) - USD ($) $ in Thousands		12 Months Ended
	Feb. 08, 2022	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Business Acquisition [Line Items]
Deferred tax liabilities				$ 900
Transaction costs		$ 8,700
SafekeepInc [Member]
Business Acquisition [Line Items]
Total purchase price	$ 32,300		$ 32,500
Escrow deposit disbursements related to property acquisition	6,000
Fair value of contingent consideration	200
Fair value of consideration transferred	32,500
Deferred tax liabilities	$ 548
Transaction costs				$ 1,200
Estimated useful life		7 years
Maximum [Member]
Business Acquisition [Line Items]
Business acquisition potential earn out amount		$ 90,000

Business Acquisition - Schedule

Business Acquisition - Schedule of Business Acquisition by Acquisition (Details) - USD ($) $ in Thousands		12 Months Ended
	Feb. 08, 2022	Dec. 31, 2023	Dec. 31, 2024
Business Acquisition [Line Items]
Fair value of contingent earnout consideration		$ 100	$ 0
SafekeepInc [Member]
Business Acquisition [Line Items]
Cash paid through closing	$ 32,300
Fair value of contingent earnout consideration	200
Total acquisition date fair value of the consideration transferred	$ 32,300	$ 32,500

Business Acquisition - Schedu_2

Business Acquisition - Schedule of Recognized Identified Assets Acquired and Liabilities Assumed (Details) - USD ($) $ in Thousands		12 Months Ended
	Feb. 08, 2022	Dec. 31, 2023	Dec. 31, 2022
Business Acquisition [Line Items]
Deferred tax liabilities			$ 900
SafekeepInc [Member]
Business Acquisition [Line Items]
Current assets	$ 150
Intangible asset-acquired technology	4,800
Total assets acquired	4,950
Current liabilities	147
Deferred tax liabilities	548
Total liabilities assumed	695
Net assets acquired	4,255
Goodwill	28,245
Total purchase price	$ 32,300	$ 32,500

Revenue - Summarizes Revenue by

Revenue - Summarizes Revenue by Type of Services (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Contract With Customer Asset And Liability [Line Items]
Revenue from Contract with Customer, Including Assessed Tax	$ 944,800	$ 866,378	$ 782,448
Software Subscriptions [Member]
Contract With Customer Asset And Liability [Line Items]
Revenue from Contract with Customer, Including Assessed Tax	906,464	830,117	752,505
Other Services [Member]
Contract With Customer Asset And Liability [Line Items]
Revenue from Contract with Customer, Including Assessed Tax	$ 38,336	$ 36,261	$ 29,943

Revenue - Additional Informatio

Revenue - Additional Information (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Contract with Customer, Contract Asset, Contract Liability, and Receivable [Abstract]
Revenue remaining performance obligation amount	$ 1,492
Revenue remaining performance obligation revenue to be recognized year	662
Revenue remaining performance obligation revenue to be recognized thereafter	830
Deferred revenue, revenue recognized	$ 42.4	$ 35.1	$ 31

Revenue - Summary of Receivable

Revenue - Summary of Receivables Contract Assets and Contract Liabilities from Contracts with Customers (Detail) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Contract with Customer, Contract Asset, Contract Liability, and Receivable [Abstract]
Accounts receivables-Net of allowances	$ 106,578	$ 102,365	$ 98,353
Deferred contract costs	22,373	17,900	16,556
Deferred contract costs-non-current	18,692	22,302	20,161
Other assets (accounts receivable, non-current)	16,946	15,198	16,437
Deferred revenues	44,915	43,567	35,239
Other liabilities (deferred revenues, non-current)	$ 1,415	$ 1,373	$ 1,240

Revenue - Summary of Deferred C

Revenue - Summary of Deferred Contract Costs (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Capitalized Contract Cost [Abstract]
Balance at beginning of period	$ 40,202	$ 36,717	$ 37,186
Costs amortized	(22,085)	(19,197)	(17,986)
Additional amounts deferred	22,948	22,682	17,517
Balance at end of period	41,065	40,202	36,717
Classified as:
Current	22,373	17,900	16,556
Non-current	18,692	22,302	20,161
Total deferred contract costs	$ 41,065	$ 40,202	$ 36,717

Revenue - Summary of Deferred R

Revenue - Summary of Deferred Revenue (Detail) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Change in Contract with Customer, Liability [Abstract]
Balance at beginning of period		$ 44,940	$ 36,479	$ 32,616
Revenue recognized	[1]	(494,598)	(434,197)	(380,977)
Additional amounts deferred	[1]	495,988	442,658	384,840
Balance at end of period		46,330	44,940	36,479
Classified as:
Current		44,915	43,567	35,239
Non-current		1,415	1,373	1,240
Total deferred revenue		$ 46,330	$ 44,940	$ 36,479

[1] 1 Amounts include total revenue deferred and recognized during each respective period.

Fair Value Measurements - Addit

Fair Value Measurements - Additional Information (Detail) - USD ($)		12 Months Ended
	May 09, 2024	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Discount rate		10%
Fair Value Adjustment of Warrants		$ (14,378,000)	$ 15,096,000	$ (26,073,000)
Asset Impairment Charges		0		$ 0
Fair Value, Recurring [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Derivative Liability			51,601,000
Derivative Asset		975,000
Contingent consideration related to business acquisition [Member] \| Fair Value, Recurring [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Derivative Liability		$ 100,000	$ 100,000
Private Warrants [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Warrants outstanding	0	0	17,800,000
Fair Value Adjustment of Warrants	$ 2.09		$ 2.89
Private Warrants [Member] \| Fair Value, Recurring [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Derivative Liability			51,501,000
Interest Rate Cap [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Derivative Asset		$ 1,000,000	6,200,000
Interest Rate Cap [Member] \| Fair Value, Recurring [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Derivative Asset		$ 975,000	$ 6,208,000

Fair Value Measurements - Fair

Fair Value Measurements - Fair Value Measurement Inputs and Valuation Techniques (Details) - Private Warrants [Member]	May 09, 2024 yr	Dec. 31, 2023 yr
Expected Term (in years) [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative Liability, Measurement Input	2.2	2.6
Expected Volatility [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative Liability, Measurement Input	0.31	0.34
Expected Dividend Yield [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative Liability, Measurement Input	0	0
Risk-free Interest Rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative Liability, Measurement Input	0.048	0.041

Fair Value Measurements - Summa

Fair Value Measurements - Summary of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Detail) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Interest Rate Cap [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Asset	$ 1,000	$ 6,200
Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Asset	975
Derivative Liability		$ 51,601
Fair Value, Recurring [Member] \| Contingent consideration related to business acquisition [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability, Statement of Financial Position [Extensible Enumeration]		Other Liabilities, Noncurrent
Derivative Liability	100	$ 100
Fair Value, Recurring [Member] \| Interest Rate Cap [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Asset	975	$ 6,208
Fair Value, Recurring [Member] \| Private Warrants [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability, Statement of Financial Position [Extensible Enumeration]		Other Liabilities, Noncurrent
Derivative Liability		$ 51,501
Fair Value, Recurring [Member] \| Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Asset	0
Derivative Liability		0
Fair Value, Recurring [Member] \| Level 1 \| Contingent consideration related to business acquisition [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability		0
Fair Value, Recurring [Member] \| Level 1 \| Interest Rate Cap [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Asset	0	0
Fair Value, Recurring [Member] \| Level 1 \| Private Warrants [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability		0
Fair Value, Recurring [Member] \| Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Asset	975
Derivative Liability		51,501
Fair Value, Recurring [Member] \| Level 2 \| Contingent consideration related to business acquisition [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability		0
Fair Value, Recurring [Member] \| Level 2 \| Interest Rate Cap [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Asset	$ 975	$ 6,208
Derivative Asset, Statement of Financial Position [Extensible Enumeration]	Other Assets, Noncurrent	Other Assets, Noncurrent
Fair Value, Recurring [Member] \| Level 2 \| Private Warrants [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability		$ 51,501
Fair Value, Recurring [Member] \| Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Asset	$ 0
Derivative Liability		100
Fair Value, Recurring [Member] \| Level 3 \| Contingent consideration related to business acquisition [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability		100
Fair Value, Recurring [Member] \| Level 3 \| Interest Rate Cap [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Asset	$ 0	0
Fair Value, Recurring [Member] \| Level 3 \| Private Warrants [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Liability		$ 0

Fair Value Measurements - Sum_2

Fair Value Measurements - Summary of Carrying Amounts and Estimated Fair Value of the Financial Instruments (Detail) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Debt Instrument [Line Items]
Long-term debt		$ 776,000
Carrying Amount [Member]
Debt Instrument [Line Items]
Long-term debt	$ 774,825	782,564
Estimated Fair Value [Member]
Debt Instrument [Line Items]
Long-term debt	$ 776,970	$ 784,000

Income Taxes - Schedule of Comp

Income Taxes - Schedule of Components of Pretax Income (Loss) Attributable to Domestic and Foreign Operations (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest [Abstract]
Domestic	$ 46,557	$ (80,486)	$ 54,799
Foreign	(2,243)	(4,061)	(4,937)
PRETAX INCOME (LOSS)	$ 44,314	$ (84,547)	$ 49,862

Income Taxes - Schedule of Co_2

Income Taxes - Schedule of Components of Income Tax Provision (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Current provision :
Federal	$ 38,378	$ 41,804	$ 37,470
State	5,217	10,053	8,387
Total current provision	43,595	51,857	45,857
Deferred provision (benefit):
Federal	(24,566)	(36,253)	(26,570)
State	(5,955)	(10,080)	(7,831)
Foreign	115	(502)	1,054
Change in valuation allowance	(115)	502	(1,054)
Total deferred benefit	(30,521)	(46,333)	(34,401)
Total income tax provision	$ 13,074	$ 5,524	$ 11,456

Income Taxes - Summary of Effec

Income Taxes - Summary of Effective Income Tax Rate Differs From The Federal Statutory Rate (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Income Tax Expense (Benefit), Effective Income Tax Rate Reconciliation, Amount [Abstract]
Federal income tax provision (benefit) at statutory rate	$ 9,306	$ (17,755)	$ 10,471
Executive compensation	20,788	12,555	12,508
Stock-based compensation	(11,386)	(3,844)	(4,074)
Research and experimentation credit	(6,950)	(6,920)	(3,510)
Fair value of warrants	(3,019)	3,170	(5,475)
Goodwill impairment	0	16,255	0
Impact of foreign operations	653	1,794	2,807
Valuation allowance	(115)	502	(1,054)
State and local taxes-net of federal income tax effect	(583)	(22)	439
Other nondeductible expenses	2,195	836	344
Uncertain tax positions	926	396	(303)
Foreign rate difference	(67)	(164)	(182)
Other—net	1,326	(1,279)	(515)
Total income tax provision	$ 13,074	$ 5,524	$ 11,456
Federal income tax provision (benefit) at statutory rate	21%	21%	21%
Executive compensation	46.90%	(14.80%)	25%
Stock-based compensation	(25.70%)	4.50%	(8.10%)
Research and experimentation credit	(15.70%)	8.20%	(7.00%)
Fair value of warrants	(6.80%)	(3.70%)	(11.00%)
Goodwill impairment	0%	(19.20%)	0%
Impact of foreign operations	1.50%	(2.10%)	5.60%
Valuation allowance	(0.30%)	(0.60%)	(2.10%)
State and local taxes-net of federal income tax effect	(1.30%)	0%	0.90%
Other nondeductible expenses	5%	(1.00%)	0.70%
Uncertain tax positions	2.10%	(0.50%)	(0.60%)
Foreign rate difference	(0.20%)	0.20%	(0.40%)
Other-net	3%	1.50%	(1.00%)
Income tax provision	29.50%	(6.50%)	23%

Income Taxes - Schedule of Defe

Income Taxes - Schedule of Deferred Income Tax Assets and Liabilities (Detail) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Deferred income tax assets:
Stock-based compensation	$ 35,539	$ 36,329
Capitalized R&E- net of amortization	43,083	26,082
Operating lease liabilities	13,142	13,751
Net operating losses—foreign	10,468	10,875
Accrued compensation	8,203	10,373
Sales allowances and doubtful accounts	1,160	1,393
Research and experimental credit	785	373
Net operating losses—domestic (state)	0	479
Other	1,563	775
Total deferred income tax assets	113,943	100,430
Valuation allowance for deferred tax asset	(10,468)	(10,875)
Net deferred income tax assets	103,475	89,555
Deferred income tax liabilities:
Intangible asset amortization	234,362	255,572
Software, equipment and property depreciation and amortization	16,813	11,541
Deferred contract costs	10,149	10,044
Operating lease assets	6,995	7,078
Interest rate cap	0	685
Total deferred income tax liabilities	268,319	284,920
Net deferred income tax liabilities	$ 164,844	$ 195,365

Income Taxes - Schedule of Chan

Income Taxes - Schedule of Change in Unrecognised Tax Benefits Excluding Interest and Penalties (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Unrecognized Tax Benefits [Roll Forward]
Balance at beginning of year	$ 4,415	$ 3,723
Additions based on tax positions related to the current year	1,700	1,062
Additions based on adjustments to tax positions related to prior years	862	527
Reductions based on adjustments to tax positions related to prior years	(221)
Reductions as a result of a lapse of statutes of limitations	(564)	(897)
Balance at end of year	$ 6,192	$ 4,415

Income Taxes - Summary of Major

Income Taxes - Summary of Major Jurisdictions Subject to Examination by the relevant Tax Auhtorities and Open Tax Years (Detail)	12 Months Ended
	Dec. 31, 2024
Maximum [Member] \| UNITED STATES \| Domestic Tax Jurisdiction [Member]
Income Tax Contingency [Line Items]
Open Tax Year	2023
Maximum [Member] \| UNITED STATES \| State and Local Jurisdiction [Member]
Income Tax Contingency [Line Items]
Open Tax Year	2023
Maximum [Member] \| CHINA \| Foreign Tax Jurisdiction [Member]
Income Tax Contingency [Line Items]
Open Tax Year	2023
Maximum [Member] \| CANADA \| Foreign Tax Jurisdiction [Member]
Income Tax Contingency [Line Items]
Open Tax Year	2023
Minimum [Member] \| UNITED STATES \| Domestic Tax Jurisdiction [Member]
Income Tax Contingency [Line Items]
Open Tax Year	2021
Minimum [Member] \| UNITED STATES \| State and Local Jurisdiction [Member]
Income Tax Contingency [Line Items]
Open Tax Year	2021
Minimum [Member] \| CHINA \| Foreign Tax Jurisdiction [Member]
Income Tax Contingency [Line Items]
Open Tax Year	2021
Minimum [Member] \| CANADA \| Foreign Tax Jurisdiction [Member]
Income Tax Contingency [Line Items]
Open Tax Year	2021

Income Taxes - Additional Infor

Income Taxes - Additional Information (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Income Tax Disclosure [Line Items]
Income tax payment	$ 51.1	$ 43	$ 55.7
Percentage of valuation allowance equal to income tax benefit	100%	100%
Maximum [Member]
Income Tax Disclosure [Line Items]
Operating Loss Carryforwards Expiration Period	2029
Minimum [Member]
Income Tax Disclosure [Line Items]
Operating Loss Carryforwards Expiration Period	2025
Foreign Tax Jurisdiction [Member]
Income Tax Disclosure [Line Items]
Valuation allowance increase decrease	$ (0.4)	$ 0.5	$ (1)
Operating Loss Carryforwards, Valuation Allowance	$ 10.5	$ 10.9

Accounts Receivable - Schedule

Accounts Receivable - Schedule of Accounts Receivable, Net (Detail) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Receivables [Abstract]
Accounts receivable	$ 111,270	$ 107,939
Allowance for credit losses and sales reserves	(4,692)	(5,574)	$ (5,339)	$ (3,791)
Accounts receivable--Net	$ 106,578	$ 102,365

Accounts Receivable - Schedul_2

Accounts Receivable - Schedule of Changes to the Allowance for Credit Losses and Sales Reserves (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Receivables [Abstract]
Balance at beginning of period	$ 5,574	$ 5,339	$ 3,791
Charges to bad debt and sales reserves	4,272	7,079	4,262
Write-offs, net	(5,154)	(6,844)	(2,714)
Balance at end of period	$ 4,692	$ 5,574	$ 5,339

Other Current Assets - Schedule

Other Current Assets - Schedule of Other Current Assets (Detail) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Prepaid Expense and Other Assets, Current [Abstract]
Prepaid SaaS costs	$ 9,112	$ 7,833
Prepaid service fees	7,352	5,992
Prepaid insurance	2,561	2,289
Prepaid software and equipment maintenance	673	5,547
Other	9,275	10,703
Total other current assets	$ 28,973	$ 32,364

Software, Equipment, and Prop_3

Software, Equipment, and Property - Schedule of Software,Equipment and Property (Detail) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Property, Plant and Equipment [Line Items]
Total software, equipment, and property	$ 331,355	$ 285,418
Less accumulated depreciation and amortization	(159,276)	(125,002)
Net software, equipment, and property	172,079	160,416
Software, Licenses and Database [Member]
Property, Plant and Equipment [Line Items]
Total software, equipment, and property	275,127	220,625
Computer Equipment [Member]
Property, Plant and Equipment [Line Items]
Total software, equipment, and property	18,993	27,467
Leasehold Improvements [Member]
Property, Plant and Equipment [Line Items]
Total software, equipment, and property	30,993	31,046
Building and Land [Member]
Property, Plant and Equipment [Line Items]
Total software, equipment, and property	4,910	4,910
Furniture and Other Equipment [Member]
Property, Plant and Equipment [Line Items]
Total software, equipment, and property	$ 1,332	$ 1,370

Software, Equipment, and Prop_4

Software, Equipment, and Property - Additional Information (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Property, Plant and Equipment [Abstract]
Depreciation and amortization expense	$ 42.9	$ 36.9	$ 27.9

Leases - Additional Information

Leases - Additional Information (Detail) - USD ($) $ in Thousands	1 Months Ended	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2022	Dec. 31, 2024	Dec. 31, 2023
Leases [Line Items]
Operating Lease, Right-of-Use Asset			$ 29,762	$ 30,456
Operating Lease, Liability			$ 54,893
Lease termination fee		$ 3,800
Loss on lease termination		$ (3,100)
Lessee, Operating Lease, Description	In December 2022, the Company terminated a corporate office lease which otherwise would have expired in March 2026.
General and Administrative Expense [Member]
Leases [Line Items]
Loss on lease termination	$ (3,100)
Corporate Office [Member]
Leases [Line Items]
Lease termination fee	$ 3,800
Maximum [Member] \| Office Space and Data Center Facilities [Member]
Leases [Line Items]
Operating lease term			17 years
Operating lease term extension			5 years
Maximum [Member] \| Equipment Leases [Member]
Leases [Line Items]
Operating lease term			3 years
Minimum [Member] \| Office Space and Data Center Facilities [Member]
Leases [Line Items]
Operating lease term			2 years
Operating lease term extension			3 years
Minimum [Member] \| Equipment Leases [Member]
Leases [Line Items]
Operating lease term			1 year

Leases - Summary of Lease Cost

Leases - Summary of Lease Cost (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Leases [Line Items]
Operating lease costs	$ 6,396	$ 5,958	$ 12,390
Variable lease costs	4,112	3,497	2,319
Total lease costs	$ 10,508	$ 9,455	$ 14,709

Leases - Summary of Supplementa

Leases - Summary of Supplemental Cash Flow and Other Information Related to Leases (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Leases [Line Items]
Weighted-average remaining lease term (years)	11 years 10 months 24 days	12 years 10 months 24 days	13 years 7 months 6 days
Weighted-average discount rate	6.50%	6.50%	6.40%
Cash payments for operating leases	$ 8,146	$ 5,706	$ 11,933
Operating lease assets obtained in exchange for lease liabilities	$ 1,792	$ 0	$ 2,825

Leases - Summary of Operating L

Leases - Summary of Operating Lease Liabilities (Detail) $ in Thousands	Dec. 31, 2024 USD ($)
Leases [Line Items]
2025	$ 7,869
2026	7,370
2027	5,576
2028	6,323
2029	6,108
Thereafter	44,894
Total lease payments	78,140
Less: Interest	(23,247)
Total	$ 54,893

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets - Additional Information (Detail) - USD ($)	1 Months Ended	12 Months Ended
	May 31, 2023	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Goodwill And Intangible Assets Disclosure [Line Items]
Goodwill impairment		$ 0	$ 77,405,000	$ 0
GOODWILL		1,417,724,000	1,417,724,000	1,495,129,000
Impairment charge		0	4,906,000	0
Amortization of Intangible Assets		71,768,000	71,972,000	72,278,000
Subsidiaries [Member]
Goodwill And Intangible Assets Disclosure [Line Items]
Goodwill impairment				0
GOODWILL				0
Amortization of Intangible Assets		$ 80,800,000	98,400,000	$ 99,200,000
China [Member]
Goodwill And Intangible Assets Disclosure [Line Items]
Goodwill impairment	$ 77,400,000		77,400,000
Percentage of weighted average cost of capital		12.50%
GOODWILL			0
Impairment charge			$ 5,300,000

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets - Schedule of Gross Amount, Accumulated Impairment Loss, and Carrying Amount of Goodwill (Detail) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Gross Amount	$ 1,520,926	$ 1,520,926
Accumulated Impairment Loss	(103,202)	(103,202)
Net Carrying Amount	$ 1,417,724	$ 1,417,724	$ 1,495,129

Goodwill and Intangible Asset_4

Goodwill and Intangible Assets - Schedule of Changes in the Carrying Amount of Goodwill (Detail) - USD ($)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Goodwill [Line Items]
Carrying Amount	$ 1,417,724,000	$ 1,417,724,000	$ 1,495,129,000
Impairment	$ 0	$ (77,405,000)	$ 0

Goodwill and Intangible Asset_5

Goodwill and Intangible Assets - Summary of Intangible Assets Balance (Detail) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Schedule Of Intangible Assets [Line Items]
Gross Carrying Amount	$ 1,296,630	$ 1,476,470
Accumulated Amortization	(552,822)	(651,894)
Net Carrying Amount	743,808	824,576
Intangible assets, Gross Carrying Amount	1,487,100	1,666,940
Intangible assets, Net Carrying Amount	934,278	1,015,046
Intangible Assets Accumulated Amortization	(552,822)	(651,894)
Trademarks [Member]
Schedule Of Intangible Assets [Line Items]
Indefinite life intangible assets	190,470	190,470
Intangible assets, Net Carrying Amount	$ 190,470	$ 190,470
Customer Relationships [Member]
Schedule Of Intangible Assets [Line Items]
Weighted- Average Remaining Useful Life (Years)	10 years 3 months 18 days	11 years 3 months 18 days
Gross Carrying Amount	$ 1,291,830	$ 1,291,830
Accumulated Amortization	(550,822)	(479,054)
Net Carrying Amount	$ 741,008	$ 812,776
Acquired Technologies [Member]
Schedule Of Intangible Assets [Line Items]
Weighted- Average Remaining Useful Life (Years)	4 years 1 month 6 days	1 year 8 months 12 days
Gross Carrying Amount	$ 4,800	$ 184,640
Accumulated Amortization	(2,000)	(172,840)
Net Carrying Amount	$ 2,800	$ 11,800
Subsidiaries [Member] \| Customer Relationships [Member]
Schedule Of Intangible Assets [Line Items]
Estimated Useful Life (Years)	18 years
Subsidiaries [Member] \| Customer Relationships [Member] \| Maximum [Member]
Schedule Of Intangible Assets [Line Items]
Estimated Useful Life (Years)		18 years
Subsidiaries [Member] \| Customer Relationships [Member] \| Minimum [Member]
Schedule Of Intangible Assets [Line Items]
Estimated Useful Life (Years)		16 years
Subsidiaries [Member] \| Acquired Technologies [Member]
Schedule Of Intangible Assets [Line Items]
Estimated Useful Life (Years)	7 years
Subsidiaries [Member] \| Acquired Technologies [Member] \| Maximum [Member]
Schedule Of Intangible Assets [Line Items]
Estimated Useful Life (Years)		7 years
Subsidiaries [Member] \| Acquired Technologies [Member] \| Minimum [Member]
Schedule Of Intangible Assets [Line Items]
Estimated Useful Life (Years)		3 years

Goodwill and Intangible Asset_6

Goodwill and Intangible Assets - Schedule of Future Amortization Expense for Intangible Assets (Detail) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Finite Lived Intangible Assets Future Amortization Expense [Line Items]
2025	$ 72,454
2026	72,454
2027	72,454
2028	72,454
2029	71,825
Thereafter	382,167
Total	$ 743,808	$ 824,576

Equity Method Investment - Addi

Equity Method Investment - Additional Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Schedule of Equity Method Investments [Line Items]
Equity Method Investments	$ 10,228	$ 10,228
Technology Company [Member]
Schedule of Equity Method Investments [Line Items]
Equity Method Investment, Ownership Percentage	7%
Subsidiaries [Member] \| Technology Company [Member]
Schedule of Equity Method Investments [Line Items]
Purchase of equity method investment	$ 10,200

Accrued Expenses - Schedule of

Accrued Expenses - Schedule of Accrued Expenses (Detail) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Accrued Liabilities, Current [Abstract]
Compensation	$ 47,505	$ 54,593
Professional services	6,260	2,183
Royalties and licenses	5,116	4,381
Software license agreements	4,613	2,233
Sales tax	3,620	2,968
Employee insurance benefits	2,235	2,572
Other	3,194	2,548
Total accrued expenses	$ 72,543	$ 71,478

Other Liabilities - Summary of

Other Liabilities - Summary of other Liabilities (Detail) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Other Liabilities, Noncurrent [Abstract]
Income taxes payable-non-current	$ 6,344	$ 3,937
Software license agreements	3,544	1,004
Deferred revenue-non-current	1,415	1,373
Contingent consideration	0	100
Total	$ 11,303	$ 6,414

Long-Term Debt - Additional Inf

Long-Term Debt - Additional Information (Detail)	1 Months Ended	12 Months Ended
Long-Term Debt - Additional Information (Detail)	Aug. 31, 2022 USD ($)	Dec. 31, 2024 USD ($)	Dec. 31, 2023 USD ($)	Dec. 31, 2022 USD ($)	Jun. 22, 2028 USD ($)
Debt Instrument [Line Items]
Debt instrument, unamortized discount		$ 1,175,000	$ 1,436,000	$ 1,669,000
Debt issuance costs, net		7,580,000	8,732,000	$ 10,485,000
Long-term debt			776,000,000
Long-Term Debt, Current Maturities		$ 8,000,000	8,000,000
Fed Funds Effective Rate Overnight Index Swap Rate [Member]
Debt Instrument [Line Items]
Debt instrument basis spread on variable rate		0.50%
LIBOR [Member]
Debt Instrument [Line Items]
Debt instrument basis spread on variable rate		1%
Interest Rate Cap [Member]
Debt Instrument [Line Items]
Derivative Asset		$ 1,000,000	6,200,000
Cash received on interest rate cap agreement		7,200,000	$ 6,500,000
Derivative, Notional Amount	$ 600,000,000
Derivative, cap interest rate	4%
Debt Instrument, Maturity Date	Jul. 31, 2025
Two Thousand and Twenty one Credit Agreement [Member]
Debt Instrument [Line Items]
Proceeds from issuance of long-term debt		$ 798,000,000
Percentage of annual excess cash flow on line of credit		50%
Line of credit facility, maximum borrowing capacity		$ 75,000,000
Percentage of aggregate commitments on borrowings		35%
Leverage ratio		0.035	0.035
Two Thousand and Twenty one Credit Agreement [Member] \| SOFR [Member]
Debt Instrument [Line Items]
Weighted average interest rate of debt outstanding		0.25%
Term Loan [Member] \| SOFR [Member]
Debt Instrument [Line Items]
Long term debt floor rate percentage		0.50%
Term Loan [Member] \| LIBOR [Member]
Debt Instrument [Line Items]
Long term debt floor rate percentage		0.50%
Maximum [Member] \| Two Thousand and Twenty one Credit Agreement [Member]
Debt Instrument [Line Items]
Leverage ratio		0.0625
Minimum [Member] \| Two Thousand and Twenty one Credit Agreement [Member]
Debt Instrument [Line Items]
Leverage ratio			0.01
Standby Letters of Credit [Member] \| Two Thousand and Twenty one Credit Agreement [Member]
Debt Instrument [Line Items]
Line of Credit Facility, Current Borrowing Capacity		$ 700,000
Term B Loan [Member] \| Two Thousand and Twenty one Credit Agreement [Member]
Debt Instrument [Line Items]
Long-term line of credit		800,000,000
Debt instrument, unamortized discount		2,000,000
Debt issuance costs, net		9,800,000
Line of credit facility, periodic payment, principal		2,000,000
Debt instrument, annual principal payment		0	$ 0
Long-term debt		776,000,000	784,000,000
Long-Term Debt, Current Maturities		$ 8,000,000	$ 8,000,000
Line of Credit Facility, Commitment Fee Percentage		0.50%
Weighted average interest rate of debt outstanding		7.60%	7.50%	4.20%
Term B Loan [Member] \| Two Thousand and Twenty one Credit Agreement [Member] \| Forecast [Member]
Debt Instrument [Line Items]
Long-term debt					$ 234,000,000
Term B Loan [Member] \| Two Thousand and Twenty one Credit Agreement [Member] \| Second Amendment [Member]
Debt Instrument [Line Items]
Debt issuance costs, net		$ 700,000
Term B Loan [Member] \| Maximum [Member] \| Two Thousand and Twenty one Credit Agreement [Member]
Debt Instrument [Line Items]
Line of credit facility, expiration period		6 years 1 month 9 days
Term B Loan [Member] \| Minimum [Member] \| Two Thousand and Twenty one Credit Agreement [Member]
Debt Instrument [Line Items]
Line of credit facility, expiration period		6 years 10 months 24 days
Two Thousand and Twenty one Revolving Credit Facility [Member] \| Second Lien Credit Agreement [Member]
Debt Instrument [Line Items]
Debt issuance costs, net		$ 1,700,000	$ 1,700,000
Two Thousand and Twenty one Revolving Credit Facility [Member] \| Two Thousand and Twenty one Credit Agreement [Member]
Debt Instrument [Line Items]
Long-term line of credit		250,000,000
Debt issuance costs, net		3,100,000
Line of Credit Facility, Current Borrowing Capacity		$ 249,300,000	$ 249,300,000
Revolving Credit Facility [Member] \| Eurodollar [Member]
Debt Instrument [Line Items]
Debt instrument basis spread on variable rate		1%
Revolving Credit Facility [Member] \| SOFR [Member]
Debt Instrument [Line Items]
Long term debt floor rate percentage		0%
Revolving Credit Facility [Member] \| LIBOR [Member]
Debt Instrument [Line Items]
Debt instrument basis spread on variable rate		1.50%
Long term debt floor rate percentage		0%

Long-Term Debt - Summary of Lon

Long-Term Debt - Summary of Long Term Debt (Detail) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Debt Instrument [Line Items]
Long-term debt—discount	$ (1,175)	$ (1,436)	$ (1,669)
Long-term debt—deferred financing fees	(7,580)	(8,732)	$ (10,485)
Long-term debt-net of discount & fees		776,000
Less: Current portion	(8,000)	(8,000)
Total long-term debt-net of current portion	761,053	767,504
Term B Loan [Member]
Debt Instrument [Line Items]
Long-term debt, gross	776,000	784,000
Long-term debt—discount	(1,175)	(1,436)
Long-term debt—deferred financing fees	(5,772)	(7,060)
Long-term debt-net of discount & fees	$ 769,053	$ 775,504

Long-Term Debt - Summary of Deb

Long-Term Debt - Summary of Debt Deferred Financing Fees and Discount (Detail) - USD ($)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Debt Issuance Costs, Net [Abstract]
Deferred Financing Fees, Beginning balance	$ 8,732,000	$ 10,485,000
Payment of fees associated with revolver modification	719
Amortization of fees and discount	(1,871,000)	(1,753,000)	$ (1,878,000)
Deferred Financing Fees, Ending balance	7,580,000	8,732,000	10,485,000
Debt Instrument, Unamortized Discount [Abstract]
Discount (contra debt), Beginning balance	1,436,000	1,669,000
Amortization of fees and discount	(261,000)	(233,000)	(257,000)
Discount (contra debt), Ending balance	$ 1,175,000	$ 1,436,000	$ 1,669,000

Long-Term Debt - Summary of Agg

Long-Term Debt - Summary of Aggregate Maturities of Our Long-Term Debt (Detail) $ in Thousands	Dec. 31, 2023 USD ($)
Debt Instrument [Line Items]
2025	$ 8,000
2026	8,000
2027	8,000
2028	8,000
2029	744,000
Long-term debt-net of discount & fees	$ 776,000

Long-Term Licensing Agreement -

Long-Term Licensing Agreement - Additional Information (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2018	Dec. 31, 2021
LongTerm Licensing Agreement [Line Items]
Contract with customer, liability	$ 46,330	$ 44,940	$ 36,479		$ 32,616
Debt instrument, unamortized discount	1,175	1,436	1,669
Licensing Agreement [Member]
LongTerm Licensing Agreement [Line Items]
Effective interest rate during the period				6.25%
Line of credit facility, annual principal payment				$ 1,200
Contract with customer, liability	27,700	30,800		45,600
Debt issuance costs, current	3,300	3,100		$ 23,200
Interest expense, debt	1,900	2,000	$ 2,200
Debt instrument, unamortized discount	$ 6,700	$ 8,600

Long-Term Licensing Agreement_2

Long-Term Licensing Agreement - Summary Of Principal Amounts Due In Each Of The Next Five Years (Detail) $ in Thousands	Dec. 31, 2024 USD ($)
LongTerm Licensing Agreement [Line Items]
2025	$ 48,904
2026	48,362
2027	65,714
2028	9,945
2029	9,900
Thereafter	19,800
Total	202,625
Subsidiaries [Member]
LongTerm Licensing Agreement [Line Items]
2025	3,257
2026	3,466
2027	3,689
2028	3,926
2029	4,177
Thereafter	9,177
Total	$ 27,692

Redeemable Non-Controlling In_3

Redeemable Non-Controlling Interest - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Millions		1 Months Ended	12 Months Ended
	Mar. 12, 2020	Nov. 30, 2023	Dec. 31, 2024	Dec. 31, 2023
Noncontrolling Interest [Line Items]
Stock issued during period, shares, new issues		65,000,000	171,500,000
Percentage of compound interest per annum on the preferred share issue price	10%
Series A Preferred Stock [Member] \| CCC Cayman [Member]
Noncontrolling Interest [Line Items]
Stock issued during period, shares, new issues	1,818
Shares issued, price per share	$ 7,854
Stock issued during period, value, new issues	$ 14.2
Percentage of shares reserved for issuance under employee incentive plan			8.60%	8.60%
Preferred stock, dividend rate, percentage			8%
Series A Preferred Stock [Member] \| CCC Cayman [Member] \| Ownership Interest [Member]
Noncontrolling Interest [Line Items]
Ownership percentage by noncontrolling owners			10%	10%

Redeemable Non-controlling In_4

Redeemable Non-controlling Interest - Schedule of activities impacting the redeemable non-controllable interest (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Noncontrolling Interest [Abstract]
Redeemable Non-Controlling Interest, Beginning balance	$ 16,584	$ 14,179	$ 14,179
Accretion of redeemable non-controlling interest	5,095	2,405	0
Redeemable Non-Controlling Interest, Ending balance	$ 21,679	$ 16,584	$ 14,179

Capital Stock - Additional Info

Capital Stock - Additional Information (Detail) - USD ($)	1 Months Ended	12 Months Ended
Capital Stock - Additional Information (Detail) - USD ($)	Nov. 30, 2023	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Class of Stock [Line Items]
Shares authorized total		5,000,000,000
Common stock par or stated value per share		$ 0.0001	$ 0.0001
Common stock shares issued		629,207,115	603,128,781
Issuance of common stock, Shares	65,000,000	171,500,000
Common stock shares outstanding		629,207,115	603,128,781
Purchase of shares	4,875,000
Repurchase and retirement of common stock			$ 328,453,000
Payments for Repurchase of Initial Public Offering			$ 2,000,000
Proceeds from issuance of common stock		$ 0
Stock issued during the period shares stock options exercised		12,427,044	8,923,718	10,081,164
Preferred stock shares issued		0	0
Preferred stock shares outstanding		0	0
Preferred stock shares authorised		100,000,000	100,000,000
Preferred stock par or stated value per share		$ 0.0001	$ 0.0001
Common stock shares description of voting rights		one
Number of trading days used to determine the share price		20 days
Number of consecutive trading days used to determine the share price		30 days
Secondary Offering [Member]
Class of Stock [Line Items]
Issuance of common stock, Shares				20,000,000
Cost incurred		$ 1,900,000
Repurchase and retirement of common stock, Shares		32,500,000
Purchase of shares			32,500,000
Repurchase and retirement of common stock		$ 328,500,000
Payments for Repurchase of Initial Public Offering				$ 1,200,000
Proceeds from issuance of common stock				$ 0
Common Stock [Member]
Class of Stock [Line Items]
Repurchase and retirement of common stock, Shares			32,500,000
Repurchase and retirement of common stock			$ 3,000
Company Earnout Shares [Member]
Class of Stock [Line Items]
Common stock shares issued		0
Issuance of common stock, Shares		15,000,000
Common stock shares outstanding		0
Share Price Greater Than Or Equal to USD Thirteen Per Share [Member] \| Company Earnout Shares [Member]
Class of Stock [Line Items]
Share price		$ 13
Share Price Greater Than or Equal to Usd Fifteen Per Share [Member] \| Company Earnout Shares [Member]
Class of Stock [Line Items]
Share price		$ 15
Number of trading days used to determine the share price		20 days
Number of consecutive trading days used to determine the share price		30 days
Share Repurchase Program [Member]
Class of Stock [Line Items]
Repurchase and retirement of common stock, Shares		300,000,000
No of shares outstanding		300,000,000
Repurchased of shares		0
Sponsor Vesting Shares [Member]
Class of Stock [Line Items]
Number of shares non transferable and subject to forfeiture		8,625,000
Common Class A [Member]
Class of Stock [Line Items]
Common stock par or stated value per share		$ 0.0001

Employee Benefit Plans - Additi

Employee Benefit Plans - Additional Information (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
CCC 401(k) Retirement Savings and Investment Plan [Member]
Defined Benefit Plan Disclosure [Line Items]
Defined contribution plan cost	$ 7	$ 6.5	$ 6.1

Stock Incentive Plans - Additio

Stock Incentive Plans - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Millions		12 Months Ended
	Oct. 31, 2021	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number		22,539,617
Share based compensation by share based award options excercised shares issued net of tax witholding obligation		12,427,044	8,923,718	10,074,354
Share based compensation by share based arrangement options vested during the period aggregate fair value		$ 2.2
Share based compensation by share based arrangement unrecognised compensation for options unvested		$ 34.2
Share based compensation by share based arrangement unrecognised compensation for options unvested remaining period for recognition		1 year 1 month 6 days
Common stock reserved for issuance		140,469,578	126,550,986
Modifications to the performance-based RSUs		(i) the extension of the performance period by one year, (ii) a change to the performance criteria, (iii) a change to the number of units to be issued depending on performance and (iv) for certain grants, imposing a maximum number of units to be issued depending on performance equal to 100% of the target.
Percentage of number of units to be issued depending on performance		100%
Number of trading days used to determine the share price		20 days
Number of consecutive trading days used to determine the share price		30 days
Common Stock [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross				10,081,164
Shares Paid For Tax Witholding For Share Based Compensation				6,810
Two Thousand and Twenty One Equity Incentive Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Common stock reserved for issuance		36,187,726
Common stock shares reserved for future issuance increase on the first day of fiscal year by number of shares percentage of total number of shares of common stock outstanding		5%
Ccc2021 Employee Stock Purchase Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Common stock reserved for issuance		12,062,991	6,031,287
Increase of Common Stock reserved under ESPP		6,031,287
Number of shares sold under plan		608,891	641,691	408,879
Ccc2021 Employee Stock Purchase Plan [Member] \| Maximum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Percentage Of Rate Of Payroll Deduction Of Compensation Of Eligible Employees	15%
Ccc2021 Employee Stock Purchase Plan [Member] \| Minimum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Percentage Of Rate Of Payroll Deduction Of Compensation Of Eligible Employees	1%
Threshold Percentage Of Lessor Of The Fair Market Value Of Common Stock To Purchase Price Of Shares Of Common Stock Purchased Under Plan	85%
Aggregate Number Of Shares Reserved For Sale Under Plan Increases On Beginning Of Period Percentage Of Total Number Of Shares Outstanding Or Lessor Amount		1%
Cayman Equity Incentive Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized		3,000,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross		761,743	539,400	1,303,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number		2,363,514	1,735,900
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number		0	0
Employee Stock Option
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Common stock reserved for issuance		23,349,505	35,788,469
Company Earnout Shares [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of additional shares		13,500,000	1,500,000
Restricted Stock Units R S U [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share based compensation by share based arrangement equity instruments other than options granted during the period		10,538,732	12,574,115	16,426,878
Common stock reserved for issuance		31,042,552	36,329,881
Incremental stock-based compensation expense		$ 67
Restricted Stock Units R S U [Member] \| Performance And Market Based Vesting Conditions [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share based compensation by share based arrangement equity instruments other than options granted during the period				783,896
Restricted Stock Units R S U [Member] \| Time Based Vesting Requirements [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share based compensation by share based arrangement equity instruments other than options granted during the period		8,266,649	10,946,224	14,859,033
Restricted Stock Units R S U [Member] \| Performance Based Vesting Requirements [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share based compensation by share based arrangement equity instruments other than options granted during the period		2,272,083	1,627,891	783,949
Common Class B [Member] \| Performance And Market Based Vesting Conditions [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share based compensation by share based arrangement unrecognised compensation for options unvested remaining period for recognition		2 years 4 months 24 days
Common Class B [Member] \| Time Based Vesting [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share based compensation by share based arrangement unrecognised compensation for options unvested		$ 159
Share Price Greater Than or Equal to Usd Fifteen Per Share [Member] \| Company Earnout Shares [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share price		$ 15
Number of trading days used to determine the share price		20 days
Number of consecutive trading days used to determine the share price		30 days

Stock Incentive Plans - Summary

Stock Incentive Plans - Summary Of Shares Of Common Stock Reserved For Future Issuance under the Plan (Detail) - shares	Dec. 31, 2024	Dec. 31, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Common Stock, Capital Shares Reserved for Future Issuance	140,469,578	126,550,986
Employee Stock Option
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Common Stock, Capital Shares Reserved for Future Issuance	23,349,505	35,788,469
Restricted Stock Units R S U [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Common Stock, Capital Shares Reserved for Future Issuance	31,042,552	36,329,881
Restricted Stock Units Available For Future Grant [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Common Stock, Capital Shares Reserved for Future Issuance	75,673,991	49,451,502
Reserved For Employee Stock Purchase Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Common Stock, Capital Shares Reserved for Future Issuance	10,403,530	4,981,134

Stock Incentive Plans - Summa_2

Stock Incentive Plans - Summary Of Restricted stock units Activity (Detail) - Restricted Stock Units (RSUs) [Member] - $ / shares	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Non-vested RSUs - Begining Balance	36,329,881	31,288,688	18,558,211
Granted	10,538,732	12,574,115	16,426,878
Vested	(14,232,526)	(5,707,373)	(2,324,324)
Canceled	(1,593,535)	(1,825,549)	(1,372,077)
Non-vested RSUs - Ending Balance	31,042,552	36,329,881	31,288,688
Non-vested RSUs - Begining Balance	$ 10.56	$ 10.34	$ 10.74
Granted	11.8	9.01	10.07
Vested	10.76	10.57	11.22
Canceled	10.68	9.9	10.93
Non-vested RSUs - Ending Balance	$ 10.92	$ 10.56	$ 10.34

Stock Incentive Plans - Summa_3

Stock Incentive Plans - Summary of Share-based Compensation Arrangements by Share-based Payment Award (Detail) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Shares - Beginning Balance	35,788,469	45,249,260	55,644,495
Shares - Exercised	(12,427,044)	(8,923,718)	(10,081,164)
Shares - Forfeited and canceled	(11,920)	(537,073)	(314,071)
Shares - Ending Balance	23,349,505	35,788,469	45,249,260	55,644,495
Shares - Exercisable	22,539,617
Shares - Vested and expected to vest	23,333,942
Weighted- Average Exercise Price - Beginning Balance	$ 2.96	$ 2.99	$ 2.95
Weighted- Average Exercise Price - Exercised	2.69	2.85	2.74
Weighted- Average Exercise Price - Forfeited and canceled	3.4	6.88	4.46
Weighted- Average Exercise Price - Ending Balance	3.11	$ 2.96	$ 2.99	$ 2.95
Weighted- Average Exercise Price - Exercisable	2.97
Weighted- Average Exercise Price - Vested and expected to vest	$ 3.11
Weighted-Average Remaining Contractual Life (in years)	3 years 2 months 12 days	4 years	4 years 10 months 24 days	6 years
Weighted-Average Remaining Contractual Life (in years) - Exercisable	3 years 1 month 6 days
Weighted-Average Remaining Contractual Life (in years) - Vested and expected to vest	3 years 1 month 6 days
Aggregate Intrinsic Value - Beginning Balance	$ 301,563	$ 258,470	$ 469,591
Aggregate Intrinsic Value - Ending Balance	201,305	$ 301,563	$ 258,470	$ 469,591
Aggregate Intrinsic Value - Exercisable	197,353
Aggregate Intrinsic Value - Vested and expected to vest	$ 201,237

Stock Incentive Plans - Schedul

Stock Incentive Plans - Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions (Detail)	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Expected term (in years)			2 years 9 months 18 days
Expected volatility			35%
Expected volatility, minimum		28%
Expected volatility, maximum		32%
Expected dividend yield		0%	0%
Risk-free interest rate			2.28%
Risk-free interest rate minimum		4.36%
Risk-free interest rate maximum		4.87%
Maximum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Expected term (in years)		2 years 1 month 6 days
Minimum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Expected term (in years)		1 year 1 month 6 days
2021 Employee Stock Purchase Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Expected term (in years)	6 months	6 months	6 months
Expected volatility			47%
Expected dividend yield	0%	0%	0%
Risk-free interest rate			0.20%
2021 Employee Stock Purchase Plan [Member] \| Maximum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Expected volatility	29%	51%
Risk-free interest rate	5.50%	4.70%
2021 Employee Stock Purchase Plan [Member] \| Minimum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Expected volatility	25%	30%
Risk-free interest rate	5.20%	2.50%
Cayman Equity Incentive Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Expected term (in years)			6 years 3 months
Expected volatility	40%	40%	40%
Expected dividend yield	0%	0%	0%
Risk-free interest rate	4.40%	3.80%	3.50%
Cayman Equity Incentive Plan [Member] \| Maximum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Expected term (in years)	5 years 5 months 1 day	5 years 5 months 1 day
Cayman Equity Incentive Plan [Member] \| Minimum [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Expected term (in years)	4 years 3 months	5 years 3 months

Stock Incentive Plans - Summa_4

Stock Incentive Plans - Summary of Share-based Payment Arrangement, Expensed and Capitalized, Amount (Detail) - Cypress Holdings Inc And Subsidiaries [Member] - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Share-Based Payment Arrangement, Expense	$ 171,038	$ 144,518	$ 109,497
Cost of Revenues [Member]
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Share-Based Payment Arrangement, Expense	9,342	8,802	5,812
Research and development [Member]
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Share-Based Payment Arrangement, Expense	47,191	25,467	19,536
Sales and marketing [Member]
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Share-Based Payment Arrangement, Expense	28,083	33,204	25,309
General and administrative [Member]
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Share-Based Payment Arrangement, Expense	$ 86,422	$ 77,045	$ 58,840

Commitments - Additional Inform

Commitments - Additional Information (Detail)	12 Months Ended
Commitments - Additional Information (Detail)	Dec. 31, 2024
Long Term Purchasing Agreement Relating To Licensing Data Used [Member]
Other Commitments [Line Items]
Long term purchase commitment month of expiry	2031

Commitments - Schedule of Contr

Commitments - Schedule of Contractual Obligation Fiscal Year Maturity (Detail) $ in Thousands	Dec. 31, 2024 USD ($)
Commitments and Contingencies Disclosure [Abstract]
2025	$ 48,904
2026	48,362
2027	65,714
2028	9,945
2029	9,900
Thereafter	19,800
Total	$ 202,625

Warrants - Additional Informati

Warrants - Additional Information (Detail) - USD ($)		12 Months Ended
Warrants - Additional Information (Detail) - USD ($)	May 09, 2024	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Class of Warrant or Right [Line Items]
Exercise price		$ 11.5
Warrants expire date		Jul. 30, 2026
Change in fair value of warrant liabilities		$ 14,378,000	$ (15,096,000)	$ 26,073,000
Warrant liabilities		$ 0	$ 51,501,000
Private Warrants [Member]
Class of Warrant or Right [Line Items]
Warrants outstanding	0	0	17,800,000
Class of warrant or right number of securities called by each warrant or right	0.214
Change in fair value of warrant liabilities	$ (2.09)		$ (2.89)
Aggregate common stock share	3,809,200

Warrants - Summary of the Priva

Warrants - Summary of the Private Warrants Valued On the Redemption Date Using the Black-Scholes Option Pricing Model (Details) - Private Warrants [Member]	May 09, 2024 yr	Dec. 31, 2023 yr
Expected Term (in years) [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative Liability, Measurement Input	2.2	2.6
Expected Volatility [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative Liability, Measurement Input	0.31	0.34
Expected Dividend Yield [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative Liability, Measurement Input	0	0
Risk-free Interest Rate [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Derivative Liability, Measurement Input	0.048	0.041

Related Parties - Additional In

Related Parties - Additional Information (Detail) - USD ($) $ in Thousands	1 Months Ended	12 Months Ended
	Nov. 30, 2023	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Shares repurchased during period	4,875,000
Revenues		$ 944,800	$ 866,378	$ 782,448
Technology Company [Member]
Equity Method Investment, Ownership Percentage		7%
Related Party [Member] \| Employee Health Insurance Benefits Expenses [Member]
Payables		$ 300	$ 500
Secondary Offering [Member]
Shares repurchased during period			32,500,000
Aggregate price of shares repurchased			$ 328,500

Related Parties - Schedule of R

Related Parties - Schedule of Revenues, Expenses and Amount Receivable with Entities Affiliated with Principal Owners (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Related Party Transaction [Line Items]
Total Revenue	$ 944,800	$ 866,378	$ 782,448
Related Party [Member] \| IT development software [Member]
Related Party Transaction [Line Items]
Expenses		130
Related Party [Member] \| IT security software [Member]
Related Party Transaction [Line Items]
Expenses	510
Credit Card Processing [Member] \| Related Party [Member]
Related Party Transaction [Line Items]
Total Revenue	1,382	1,051	811
Employee Health Insurance Benefits [Member] \| Related Party [Member]
Related Party Transaction [Line Items]
Expenses	4,202	3,641	3,166
Payables	300	500
Human Resource Support Services [Member] \| Related Party [Member]
Related Party Transaction [Line Items]
Expenses		313	237
Board of Director Fees for Services Including Related Travel and Out-of-Pocket Reimbursements [Member] \| Related Party [Member]
Related Party Transaction [Line Items]
Expenses	$ 275	$ 306	131
Sales tax processing and license fees for tax information [Member] \| Related Party [Member]
Related Party Transaction [Line Items]
Expenses			$ 561

Other Income-Net - Schedule of

Other Income-Net - Schedule of Other Income-Net (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Other Income, Nonoperating [Abstract]
(Loss) gain from change in fair value of derivative instruments	$ (5,233)	$ (5,743)	$ 5,663
Income from derivative instruments	7,167	6,460	0
Other income-net	302	1,082	699
Total other income-net	$ 2,236	$ 1,799	$ 6,362

Net Income (Loss) Per Share - A

Net Income (Loss) Per Share - Additional Information (Detail) - shares	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]
Antidilutive securities excluded from the computation of earnings per share	200,000	33,700,000	8,100,000
Sponsor Vesting Shares [Member]
Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Line Items]
Weighted Average Number of Shares Outstanding, Diluted, Adjustment	8,625,000	8,625,000	8,625,000

Net Income (Loss) Per Share - S

Net Income (Loss) Per Share - Schedule Of Earnings Per Share, Basic and Diluted (Detail) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Numerator
Net income (loss)	$ 31,240	$ (90,071)	$ 38,406
Accretion of redeemable non-controlling interest	(5,095)	(2,405)	0
Net income (loss) attributable to common stockholders	$ 26,145	$ (92,476)	$ 38,406
Denominator
Weighted average shares of common stock - basic	610,761,424	617,889,384	607,760,886
Dilutive effect of stock-based awards	$ 31,114,101	$ 0	$ 35,080,710
Weighted average shares of common stock - diluted	641,875,525	617,889,384	642,841,596
Net income (loss) per share attributable to common stockholders:
Basic	$ 0.04	$ (0.15)	$ 0.06
Diluted	$ 0.04	$ (0.15)	$ 0.06

Segment Information And Infor_3

Segment Information And Information About Geographic Areas - Additional Information (Detail)	12 Months Ended
	Dec. 31, 2024 Segment
Revenues from External Customers and Long-Lived Assets [Line Items]
Segment Reporting, CODM, Individual Title and Position or Group Name [Extensible Enumeration]	srt:ChiefExecutiveOfficerMember
Segment Reporting, CODM, Profit (Loss) Measure, How Used, Description	The CODM uses net income to evaluate income generated from operations in deciding whether to reinvest profits into the Domestic Segment or use for acquisitions, to pay dividends or repurchase outstanding shares of common stock
Domestic Segment [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Number of reportable segments	1

Segment Information And Infor_4

Segment Information And Information About Geographic Areas - Schedule of Segment Revenue, Significant Segment Expenses, and Reconciliation of The Company (Details) - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Revenues:
Total Revenue		$ 944,800	$ 866,378	$ 782,448
Segment Expenses:
Interest expense		64,608	63,577	38,990
Interest income		(12,203)	(16,252)	(908)
Income tax provision		13,074	5,524	11,456
Total operating expenses		633,698	660,084	516,587
Net Income (Loss)		31,240	(90,071)	38,406
Operating Segments [Member]
Segment Expenses:
Data licenses and royalties - adjusted	[1]	43,698	40,957	39,837
Customer services - adjusted	[2]	98,589	90,801	83,241
Products and technology - adjusted	[3]	255,814	241,324	215,140
Revenue enablement - adjusted	[4]	120,088	113,508	99,638
General corporate and administrative - adjusted	[5]	69,641	62,985	58,349
Other segment items	[6]	145,819	198,358	104,144
Amortization expense		80,768	98,035	97,993
Depreciation expense		42,809	36,793	27,898
Interest expense		64,608	63,577	38,990
Interest income		(12,203)	(16,252)	(908)
Significant non-cash items	[7]	(9,145)	20,839	(31,736)
Income tax provision		13,074	5,524	11,456
Total operating expenses		913,560	956,449	744,042
Net Income (Loss)		31,240	(90,071)	38,406
Domestic Segment [Member]
Revenues:
Total Revenue		938,031	859,548	774,697
Other [Member]
Revenues:
Total Revenue	[8]	$ 6,769	$ 6,830	$ 7,751

[1] Data licenses and royalties – adjusted expenses include third party costs for data licensing and royalty fees. Data licenses and royalties – adjusted excludes stock-based compensation expense and related employer payroll tax and contract termination costs. Customer services – adjusted expenses include the costs to deliver services to customers, including software configuration, integration and implementation services and customer support activities. Customer services – adjusted excludes stock-based compensation expense and related employer payroll tax. Products and technology – adjusted expenses include costs related to the engineering, product management design and development of the Company’s solutions, and costs related to the Company’s hosting environments, support of production infrastructure, support of internal systems and infrastructure and IT security. Products and technology – adjusted excludes stock-based compensation expense and related employer payroll tax and contract termination costs. Revenue enablement – adjusted expenses include costs for sales and marketing functions, including sales incentives, advertising costs, and event costs. Revenue enablement – adjusted excludes stock-based compensation expense and related employer payroll tax. General corporate and administrative – adjusted expenses include costs for our executive management and administrative employees, including finance and accounting, human resources, facilities and legal functions. Additional expenses include professional service fees, insurance premiums and other corporate expenses that are not allocated to the other adjusted expense categories. General corporate and administrative – adjusted excludes stock-based compensation expense and related employer payroll tax, litigation costs in which the Company is the plaintiff and related antitrust matters, costs associated with the acquisition and integration of completed and potential mergers and acquisitions, costs related to equity transactions, including secondary offerings, lease abandonment charges, lease overlap costs for the incremental expenses associated with the Company’s new corporate headquarters prior to termination of its then existing headquarters and changes in the fair value of contingent consideration. Other segment items include those items excluded from the significant segment expense categories and identified in the above descriptions, adjustments for capitalized labor costs incurred on internal development projects, and expenses of an insignificant segment, including impairment charges, that does not meet the quantitative thresholds for determining reporting segments. Significant non-cash items include changes in fair value of derivative instruments and changes in fair value of warrant liabilities. Represents revenue from an insignificant segment that does not meet the quantitative thresholds for determining reportable segments.

Segment Information And Infor_5

Segment Information And Information About Geographic Areas - Schedule of Revenues by Geographic Area (Detail) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Revenues from External Customers and Long-Lived Assets [Line Items]
Total revenues	$ 944,800	$ 866,378	$ 782,448
United States [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue from Contract with Customer By Geographic Area	938,031	859,548	774,697
China [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Revenue from Contract with Customer By Geographic Area	$ 6,769	$ 6,830	$ 7,751

Segment Information And Infor_6

Segment Information And Information About Geographic Areas - Schedule of Software, Equipment and Property, Net by Geographic Area (Detail) - USD ($) $ in Thousands	Dec. 31, 2024	Dec. 31, 2023
Revenues from External Customers and Long-Lived Assets [Line Items]
Net software, equipment, and property	$ 172,079	$ 160,416
United States [Member] \| Property Plant And Equipment Net [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Long-Lived Assets	171,864	160,064
China [Member] \| Property Plant And Equipment Net [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Long-Lived Assets	$ 215	$ 352

Gain on Sale of Cost Method I_2

Gain on Sale of Cost Method Investment - Additional Information (Detail) - USD ($) $ in Millions	1 Months Ended	12 Months Ended
	Feb. 28, 2022	Dec. 31, 2022	Dec. 31, 2021
Statement of Cash Flows [Abstract]
Proceeds from sale of equity method investments	$ 3.9
Cost method investments recognized gains		$ 3.6
Cost method investments carrying value			$ 0.3

Subsequent Events - Additional

Subsequent Events - Additional Information (Details) - USD ($) $ in Thousands			1 Months Ended	12 Months Ended
	Mar. 31, 2025	Jan. 06, 2025	Feb. 28, 2025	Dec. 31, 2024	Jan. 23, 2025	Dec. 31, 2023
Subsequent Event [Line Items]
Acquisition related expenses				$ 8,700
Long-term debt						$ 776,000
Common stock shares issued				629,207,115		603,128,781
Secondary Offering [Member]
Subsequent Event [Line Items]
Cost incurred				$ 1,900
Subsequent Event [Member]
Subsequent Event [Line Items]
Term loan aggregate principal amount		$ 225,000			$ 225,000
Debt instrument payment terms discription		Long-Term Debt and Refinancing—In conjunction with the acquisition of EvolutionIQ, the Company entered into the third amendment to the 2021 Credit Agreement that provided the Company with an Incremental Term Loan for $225 million. Prior to the Fourth Amendment (as defined below) the Incremental Term Loan was repayable in quarterly installments in an amount equal to 0.25% of the original principal amount, with the balance payable at maturity, September 21, 2028.
Subsequent Event [Member] \| Interest Rate Swap [Member]
Subsequent Event [Line Items]
Derivative, Notional Amount			$ 500,000
Average fixed interest rate			4%
Debt Instrument, Maturity Date			Jul. 31, 2027
Subsequent Event [Member] \| BaseRate [Member] \| Moody's, Ba3 Rating [Member]
Subsequent Event [Line Items]
Interest Rate Effective Percentage					0.75%
Subsequent Event [Member] \| BaseRate [Member] \| Moody's,Below Ba3 Rating [Member]
Subsequent Event [Line Items]
Interest Rate Effective Percentage					1%
Subsequent Event [Member] \| SOFR [Member] \| Moody's, Ba3 Rating [Member]
Subsequent Event [Line Items]
Interest Rate Effective Percentage					1.75%
Subsequent Event [Member] \| SOFR [Member] \| Moody's,Below Ba3 Rating [Member]
Subsequent Event [Line Items]
Interest Rate Effective Percentage					2%
Term Loan [Member] \| Forecast [Member]
Subsequent Event [Line Items]
Maturity Date	Jan. 23, 2032
Term Loan [Member] \| Subsequent Event [Member]
Subsequent Event [Line Items]
Maturity Date		Sep. 21, 2028
Repayable structure		quarterly
Term Loan [Member] \| Subsequent Event [Member] \| Two Thousand and Twenty one Credit Agreement [Member]
Subsequent Event [Line Items]
Long-term debt		$ 225,000
Evolution IQ [Member] \| Forecast [Member]
Subsequent Event [Line Items]
Incremental term loan repayable in quarterly installments percentage of the original principal Amount	0.25%
Evolution IQ [Member] \| Subsequent Event [Member]
Subsequent Event [Line Items]
Total purchase price		$ 730,000
Percentage of Consderation Payment in Cash		58.90%
Percentage of consderation payment in share		41.10%
Incremental term loan repayable in quarterly installments percentage of the original principal Amount		0.25%